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Abstract
Myelin is a unique lipid-enriched membrane, produced by oligodendrocytes in the
central nervous system, that is enwrapped around axons in the multilayered fashion
to ensure a swift saltatory conduction of the neuronal impulses.
Myelin has a unique composition. It is enriched in the cholesterol, sphingomyelin
and myelin lipids possess high number of long-chain fatty acids in their structure.
Previous results have shown that myelin basic protein (MBP) acts as a diffusion
barrier within myelin sheath, preventing the majority of the proteins to enter the
sheath region. Therefore, myelin sheaths are deprived of cytoplasm and proteins,
and do not contain cortical actin cytoskeleton. This specific composition raises the
question of how lipid diffusion might be affected in the myelin sheath.
We used primary oligodendrocyte culture as a well-established model to study
lipid diffusion in myelin sheath. To assess lipid diffusion modes, we used STED-FCS
(stimulated emission depletion microscopy combined with fluorescence correlation
spectroscopy). We showed that artificial analogs of phosphatidylethanolamine, sph-
ingomyelin and galactosylcerebroside (PE, SM and GalC, respectively) introduced
into the cellular membrane, have a faster diffusion within oligodendrocytes, when
compared to the diffusion within control membrane of the fibroblasts cell line (PtK2
cells). Moreover, we could show a complete absence of trapping for SM and a de-
crease in the trapping for GalC in the membrane of oligodendrocytes. Additionally,
using a model of the reconstituted oligodendrocyte sheets in PtK2 cells, we could
demonstrate that MBP presence is sufficient to reorganize cellular membrane and
change the mode of the lipids behaviour, from trapping to the free diffusion.
In the second project we addressed the question of the polarised distribution
of phosphatidylinositols in oligodendrocyte membrane. We could demonstrate a
distribution of PIP2 and PIP3 into two distinct cellular regions: sheets for PIP2 and
outer rim and processes for PIP3. We showed that MBP interacts with PIP2 in the
sheets and masks it from antibody staining, but not with PIP3 in the processes.
Furthermore, we found that oligodendrocytes are highly susceptible to the changes
in the PIP3 levels: upon its augmentation the size of non-compact domains within
oligodendrocytes increased. We found that an increase of actin accompanied an with
enlargement of the non-compact regions. We speculate that this augmentation of the
filamentous actin is a reason that would prevent MBP from zipping the non-compact
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1.1 Myelin origin in CNS: oligodendrocytes
Myelin is a lipid-rich membrane structure, spirally wrapped around axons, insu-
lating them from the extracellular environment. The term myelin has been intro-
duced by Virchow in the early 50-ties of the 19th century (Virchow, 1854). Myelin
is produced by oligodendrocytes in the central nervous system (CNS) and by the
Schwann cells in the peripheral nervous system (PNS). These cells send their cellular
extensions (processes) to the neuronal axons and engulf them with special mem-
brane structures – sheaths, formed upon the contact of every process with an axon
(Peters, 1964). The ensheathment of the axons enables the speed saltatory conduc-
tion of the neuronal impulses, axon survival and maintenance (Hartline & Colman,
2007). Myelin takes up 40–50% of dry weight in the central nervous system. Due
to its low density, it is fairly easy to fractionate it by sucrose gradient centrifugation
to study separated fraction further with biochemical methods (Norton & Poduslo,
1973). Moreover, studies of the myelin biogenesis, molecular structure and develop-
ment are facilitated by possibility to cultivate primary cultures of the myelinating
cells – oligodendrocytes. These cell cultures reproduce all essential morphological
counterparts (processes and sheets), and express full myelin protein profile upon
cultivation on the coverslips (Cole & Vel, 1993; Chen et al., 2007).
1.1 Myelin origin in CNS: oligodendrocytes
The term neuroglia first was proposed by Virchow, to describe cells other than
neurons (Virchow, 1854). After Cajal and Hortega developed metallic impregnation
techniques for the microscopic studies, characterisation of the glial cells became easier
and more rapid. The term oligodendroglia was first introduced by Hortega (Baumann
& Pham-Dinh, 2001).
Oligodendrocytes are smaller than astrocytes, have greater density of cytoplasm
and nucleus; they also lack intermediate filaments and glycogen in their cytoplasm,
possessing, however, a large number of microtubules in their processes (Baumann &
Pham-Dinh, 2001). Each oligodendrocyte extends many processes that upon contact
with the neurons transform to the enwrapping sheath structures (Bunge, 1968).
Every oligodendrocyte is capable to myelinate up to 40 different axons. Moreover,
same axon may enwrap several oligodendrocytes (Baumann & Pham-Dinh, 2001).
1.1.1 Developmental characteristics of oligodendrocytes
Before being able to myelinate, oligodendrocytes undergo a long developmental
journey from migratory and mitotic precursors, via oligodendrocyte progenitors cells
(OPC) and finally transforming into mature postmitotic myelin-producing cells. On
every stage oligodendrocytes are characterised by different markers, summarised in
Table 1.1.
Maturation of oligodendro- and astroglia occurs in the early postnatal embryo
(Bradl & Lassmann, 2010). Medial ganglionic eminence and anterior entopeduncu-
lar area are the origins of the first wave of oligodendrocyte precursor cells (OPC)
formation in the forebrain. The second wave of OPCs derives from the lateral and/or
caudal ganglionic eminences and joins the first one. Both waves populate entire em-
bryonic telencephalon, including the cerebral cortex. The third wave comes from
postnatal cortex (Kessaris et al., 2006).
3
Introduction
Marker Developmental stage Comments Reference
A2B5 OPC recognises gangliosides GT3
and its O-acetylated deriva-
tive;
both are downregulated in
the mature oligodendrocyte
(Farrer & Quarles, 1999;
Dubois et al., 1990)








compact myelin (Baumann & Pham-Dinh,
2001)






MBP differentiated, mature oligo-
dendrocytes
compact myelin (Baumann & Pham-Dinh,
2001)
MAG differentiated, mature oligo-
dendrocytes
non-compact myelin (Schachner & Bartsch,
2000)
MOG differentiated, mature oligo-
dendrocytes




O1 OPC recognises galactocerebro-






O4 OPC, decreases in mature
oligodendrocytes
recognises sulfoglycolipids (Sommer & Schachner,
1981)
PLP OPC compact myelin; remains in
mature stage.
(Timsit et al., 1992)
Table 1.1: Markers for oligodendrocytes development.
Oligodendrocytes need to migrate a long way from their origin to enable a proper
coverage of the developing brain (Frost et al., 1996). Since oligodendrocytes loose
they migration ability upon maturation, it is crucial to prevent their premature
differentiation. This is achieved via the Notch pathway activation (Wang et al.,
1998). Several migratory cues to guide oligodendrocytes on their way are described:
the chemokine CXCL1 (de Castro & Bribián, 2005), growth factors like PDGF,
FGF (Redwine et al., 1997; Spassky et al., 2001), and hepatocyte growth factor
(Yan & Rivkees, 2002); chemotropic molecules like netrins and secreted semaphorins
(Jarjour et al., 2003; Tsai, 2003). However, the exact molecular mechanism still
remains unknown (Bradl & Lassmann, 2010). After reaching their targeted location,
oligodendrocyte progenitors cells settle down along the nerve. At this stage cells
start to express the O4 marker (Sommer & Schachner, 1981), become less motile
(Baumann & Pham-Dinh, 2001) and loose their response to PDGF (Gao et al.,
1998). They form multiple processes and are able to proliferate.
Upon acquiring galactosylceramide (GalC) and loosing the expression of GD3
4
1.1 Myelin origin in CNS: oligodendrocytes
Figure 1.1: Schematic overview of the developmental stages of oligodendrocytes in
culture. (A) oligodendrocyte progenitor cells: possess only several non-branched processes; (B)
immature oligodendrocyte: number of processes increases and they become branched; (C) non-
myelinating oligodendrocyte: non-compacted myelin-like sheets begin to form in between branched
processes, filled with CNP (red); (D) myelinating (mature) oligodendrocyte: MBP (green) is ex-
pressed and fills the sheets, zipping them and squeezing CNP (red), along with other proteins, to
the margins of the cell (processes and the rim); in this way the functional and structural polarisa-
tion is achieved; (E) co-culture with neurons (blue): onset of the proper myelination upon contact
of the oligodendrocyte sheets with axons.
and A2B5 antigens on the cell surface, preoligodendrocytes become immature oligo-
dendrocytes (Reynolds & Wilkin, 1991). CNP is the first marker protein to be
expressed at this stage (Sprinkle, 1989; Reynolds & Wilkin, 1988). Myelin basic pro-
tein (MBP), myelin-associated glycoprotein (MAG) and proteolipid protein (PLP)
follow and signify by their appearance the terminal maturation stage of oligodendro-
cytes. Myelination starts shortly after (Figure 1.1) (Kamholz et al., 1988; Pfeiffer
et al., 1993).
The ability of oligodendrocyte progenitors to differentiate into oligodendrocytes is
independent from the presence of neurons (Temple & Raff, 1986). Cultures of oligo-
dendrocytes, derived from the newborn (P0) mice are able to create a myelin-like
membrane in the absence of axons, (Figure 3.1) (Baumann & Pham-Dinh, 2001).
Therefore, these cultures are a very useful tool to investigate myelin biogenesis and
development. This structural separation of mature oligodendrocytes into compact
sheets and non-compact processes leads to high functional polarisation of these cells:
compact domains recapitulate myelin in vivo and non-compact processes play a




Generation of the specific number of oligodendrocytes to successfully myelinate
a given amount of axons depends on the proliferative rate of oligodendrocyte pro-
genitors, level of programmed cell death that occurs during development and on
axon-to-oligodendrocyte signalling (Barres & Raff, 1999).
Axons with diameter above 0,2 µm are selected by oligodendrocytes for the myeli-
nation event (Simons & Trajkovic, 2006). The cues for this recognition in central
nervous system (CNS) are unknown, whereas in peripheral nervous system (PNS)
this signal comes from neuronal neuregulin-1 (NGR1) type III, interacting with ErbB
receptors on the Schwann cells (Vartanian et al., 1997).
Electrical activity of the neurons might play a signalling role for the oligoden-
drocytes to start myelination in CNS. The subsequent release of ATP and adenosine
due to the axonal firing can mediate neuro-glial communications. It was shown that
adenosine triphosphate (ATP) can inhibit OPC proliferation and stimulate their dif-
ferentiation and promote myelination (Bradl & Lassmann, 2010).
Myelination onset has a very short starting window: within 12 – 18 hours the first
wrapping events should be accomplished. Therefore, oligodendrocytes are capable
of the rapid synthesis of large membrane amounts, together with rapid translation
and trafficking of the proteins (Cahoy et al., 2008). Several features of oligodendro-
cyte protein machinery were described so far. Myelin basic protein, for instance, is
translated next to the myelin sheath. mRNA of MBP is transported within hnRNP
granules in there directly from the pericarion. This enables fast incorporation of
MBP in between the two membrane layers to zip the myelin sheath (Ainger et al.,
1997). Other major component of the myelin sheath, PLP/DM20, is delivered by
vesicular transport. Both processes are suggested to be under surveillance of the
neuronal signals (Bradl & Lassmann, 2010).
Almost all knowledge collected throughout decades about myelin biosynthesis and
oligodendrocyte development has been elucidated using rodents (rat and mice) as
model systems and further extrapolated to humans. However, there are several main
differences to be mentioned and to payed attention to when using such a simplified
approach (reviewed in: (Bradl & Lassmann, 2010)):
• Difference in the time of myelination: decades in human and weeks in mice,
due to the more simple organisation of the rodent.
• Even though the density of oligodendrocytes per mm3 is similar between ro-
dents and human, rodents have far less oligodendrocytes.
• Several brain regions have a different level of development. Neocortical regions
in humans are absent in mice, whereas the olfactory bulbs are underdeveloped
in humans, but highly advanced in rodents.
• Certain guiding factors have a different effect on the human and rodent OPCs
(Wilson et al., 2003; Zhang et al., 2000).
Nevertheless, studies of the rodent brain tissues and cultures of the primary cells
from the rodent brains (neurons and glia) have led to immense insight of functioning
and developing of the CNS.
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Figure 1.2: Schematic overview of the myelin architecture in vivo. (A) Longitudinal axes
of the axon (blue), nodes of Ranvier (light green) and myelin domains: paranode (red, juxtaparan-
ode (purple). (B) Myelin sheath in an unwrapped state (orange) with the corresponding domains:
axon in blue, node of Ranvier in green, paranode (PN) in red, juxtaparanode in purple. Arrowed
line shows direction to the oligodendrocyte body. Modified from (Salzer & James, 2003).
Apart from the myelin ensheathment, oligodendrocytes also influence the clus-
tering of sodium channels in the node of Ranvier (Kaplan, 1997). Moreover, oligo-
dendrocytes influence the axonal transport and viability, since any disturbances of
the myelination result in the axonal swellings, increased axonal diameter, changed
rates of the axonal transport and decrease in the microtubules number and stability
(Colello et al., 1994; Mason et al., 2001; Sánchez et al., 1996; Kirkpatrick et al.,
2001; Dupree et al., 1999).
1.2 Myelin structure
In the CNS each oligodendrocytes can enwrap up to 40 axons. The regions,
covered by the insulating myelin sheath are called internodes.
The adjacent internodes are separated by nodes of Ranvier – the myelin-free
regions (Figure 1.2). Here the axonal membrane (axolemma) is exposed to the ex-
tracellular milieu (Bunge, 1968). These regions contain a high density of Na+/K+
ATPases, Na+/Ca2+ exchangers and sodium and potassium channels, all together
allowing the generation of the action potential (Waxman & Ritchie, 1993). The
primary node, where the action potential is generated, is placed immediately after
the end of axonal body and is named – axon initiation segment (AIS). Upon
excitation of the membrane in this region, current can not flow through the myelin
insulating sheath. Thus, depolarisation of the membrane occurs only at the adjacent
node of Ranvier, leading to the speed saltatory conduction of the impulse. The term
saltatory conduction (from Latin saltare – to jump, to leap, to dance) was proposed
in 1952 by Hodgkin and Huxley (Hodgkin & Huxley, 1952).
The glial cells abruptly open at the inner and outer regions around the tightly
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compacted myelin, forming less compacted tongues: inner and outer – paranodal
loops (paranode) (Figure 1.2). These loops display a regular pattern on each side
of the node of Ranvier, weaving spirally around an axon and retaining glial cyto-
plasm. Each of these paranodal loops is tightly attached to the axolemma through
a septate-like junctions. Two complexes (Caspr/paranodin and contactin/F3) are
highly enriched in the paranodes from the axolemma site (Menegoz et al., 1997; Rios
et al., 2000), whereas glial part in this region contains a 155 kDa isoform of neu-
rofascin NF155. Contactin brings together two membranes via interaction with the
NF155, anchored in the glia membrane and a Caspr/paranodin from the axolemma
(Salzer & James, 2003).
The small innermost region following the paranode is called juxtaparanode.
Axolemma in these regions contains high number of K+-channels, whereas the glia
side harbours TAG-1 (transient axonal glycoprotein-1) (Poliak & Peles, 2003).
Adaxonal and abaxonal domains create the asymmetry along the radial axis
of myelin. Adaxonal region is an inner most non-compact layer of myelin that runs
parallel to the axon. It contains MAG and Necl4 (Quarles, 2007; Spiegel et al.,
2007). Abaxonal region is a small cytoplasmic part on the outside of the myelin
sheath. This outer most layer also lacks the compaction (Salzer & James, 2003).
For the schematic overview of the domains localisation (Figure 1.2).
1.3 Myelin lipid composition
Lipids are main components of the myelin, representing 80% of its dry weight.
Lipids within myelin tissues have a low turnover rate. Upon injection of radioactive
cholesterol label into mouse brain, grey matter got clear of it within several weeks;
radioactive signal from the myelin tissues, however, could be read after as long as a
year (O’Brien, 1965b).
Main functions of the lipid molecules within the animal cell are: to store the en-
ergy (triacylglycerols only) and to structure membrane. Furthermore, several type of
lipids are important signalling molecules (IP3, DAG), or they are involved in the pro-
tein tethering to the membrane (prenyl, farnesyl and other isopren residues) (Siegel,
2006). In addition, lysophospholipids and steroids modulate cellular metabolism
via interaction with receptors on the endoplasmatic reticulum and in the nucleus
(Bieberich, 2012).
Since myelin is deprived from triacylglycerols, storage function of the lipids in
this membrane is not of a great importance (Siegel, 2006). However, almost all main
classes of lipids are present within the myelin membrane: glycerolipids, cerebrosides
and cholesterol (Figure 1.3). Molar ratios of these classes in different parts of the
brain are summarised in Table 1.2.
Within myelin lipids play an insulating role to achieve a high resistance capacity
against electric impulses and provide their speed conduction along the nerves. More-
over, there are studies claiming that myelin galactolipids (galactosylcerebroside and
sulphatides) are involved in glycosynapse formation that guide a proper establish-
ment of the paranodal-axoglial junction by acting as ligands for axolemmal proteins
(Boggs et al., 2004; Boggs et al., 2010). Further functions of the myelin lipids are
discussed below in the corresponding subsections.
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Substance Myelin White matter Grey matter Whole brain
Human Rat Human Human Rat
Protein 30.0 29.5 39.0 55.3 56.9
Lipid 70.0 70.5 54.9 32.7 37.0
Cholesterol 27.7 27.3 27.5 22.0 23.0
Cerebroside 22.7 23.7 19.8 5.4 14.6
Sulfatide 3.8 7.1 5.4 1.7 4.8
Total galactolipid 27.5 31.5 26.4 7.3 21.3
Ethanolamine phosphatides 15.6 16.7 14.9 22.7 19.8
Phosphatidylcholine 11.2 11.3 12.8 26.7 22.0
Sphingomyelin 7.9 3.2 7.7 6.9 3.8
Phosphatidylserine 4.8 7.0 7.9 8.7 7.2
Phosphatidylinositol 0.6 1.2 0.9 2.7 2.4
Plasmalogens 12.3 14.1 11.2 8.8 11.6
Total phospholipid 43.1 44.0 45.9 69.5 57.6
Table 1.2: Comparison of the human and rat brain composition. Protein and lipid values
are given in percentage of the dry weight; everything else in total lipid weight percentage. Modified
from (Quarles, 2002).
1.3.1 Glycerolipids and glycerophospholipids
Glycerolipids are derivatives of the phosphatidic acid (PtdOH) and represent the
main entities of the lipid bilayer of any cell. Their backbone consists of a diacy-
lated sn-glycerol-3-phosphate, with sn referring to stereochemical numbering. Upon
esterification with fatty acids on the position sn-1 and sn-2, PtdOH yields a di-
acylglycerol (DAG). Fatty acids in sn-1 are usually saturated, whereas in sn-2 –
unsaturated. Moreover, there are sometimes differences in the linkage of the fatty
acids. There are lipid species with ether-linkage to an aliphatic alcohol, termed alkyl,
or to an unsaturated alcohol, termed alk-1’-enyl. The latter lipids are referred to as
plasmalogens (Siegel, 1998).
When DAG, produced from PtdOH, undergoes phosphodiester linkage in po-
sition sn-3 to a different bases (Table 1.3), it yields a broad range of the glyc-
erophospholipids: phosphatidylethanolamine, phosphatidylcholine, phosphatidylser-
ine, phosphatidylinositols and plasmalogens (Siegel, 1998). The amount and distri-
bution of these lipids differ between brain, white and grey matter (Table 1.2) (Wells
& Dittmer, 1967).
Apart from phosphotidylinositols (reviewed further), phospholipids are synthe-
sised on the cytoplasmic leaflet of the endoplasmatic reticulum (ER) and to the lesser
extent in the Golgi complex and inside mitochondria (phosphatidylethanolamine).
Catabolic processes of phospholipids degradation depend highly on the lipid species
and are often unique, however, several catabolic pathways are common. All glyc-
erophospholipids undergo a remodelling by phospholipase A isoform (PLA) that
breaks the bonds in position sn-1 or sn-2, releasing glycerol moiety and a fatty acid.
PLA1 removes 1-acyl chain and PLA2 releases 2-acyl chain from the phospholipid
backbone. Phospholipase B releases both fatty acids (Bohdanowicz & Grinstein,
2013).
The contribution of phospholipids to the cellular homeostasis and well-being is
enormous. They are involved in the membrane structuring and curvature changing;














CH2 CH2 N⊕H3 Phsophatidylethanolamine PE








CH2 HO Phosphatidylglycerol PtdGro
Phosphatidylglycerol (several) Cardiolipin PtdGroPtd
Table 1.3: Structure of glycerophospholipids. X and Y in the upper formula correspond to
a different ligands, mentioned further in the table.
to the membrane. Disregulation of phospholipid metabolism may be divided into
three groups, depending on the stage of the phospholipids metabolism disfunction:
synthesis, distribution and catabolism. Each stage is associated with several severe
disorders (Bohdanowicz & Grinstein, 2013).
Phosphatidylcholine
Phosphatidylcholine (PC) is a zwitterionic phospholipid with a choline residue as
a headgroup (Table 1.3). Apart of the choline head group, the glycerol backbone is
esterified with two additional fatty acids that could be greatly variable: one being
a saturated fatty acid (palmitic or hexadecanoic acid, margaric or heptadecanoic
acid) and one being an unsaturated fatty acid (oleic acid, or 9Z-octadecenoic acid)
(Bohdanowicz & Grinstein, 2013).
PC is a major component of biological membranes, comprising 45-55% of the
total lipids (Fernández-Murray, 2007). It is commonly found in the outer leaflet, as
a result of aminophospholipid depletion by the flippases (Figure 1.3) (Devaux, 1992).
To synthesise PC, choline phosphotransferase couples cytidine diphosphate (CDP)-
choline with diacylglycerol (DAG), releasing cytidine monophosphate (CMP). This
is a ubiquitous pathway, however in hepatocytes an alternative pathway via three
sequential methylation of phosphatidylethanolamine takes place (Cui et al., 1993).
PC is usually regarded as a strictly structural component of the cellular mem-
brane. Nonetheless, it was reported to be involved in signal transduction events,
serving as a substrate for the phospholipases to generate signal messengers: it is hy-
drolysed to release DAG, lysophosphatidylcholine, PtdOH (by phospholipase D) and
arachidonic acid (by phospholipase A2). In neurons, PC can be additionally cleaved
by phospholipase B, yielding one glycerophosphocholine molecule and two free fatty
acids (Fernández-Murray, 2007).
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Phosphatidylethanolamine
Phosphatidylethanolamine (PE) is a zwitterionic lipid with mostly structural
function, constituting 15 – 25% of the phospholipids (Vance, 2008). PE is enriched
in the inner membrane leaflet, due to the its active translocation across the membrane
by the aminophospholipid flippases (Figure 1.3) (Balasubramanian & Schroit, 2003).
Due to a small size of the head group, PE adopts a moderately conical shape and
induces a negative curvature to the membrane (Bohdanowicz & Grinstein, 2013).
PE consists of a combination of glycerol, esterified with two fatty acids and phos-
phoric acid, with the phosphate group of it combined with the ethanolamine (Table
1.3). The two fatty acids may be the same, or different, and are usually in the sn-1
or sn-2 position (Balasubramanian & Schroit, 2003). There are two main synthetic
pathways fro PE. One of it is an addition of CDP-ethanolamine to diglycerides, re-
leasing CMP. The second one is a decarboxylation of phosphatidylserine . Last one
occurs mostly in the mitochondria, executed by phosphatidylserine- decarboxylase
enzyme. The step of phosphatidylserine substrate translocation to the mitochondria
is a rate limiting step of this reaction (Voelker, 1989).
PE plays an important role in the general phospholipid metabolism, being a
substrate for almost all other phospholipid classes. Phosphatydilserine synthase
2 (PSS2) makes phosphatidylserine out of phosphatidylethanolamine at the ER
(Voelker, 1984). Phosphatydilethanolamine also provides an ethanolamine for the
protein modifications (Bohdanowicz & Grinstein, 2013). S-Adenosyl methionine can
subsequently methylate the amine of PE to yield phosphatidylcholine (Bohdanowicz
& Grinstein, 2013).
Apart of its biosynthetic role, PE is an important autophagy marker. It is known
to target soluble adaptors (p62 and NDP52) to the phagosome membrane leading to
autophagosome formation (Tanida et al., 2008).
Phosphatidylserine
Phosphatidylserine (PS) is a phospholipid, exclusively kept on the inner leaflet
of cell membranes by the activity of aminophospholipid translocases (Figure 1.3). It
comprises 2 – 10% of the total cellular phospholipid and by virtue of its phosphoserine
head group is an anionic lipid (Table 1.3) (Bohdanowicz & Grinstein, 2013).
In mammals, phosphatidylserine is produced by calcium-dependent base-exchange
reactions between phosphatidylcholine or phosphatydilethanolamine with L-serine.
This reaction is held out by phosphatidylserine synthases, PSS1 or PSS2 respectively,
both being an integral membrane proteins of the ER membrane (Arikketh et al.,
2008). As mentioned before, the major catabolic pathway of the phosphatidylser-
ine via decarboxylation gives rise to phosphatidylethanolamine in the mitochondria
(Voelker, 1989).
PS is an important signal messenger inside and outside of the cell. Upon apoptotic
changes within a cell, phosphatidylserine becomes exposed to the outer membrane
leaflet. A calcium-sensitive scramblases are the enzymes that trigger this swift ex-
posure. It serves as an "eat me" signal to the macrophages and other professional
and non-professional phagocytes (Li et al., 2003; Bohdanowicz & Grinstein, 2013).
Besides, PS interacts with several protein classes. Some proteins recognise PS
via their C2 domain in the calcium-dependent manner and get activated upon this
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recognition (Vance & Steenbergen, 2005). Proteins with polybasic motifs in the form
of an amphiphilic alpha-helixes in their structures (K-Ras, Rho GTPases, MBP) get
attracted electrostatically to the membrane PS moieties (Hancock et al., 1990; Musse
et al., 2008; Zhang et al., 2001).
These interactions are important for the protein targeting to the membrane and
for inducing conformational changes to regulate protein function.
Plasmalogens
Plasmalogens are glycerophospholipids that possess a fatty alcohol at positions
sn-1, instead of fatty acid. The fatty alcohol used are mostly restricted to a saturated
species with C16, or saturated and mono-unsaturated C18. They ether linkages differ.
It is either a modified vinyl ether bond, named 1-0-(1Z-alkenyl) that is prominent
for glycerophosphoethanolamines (GPEtn), or a 1-0-alkyl bond characterised for the
glycerophosphocholines (GPCho). At the sn-2 position, plasmalogens are enriched
in polyunsaturated fatty acids, especially docosahexaenoic, or arachidonic acid (Fahy
et al., 2005).
Amount of plasmalogens in the cellular membrane is about 15 – 20% of the total
phospholipids, and more than 50% of all are glycerophosphoethanolamines (GPEtn)
(Figure 1.3. Brain plasmalogens consists almost 90% out of GPEtn and comprise
22% of the total brain lipids (Braverman & Moser, 2012). The total amount of
plasmalogens is age-dependent and increases during development and myelination
(Nagan & Zoeller, 2001). The plasmalogen synthesis occurs on the luminal side of
peroxisome membrane (Brites et al., 2004) and is accomplished by 2 enzymes: glyc-
eronephosphate O-acyltransferase (GNPAT) and alkylglycerone phosphate synthase
(AGPS).
Grey matter plasmalogens are highly unsaturated at the sn-2 position that in-
fluence their bioactivity, contributing to a cell-cell communication events and facil-
itating membrane fusion events. The myelin plasmalogens are rather inert, due to
the predominance of saturated and monounsaturated species and thus conducting
a membrane structuring role (Han et al., 2001). The structural role of plasmalo-
gens includes a maintenance of a physical bilayer properties such as phase transition
temperature from gel to fluid state and packing of acyl chains and lateral domains
(Farooqui et al., 2000). In diacylglycerophospholipids, the acyl chain at the sn-2
position creates an additional bend that increases the molecular cross sectional area.
Plasmalogens lack this bend, thus their sn-2 and sn-1 chains are in a closer prox-
imity, resulting in a decreased fluidity and an increased membrane order (Paltauf,
1994).
Another prominent feature of plasmalogens and their impact on the overall mem-
brane stability, apart of structural, is their prompt oxidation, when exposed to the
free radicals. It occurs due to a relatively low disassociation energy of the hydrogen
atoms adjacent to the vinyl ether. It makes plasmalogens a sacrificial oxidant, to
spare the polyunsaturated fatty acids and other vulnerable lipids. Furthermore, ox-
idative products of plasmalogens are unable to propagate lipid peroxidation (Sindelar
et al., 1999).
12
1.3 Myelin lipid composition
Figure 1.3: Schematic representation of the lipid distribution within outer and inner
membrane leaflets. Colour-coded signs of the corresponding lipids are boxed. See text for more
information.
1.3.2 Phosphatidylinositol, PtdIns
This anionic lipid species comprises 10 – 15% of the cellular phospholipids. They
are present in a various membrane compartments of the cell; in the plasma membrane
it is enriched in the inner leaflet (Figure 1.3) (Devaux, 1992). PtdIns possesses
a unique feature of being able to undergo reversible and transient changes at its
head-group: phosphorylation on position 3,4 and/or 5. This yields seven distinct
phosphoinositides species, involved in the regulation of the broad spectra of the
cellular metabolic pathways (Bohdanowicz & Grinstein, 2013).
The main precursor of PtdIns synthesis is CDP-DAG. An enzyme, PtdIns syn-
thase, is a soluble protein, associated with ER. It condensates myo-inositol and
CDP-DAG to produce PtdIns (Antonsson, 1997). Secondary pathway to obtain Pt-
dIns acts via dephosphorylation of already available phosphoinositides; for example
via dephosphorylation of phosphatidyl-3,4,5-triphosphate (PIP3 ) by myotubularin
phosphatases (Sasaki et al., 2009).
Apart of being a precursor of the plethora of phosphoinositides species, PtdIns is
also an important source of the glycosylphosphatidylinositol (GPtdIns) – an anchor
for the membrane-destined proteins. The synthesis of GPtdIns occurs on the cytosolic
side of ER, with subsequent flipping of the product inside the lumen, where the
COOH terminus of the proteins can be covalently attached.
Phosphatidylinositol-(4,5)-bisphosphate, PIP2
Phosphatidylinositol-(4,5)-bis-phosphate is mostly enriched in the inner leaflet
of the plasma membrane, and represents 1 – 2% of the total phospholipids. It is
produced from PtdIns(4)P and PtdIns(3)P by specific kinases. Another pathway
to acquire PIP2 is a dephosphorylation of PIP3 by a phosphatase and tensin homo-
logue (PTEN) phosphatase. Furthermore, PIP2 itself can be dephosphorylated by
a number of 5′-phosphatases (synaptojanin, OCRL, Inpp5B) (Sasaki et al., 2009).
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Moreover, PIP2 could be subjected to the cleavage by lipases to produce DAG and
IP3 (a key to the Ca2+ mobilisation). Phosphorylation by kinases (PI3K) produces
a PIP3 out of PIP2, a critical signal molecule in the cellular activation (Balla et al.,
2009).
Apart from its precursor destiny, PIP2 is involved in the protein recruitment to
the plasma membrane. Several classes of protein possess a range of PIP2-recognition
domains, such as PH (pleckstrin homology), ETNH (epsin NH2-terminal homology),
FERM (band 4.1/ezrin/radixin/moesin) and others (Lemmon, 2008) that recognise
and binds specifically to the PIP2 moiety in the inner leaflet. Due to this key feature
of the membrane targeting, PIP2 is involved into ample amount of cellular events
(Czech, 2000; McLaughlin et al., 2002).
Functions of PIP2-targeted proteins:
• Enzyme activation: PIP2 controls the self-production by regulation via posi-
tive and negative feedback loops the functionality of PtdIns kinases and phos-
phatases (McLaughlin et al., 2002).
• Control of the cytoskeleton: PIP2 plays an important role in the cytoskele-
ton attachment to the membrane, via activation of the actin-binding proteins
(Czech, 2000; Sechi & Wehland, 2000).
• Membrane traffic: there is a plethora of PIP2-binding molecules that orches-
trate exocytosis and clathrin-mediated endocytosis: AP-2 and AP180 adaptor
proteins, dynamin, synaptotagmin, synaptojanin-1, to name a few (Simonsen
et al., 2001; Martin, 2001).
• Regulation of ion channels: mainly via IP3 and DAG production from phos-
phatidyl-(4,5)-bisphosphate (Haugh et al., 2000).
• Binding of scaffolding proteins: PIP2-recognition domains, such as PH (pleck-
strin homology), ETNH (epsin NH2-terminal homology), FERM (band 4.1/-
ezrin/radixin/ moesin) serve as an anchoring point for the scaffolding proteins
(McLaughlin et al., 2002; Lemmon, 2008).
PIP2 has a unique feature to keep its negative charges at a normal pH, contribut-
ing to the overall electronegativity of the inner leaflet of the plasmalemma. Nega-
tively charged domains of PIP2 create binding platforms for the positively charged
proteins. One family of the PIP2-sequestering proteins are MARCKS (myristoy-
lated alanine-rich C kinase substrate) proteins. They are intrinsically disordered,
membrane-bound via a lipid anchor and possess a polybasic domain in the middle.
This domain consists of 13 basic residues (Wang et al., 2001) and bind preferentially
to PIP2, however PIP3 binding is also not excluded (McLaughlin et al., 2002). These
interactions have a dual significance: MARCKS proteins get targeted and anchored
into the plasma membrane, and, subsequently, PIP2 moiety gets sequestered within
this regions. Release of these interactions leads to a swift increase in the pool of
PIP2, upon necessity. Local increase of actin due to the release of the PIP2 from this
sequestration might also take place (Bohdanowicz & Grinstein, 2013).
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PIP2 as a general actin modulator
A tremendous impact PIP2 displays on the actin cytoskeleton. It achieves this
upon interaction with a plethora of proteins that exhibit actin-regulation activity.
PIP2 mostly promotes actin polymerisation scenario via aiding in the dissociation of
globular (G)-actin from the filament-severing and actin-monomer-binding proteins
(profilin, gelsolin, villin, severin, other Cap proteins) (Lassing & Lindberg, 1988;
Machesky & Hall, 1997). Most of the PIP2-binding peptides possess a positively
charged residues clusters or specific PH-domains (Sechi & Wehland, 2000).
PIP2 influence on actin is also modulated via Rho-family of small GTPases: Rho,
Rac and Cdc42 (Schmidt & Hall, 1998). Rho-GTPase, for instance, activates a
phosphatidyl 4-phosphate 5-kinase (PtdIns(4)P 5-kinase) leading to an increase in
PIP2 levels (Hartwig & Kwiatkowski, 1991). Similar role has been described for the
Rac-GTPase, after a specific Rac-activated PtdIns(4)P 5-kinase has been identified
(Tolias et al., 1998). PIP2 was shown to be a co-activator of the WASP family pro-
teins, acting via Cdc42 that favours the nucleation of actin polymerisation through
the Arp2/3 complex (Fawcett & Pawson, 2000).
Moreover, another class of small GTPases, the ADP-ribosylation factor (ARF)
proteins, has recently been described to be involved in the PIP2 production. This
class of proteins generally participates in the membrane traffic regulation, membrane
ruffling and cell spreading. ARF6 co-localises with Rac at the plasma membrane
and is involved in the clathrin-mediated endocytosis and Fc-dependent phagocytosis
(Donaldson & Jackson, 2000). ARFs were shown to co-localise and further activate
type α PtdIns(4)P 5-kinase at the plasma membrane with the subsequent increase
in the PIP2 production and cytoskeleton remodelling (Honda et al., 1999).
Implementations of the PIP2-specific PH domains, fused to GFP, revealed that
almost all PIP2-specific markers were targeted to the cellular plasma membrane and
not to the internal membrane (ER, Golgi or nuclear). The same is true for the
cytoskeleton structures: their assembly always occurred at the plasma membrane.
This was even further illustrated by the studies of the actin nucleation sites that
are essentially all located just beneath the plasma membrane. New actin monomers
were added between plasma membrane and the actin nucleation sites, whereas actin
disassembly occurred within the cell body (Insall & Weiner, 2001).
Another feature of the actin assembly is an outward alignment of the filaments
near the plasmalemma. Cell movements occur by intercalating new monomers be-
tween plasma membrane and the existing actin cortex and thus pushing the mem-
brane forward. This requires a specific orientation of the growing, barbed, ends of
the actin filaments. Therefore some signalling mechanism must exist to regulate a
positioning of a growth of new actin filaments. PIP2 might regulate this via inter-
actions with the actin-capping proteins. These proteins bind to the barbed ends of
the filament and prevent further growth. PIP2, in turn, can displace them, enabling
elongation, but only if the direction of the growth is a proper one (Insall & Weiner,
2001).
Furthermore, all described mutual activations of actin-binding proteins also occur
only at the plasma membrane. Taking into account that PIP2 levels are relatively
high in the cell, it has been suggested that PIP2 impact on the actin regulation results
mainly in the general localisation of the actin assembly to the plasma membrane and
the proper directionality of this assembly, rather than local increase in the actin
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levels (Insall & Weiner, 2001).
Phosphatidylinositol-(3,4,5)-triphosphate, PIP3
Amount of PIP3 in the resting cell is scarce, and even upon activating signals it
does not rise more than 1% of the total lipid amounts (Stephens et al., 1993). PIP3 is
a major signalling molecule within a plasmalemma and a potent growth and survival
signal (Bohdanowicz & Grinstein, 2013). Phosphatidylinositol-(3,4,5)-triphosphate
is mostly synthesised from phosphatidylinositol-(4,5)-bisphosphate due to activity
of class I membrane PI3-kinases (Engelman, 2009). The breakdown of PIP3 occurs
via its phosphorylation by 3′-phosphatases (PTEN) and 5′-phosphatases (SHIP I
and SHIP II) (Sasaki et al., 2009; Liu & Casaccia, 2010). Failure in at least one
of the enzymes, controlling PIP3 turnover is sufficient to induce tumorogenesis in
mice (Kinross et al., 2012) and a broad range of mutations in PI3K and PTEN are
reported to be often found in the cases of human cancer (Chalhoub & Baker, 2009).
Despite its high negative charge, PIP3 does not largely contribute to the overall
charge of the inner plasma membrane leaflet, due to its low abundance. In contrary,
main function of the PIP3 in the membrane is to recruit an ample variety of proteins
to the place of their action. These proteins usually possess a specific type of PH
(pleckstrin homology) or PX (phagocyte oxidase homology) domains (Scheffzek &
Welti, 2012; Wishart et al., 2001) required for the PIP3 recognition on the mem-
brane. Among these proteins are PLC-γ, Akt, Vav, PDK isoforms (Bohdanowicz &
Grinstein, 2013).
PIP3 as local actin assembly regulator
PIP3 is a potent second messenger and actin polymerisation is a primary respond
within the cell when the PIP3 levels get elevated (Stephens et al., 1991). Broad
range of the pharmacological agents, together with mutant receptors, used to inhibit
PI3-kinases have been found to interfere with stimulus-induced actin polymerisation
in cells, including neutrophils (Niggli & Keller, 1997) and fibroblasts (Wennström
et al., 1994). Even though PIP3 is not always required for the actin polymerisation
(Kovacsovics et al., 1995), production of this lipid alone is sufficient to burst actin
nucleation in most of the cell types. It is consistent with the artificial increase of
the PIP3 amount either via exogenous delivery of this lipid or via expression of the
dominant-positive versions of the PI3-kinase (Derman et al., 1997; Niggli, 2000),
resulting in the actin rearrangements. Coupling of PIP3-signalling to the actin poly-
merisation is suggested to be via guanine nucleotide exchange factors (GEFs) involved
in the activation of Rho family proteins: Cdc42 and Rac, since GEF possess a PIP3-
specific PH-domain in their structure. When PIP3 increase was blocked pharmaco-
logically, Cdc42 and Rac activation in neutrophils and Rac activation in fibroblasts
were inhibited (Hawkins et al., 1995). Cdc42 stimulates actin polymerisation though
the Wiskott-Aldrich Syndrome protein (WASP) and its relatives. They cause actin
polymerisation by activating the Arp2/3 complex (Machesky et al., 1999).
Intriguingly, in other studies, similar pathways were described as being a PIP2-
dependent. This issue brought up a speculation that even though PIP2 and PIP3 or-
chestrate their stimuli via common pathways, the outcome is different. The common
persistent theory in the field is: PIP3 plays a role of the switch to turn on local swift
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polymerisation of actin filaments in respond to the inner and outer cues, whereas
PIP2 is a marker that ensures filaments to grow at the right site and in the right
direction for the constant support of the cellular shape and trafficking. Both signals
are required for proper actin regulation, and they often share regulatory machinery,
but their spacial and temporal activation is the ultimate determinant where, when
and why actin polymerisation is due to take place (Insall & Weiner, 2001).
1.3.3 Sphingolipids
The backbone of these class of lipids is build up from a ceramide and not glycerol.
This backbone consists of a sphingoid base, amide-linked through its amino group to
a fatty acid. To synthesise ceramide de novo, first the condensation of L-serine and
palmitoyl-CoA to form 3-ketosphinganine occurs, driven by serine palmitoyltrans-
ferase. This product is then reduced, resulting in dihydrosphingosine that undergoes
N-acylation by ceramide synthase to yield a ceramide. These reactions take place on
the cytosolic side of the endoplasmatic reticulum (ER) (van Meer & Lisman, 2002).
The most prominent representatives of sphingolipids in myelin are glycosphin-
golipids and sphingomyelin (Table 1.4).
Glycosphingolipids
This subclass of sphingolipids is build by a ceramide backbone with an added
sugar headgroup. Hydrophobic ceramide is inserted in a membrane, whereas a sugar
moiety faces the extracellular space (Siegel, 1998).
The biosynthesis of glycosphingolipids continues from the acquirement of a ce-
ramides on the cytosolic face of the ER. Ceramide can spontaneously cross ER mem-
brane and be converted to galactosylceramide (GalC) within ER lumen. This occurs
due to the transfer of a galactose residue (Gal) from the uridine diphosphate (UDP)-
Gal to the ceramide by UDP-Gal:ceramide galactosyltransferase (CGT) (Schulte &
Stoffel, 1993; Morell & Radin, 1969).
The sugar residues could also consist of glucose, received from UDP-glucose that
would yield glycosphingolipids (Radin, 1984). Glycosphingolipids are precursors of
two subclasses of sphingolipids: globosides – neutral sphingolipids and gangliosides
– acidic sphingolipids. In short: globosides contain more than one sugar: a combina-
tion of D-glucose, D-galactose and N-acetylgalactosamine. Gangliosides, in addition,
have several residues of the n-acetylneuraminic (sialic) acids (NANA) bound to the
sugar moieties. More than 60 gangliosides are described so far, all differing mainly
in the amount and position of the NANA molecules (Siegel, 2006).
Gangliosides are ubiquitously distributed over all organism, however their con-
centration in brain far more exceeds that one in other tissues (Farrer & Quarles,
1999).
Interestingly, to assess any kind of the phenotype by a knocking out the gan-
glioside pathway, one should perform a double knock-out, since a high level of the
redundancy between gangliosides is observed and a single knock-outs do not yield a
decent phenotypes (Yamashita et al., 2005). Mice devoid from any of ganglio-series
develop severe neurodegeneration and dye shortly after weaning. Investigation of the
brain phenotype of these mice suggested a role of gangliosides in the axon-glia at-














O CH2 CH2 N⊕(CH3)3 Sphingomyelin SM
galactose Galactocerebroside GalC
glucose Glucocerebroside GlcC
Lactose (Glc-Gal) Lactosylceramide LacC
Table 1.4: Structure of sphingolipids. X in the upper formula corresponds to a different
ligands, found in the table.
partner (Chiavegatto et al., 2000).
Sulfatide version of galactosylceramide (GalC) is acquired by addition of a sul-
phate molecule from 3′phosphoadenosine-5′phosphosulphate to the galactose of GalC
in the lumen of the Golgi apparatus (Coetzee et al., 1998).
Sphingomyelin, SM
Ceramide backbone and a phosphocholine head group are the constituents of the
sphingomyelin. It is synthesised in the ER and its concentration increases, starting
from ER, through Golgi and reaching its highest in the outer leaflets of the plasma
membrane(Figure 1.3). Sm is mostly responsible for membrane stability However,
there are some studies, revealing it presence in the inner leaflet as well (Linardic &
Hannun, 1994). The hydrophobic part of this lipid is much more saturated than in
phospholipids, plus its melting temperature is higher, nearing 37◦C (Bohdanowicz &
Grinstein, 2013). They also tend to self-aggregate and form a separate phase that
features decreased fluidity properties, comparing to a glycerol-based phospholipids
of the overall membranes. It makes sphingolipids one of the main constituent of so
called ’lipid rafts’ (van Meer & Lisman, 2002).
Sphingomyelin is mostly found together with cholesterol in the parts of mem-
brane that together forms detergent-resistance domains upon extraction. Here SM
is involved in plasma membrane signal transduction, cholesterol efflux and intra-
cellular lipid and protein trafficking (Rietveld & Simons, 1998; Brown & London,
2000). To synthesize sphingomyelin, an enzymatic transfer of the phosphocholine
from phosphatidylcholine to a ceramide should occur. It takes place in Golgi appa-
ratus. Sphingomyelin synthase is responsible for this step, yielding diacylglycerol as
a byproduct of the reaction (Zhang et al., 2006).
Sphingomyelin is involved in several signal transduction pathways. Starting from
a notion that upon its synthesis, diacylglycerol – one of the major signal lipids in
the cellular system – is released. In contrary, the breakdown of sphingomyelin yields
ceramide that is as well involved in the signalling (Kolesnick, 1994). It is, for ex-
ample, highly produced in several conditions leading to apoptosis, suggesting sphin-
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gomyelin to play an important role in a cellular decision to leave or to die (Green,
2000). A more peaceful role sphingomyelin has as a structural agent, forming ordered
lipid phase together with cholesterol and glycolipids among a liquid disordered phase
of phosphoglycerolipids, increasing membrane rigidity and stability (Massey, 2001).
The increase in membrane rigidity is achieved in part due to the higher melting tem-
perature of sphingolipids as well as the interactions of these lipids with cholesterol.
Cholesterol is a relatively small, nonpolar molecule, thus it can fill the space between
the sphingolipids that increases the rigidity of the membrane (Massey, 2001).
Malfunctions of the sphingomyelin metabolism are known to trigger several se-
vere diseases. One that is relevant to a nervous system is multiple sclerosis (MS).
The general upregulation of cytokines, especially tumour necrosis factor alpha, in
the cerebral-spinal fluid (CSF) of MS patients, activates sphingomyelinase. This re-
sults in a sphingomyelin breakdown, high ceramide production and increase in the
apoptotic events (Jana & Pahan, 2010).
1.3.4 Cholesterol
This steroid species comprises almost 23% of the body sterol pool (Figure 1.3)
(Dietschy & Turley, 2004). Moreover, 70% of brain cholesterol is compressed within
a myelin sheaths (Saher et al., 2005). The highest synthetic rate of the cholesterol
in oligodendrocytes is during active myelination with a subsequent decrease after
its completion (Dietschy & Turley, 2004). A low rate synthesis still remains in
the astrocytes in the adolescence (Nieweg et al., 2009). The steady high amount
of cholesterol within brain is sustained either by external delivery via circulating
lipoproteins or via endogenous de novo synthesis. The last one includes over 30
different enzyme and a crucial rate-limiting step, controlled by 3-hydroxy-3-methyl-
glutaryl-CoA (HMG-CoA) reductase (Dietschy & Turley, 2004). Even though it
was shown that de novo synthesis of cholesterol in the brain is 20-80 fold lower in
comparison to a liver (Spady & Dietschy, 1983), it is the only source of cholesterol
accretion, since no penetration of the blood-brain barrier by plasma lipoproteins
could be demonstrated (Dietschy & Turley, 2004).
Strikingly, disruption of the cholesterol de novo synthesis in oligodendrocytes re-
sulted in only 30% decrease of a cholesterol amount in wild type myelin. It might
be due to the fact that oligodendrocytes can start a cholesterol uptake for myelin
synthesis, or receive this compound from the neighbouring glia cells (astrocytes or
microglia) (Saher et al., 2005). The half-life of the cholesterol molecules in the brain
is remarkably long (4–6 months in rodents and up to 5 years in humans) (Dietschy
& Turley, 2004). Low rate of the cholesterol synthesis in the adulthood and absence
of the cholesterol degradation in the CNS contribute to its high stability. How-
ever, a small fraction (0.02–0.4%) of the cholesterol pool is nevertheless excreted
from the brain every day (Dietschy & Turley, 2004). The major mechanism involves
an enzyme 24-hydroxylase (CYP46) that is expressed in a subset of neurons. 24-
hydroxycholesterol, a product of 24-hydroxylase, can cross the blood-brain barrier
and enter the peripheral circulation (Russell et al., 2009).
Cholesterol is of a great importance to the myelin biogenesis, since mice with
cholesterol-pathway failure (squalene synthase knock-out) showed myelination defi-
ciencies, ataxia and tremor (Saher et al., 2005). Common neurodegenerative dis-
orders, such as Alzheimer, Parkinson, Huntington diseases, also are characterise by
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a disregulation of cholesterol metabolism. However, there is so far no direct link
to explain whether cholesterol metabolism abnormality is a primary cause or the
consequence of the neurodegeneration (Vance, 2012).
1.3.5 Fatty acid composition of myelin lipids
Fatty acids in the nervous tissue occur mainly as a O-acyl groups of the glyc-
erolipids, or as N -acyl groups of sphingolipids. Small amounts also are found in the
free or unesterified form. Chain length of the fatty acids varies from 14 to 24 carbon
atoms and contain from one to six double bonds. However, some minor fatty acids
with up to 35 carbon atoms were also reported. Generally, fatty acids of the nervous
tissue may be divided into four groups: saturated, unsaturated, saturated hydroxy
and unsaturated hydroxy acids (Siegel, 1998).
Synthesis of the fatty acids can occur de novo in the brain, but the uptake from
the blood also takes place. The last one is of great importance for the essential fatty
acids, linoleic (18:2ω6) and linolenic (18:3ω3), which serve further as precursors for
20:4ω6 and 22:6ω3 fatty acids (Sastry, 1985).
The work of O’Brien, gives a comprehensive overview about the discrepancies
in the fatty acid profiles among the brain lipids. According to this study, phos-
phatidylethanolamine and phosphatidylserine are enriched in the 20- and 22-carbon
polyunsaturated fatty acids, the major one among them – 20:4, 22:5ω6 and 22:6,
whereas phosphatidylcholine contained very small amount of this fatty acids (O’Brien,
1965a).
From the unsubstituted fatty acids, a broad range is present in the sphingolipids,
from 14 to 26 carbon atoms, including odd-chain fatty acids, saturated and mo-
nounsaturated derivatives (Norman, 1961; O’Brien, 1965a). In general they could
be subdivided into two groups: medium-chain fatty acids (14–18 carbon atoms) and
the long-chain fatty acids (19–26). Grey matter has mostly medium-chain, while
myelin and white matter consist of a long-chain species with a very large (up to 9-
fold) quantitative differences. Interestingly, in humans, fatty acid content of the grey
matter sphingolipids changed throughout the life time, with a tendency to increase
the length of the carbon chain with age. However, myelin sphingolipids contained the
large proportion of the long chain fatty acids very early in development (10 months)
(O’Brien et al., 1965).
These characteristics of the myelin lipids are thought to contribute to myelin
membrane organisation and its extreme stability, since more saturated hydrocarbon
chains are packed tighter in a membrane than polyunsaturated ones. Their con-
figuration and longer hydrocarbon chains provide stronger hydrophobic interactions
between the lipids with longer-chain fatty acids, in comparison to the shorter ones
(O’Brien, 1965b).
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Figure 1.4: Schematic overview of the protein distribution in a myelin sheath. Non-
compact regions marked with blue, compact regions shown in green. Most prominent myelin pro-
teins are depicted.
1.4 Myelin protein composition
1.4.1 Myelin basic protein, MBP
Myelin basic protein is the most abundant protein species within the myelin
sheath, corresponding to a 30% of all proteins (Baumann & Pham-Dinh, 2001). MBP
belongs to the group of intrinsically unstructured (or "natively unfolded") proteins
and bears a large overall positive charge, due to a high amount of positive polar
amino acids (Lysine and Arginine). Since MBP is unstructured in the solution, that
makes it impossible to resolve its proper structure. It folds to achieve a conformation
only upon interaction with lipids (Harauz et al., 2009). Localisation of MBP, revealed
by electron microscopy, is restricted to the major dense lines, thus to the compact
region of the myelin. This localisation led to a suggestion that MBP functions as
glue between two adjacent membranes in vivo (Figure 1.4) (Harauz et al., 2009).
Seven exons of the MBP gene are found within a larger gene complex, termed Golli
(Genes of OLigodendrocyte Lineage), that produces a number of alternatively spliced
transcripts. This results in several protein isoforms for MBP: 21.5, 20.2, 18.5 and
17.2 kDa in human, and 21.5, 20.2, 18.5, 17.24, 17.22 and 14 kDa in mouse (Harauz
et al., 2004; de Ferra et al., 1985; Kamholz et al., 1988). The major MBP isoform
in human CNS is 18.5 kDa and in mice – 14 kDa (Baumann & Pham-Dinh, 2001).
Post-translational modifications of MBP create even further diversity of MBP. The
major modification occurring at various amino acid residues throughout the peptide
chain are:
• Ser/Thr phosphorylation (Chou et al., 1976),
• deimination of Arginine to Citrulline (citrullination) (Wood & Moscarello,
1989),
• deamidation (Harauz et al., 2004),
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• acylation of N-terminal Alanine (Costentino et al., 1994),
• ADP-ribosylation (Moscarello et al., 1994),
• GTP-binding (Chan et al., 1988).
This broad variety creates the following charged isoforms MBP: C1, C2, C3,
C4, C5, C6 and C8, with C1 being the least modified and most highly positively
charged form and C8 the least positively charged and the most modified one (Boggs,
2006). These modifications occur naturally at the physiological conditions, however,
they might also have a pathophysiological background. For example, phosphorylated
MBP isoforms are known to have a higher turn-over, suggesting this modification
to be involved in the dynamic structuring and clearance of MBP (des Jardins &
Morell, 1983). Moreover, phosphorylation of MBP changes in response to the action
potential of neurons (Murray & Steck, 1984; Atkins et al., 1997).
A primary role of MBP was considered to be an adhesion of two adjacent lipid
membranes of the myelin sheath to create a compacted structure, process referred
to as a zipping (Omlin et al., 1982; Smith, 1992; Riccio et al., 2000). Using fluo-
rescent dye – Laurdan – it was demonstrated by Fitzner et al. that MBP increases
the lipid order and is required for the condensation of the myelin lipid bilayer in
oligodendrocytes (Fitzner et al., 2006). Therefore, an additional function of MBP
was suggested, namely, an active enrichment of myelin membrane with lipids and
their reorganisation within the sheath (Fitzner et al., 2006; Rosetti & Maggio, 2007;
Hu & Israelachvili, 2008). More recently it was reported that MBP functions not
only as a myelin-forming ’glue’, but an actual size-limiting sieve, forming a barrier
that restricts the diffusion of proteins with large cytoplasmic domains from one non-
compact region to the myelin sheath. It was demonstrated that MBP undergoes
a self-assembly, resulting in a protein meshwork that creates this molecular sieve.
Moreover, MBP was shown to exhibit an active extruding properties to filter out the
cytosolic proteins from the myelin sheath region to generate a lipid-rich membrane
(Figure 1.4) (Aggarwal et al., 2011).
MBP interactions with lipids have been studied with a plethora of different meth-
ods: differential scanning calorimetry, use of lipid probes, small angle X-ray and neu-
tron scattering, atomic force microscopy and spectroscopy, and miscellaneous other
biophysical techniques (Hu et al., 2004; Rispoli et al., 2007; Min et al., 2009). They
revealed MBP interactions with lipid membranes to be a combination of electrostatic
and hydrophobic interactions.
Bearing a high positive charge, MBP interacts primarily with negatively charged
lipids. It was shown that MBP laterally sequesters PIP2 in the large unilamellar
vesicles in vitro and in the cellular environment (Musse et al., 2008) via non-specific
electrostatic bonding. Interactions between MBP and cytoplasmic site of the mem-
brane could be disrupted by Ca2+ influx (Nawaz et al., 2009). Thus, MBP was sug-
gested to be a part of other class of intrinsically unstructured proteins of a similar
characteristics – MARCKS (myristoilated alanine-rich C kinase substrate) – already
mentioned in the text (McLaughlin et al., 2002). However, unlike MARCKS that
have their membrane-interacting domain concentrated within a particular cluster-
forming region, MBP has its basic residues evenly distributed over its surface. This
feature might be a key to the explanation of how MBP fulfils its function of bring-
ing two opposing membrane of the myelin sheath together. Additional formation of
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the hydrogen bonds with phospholipid headgroups might also contribute to the zip-
ping (Harauz et al., 2009). Moreover, cellular investigations revealed that MARCKS
proteins can affect spatial distribution of PIP2 at the plasma membrane and create
cholesterol-dependent PIP2-microdomains, function that now is also proposed to be
a feature of MBP (Musse et al., 2008; Harauz et al., 2009). The cellular outcome
from the formation of these PIP2-microdomains is actin accumulation, and possible
recruitment of actin-binding proteins.
MBP-mediated adhesion of two membrane leaflets falls under several other reg-
ulatory mechanisms. Variation in the local pH and ionic strength occurring in vivo
may alter the repulsion between negatively charged membrane leaflets and thus con-
tribute to the MBP’s adhesive strength (Ro & Carson, 2004). Unique lipid compo-
sition of the myelin sheath might also affect binding of MBP: it was also suggested
that high amount of cholesterol and sphingomyelin may contribute to the strength of
MBP/lipids interactions (Rivas et al., 1998; Surewicz et al., 1986; Rivas et al., 1997;
Epand & Moscarello, 1982). General influence of the cholesterol and sphingomyelin
amount and distribution in the cellular membrane on the lipid-protein interactions
is discussed elsewhere (Maxfield & Tabas, 2005; Gorbenko & Kinnunen, 2006).
Mechanism of MBP translation ensures that MBP exerts its adhesive action to the
negatively charged lipid in the proper place in the cell. Its translation occurs locally,
precisely on the border of the processes/sheets regions, where mRNAs of MBP are
transported via vesicular transport in form of the mRNA granules (Barbarese et al.,
2000).
The overall importance of MBP in the CNS myelin formation and compaction is
perfectly illustrated by a severe phenotype of the shiverer mice. In this naturally
occurring mutants, the large portion of MBP gene is deleted (Chernoff, 1981). Most
compact myelin in CNS (but not in PNS) is not presented upon this mutation.
CNS myelin lamellae are poorly formed and major dense line is absent. Shiverer
mice suffer from severe hypomyelination, tremor, seizures and early death (Chernoff,
1981). These effects emphasise the role of MBP in the CNS myelin compaction
(Privat et al., 1979; Mikoshiba et al., 1981).
1.4.2 2′,3′-cyclic-nucleotide phosphodiesterase, CNP
CNP comprises 4% of the myelin protein amount and has a molecular weight of
48 kDa. Localisation of the CNP is restricted to the non-compact regions of the
myelin (Figure 1.4) (Baumann & Pham-Dinh, 2001). CNP contains a catalytic C-
terminal domain with phoshodiesterase activity and N-terminal domain with distinct
relation to the P-loop, containing nucleoside triphosphate hydrolases (Kursula, 2001;
Stingo et al., 2007). The very C-terminus is linked to the plasma membrane via an
isoprenilated region. Catalytic C-terminus classifies CNP into the family of 2H-
phosphodiesterases (Mazumder et al., 2002) and both crystal and NMR structures
were revealed only for this region (Kozlov et al., 2003; Sakamoto et al., 2005), while
the whole structure is yet to be determined. CNP enzymatic activity resides in the
phosphodiester hydrolysis of 2′,3′-cyclic nucleotides to 2′-nucleotides (Drummond,
1962).
CNP knock-out mice suffer from progressive axonal degeneration (Lappe-Siefke
et al., 2003). Interestingly, the phenotype of mice overexpressing CNP was similar
to the aged rhesus-monkeys, hinting on role of CNP in the age-dependent myelin
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disruption (Gravel et al., 1996).
Despite being well-characterised, the physiological relevance of CNP still remains
enigmatic, since its substrate has not been found in the brain. Several main proper-
ties are described for CNP apart from its main enzymatic activity, such as: membrane
attachment (Braun et al., 1991); cytoskeleton interactions (Bifulco et al., 2002; An-
gelis & Braun, 1996; Lee et al., 2005) and RNA binding (Gravel et al., 1996). Based
on these findings, the role of CNP as regulator of RNA trafficking, splicing and
metabolism, as well as oligodendrocyte maturation and myelin gene expression was
proposed (Myllykoski et al., 2012).
It was suggested that catalytic mechanism of CNP is similar to that of RNaseA
(Sakamoto et al., 2005). Thus, CNP might be involved in the RNA metabolism
regulation, taking into account that some proteins in myelin (MBP for instance), are
synthesised "on spot" in the processes, rather than in the cell body, after their mRNA
is delivered there (Carson et al., 1998; Ainger et al., 1997). Moreover, N-terminal
domain of CNP was shown to have a high structural homology to the N-terminal
kinase domain of T4 polynucleotide kinase involved in the RNA repair (Myllykoski
et al., 2012).
1.4.3 Proteolipid protein, PLP
PLP represents the most abundant protein in the myelin compact regions (Figure
1.4). It is a 276 amino acids long, 30 kDa transmembrane protein with 4 α-helixes
spanning the membrane (Greer & Lees, 2002). It is encoded by a 15 kb long 7-exons
gene on the X-chromosome that could be also alternatively spliced to yield a minor
PLP isoform, known as DM20. These two isoforms share a completely identical
sequences, except of 35 amino acids segment encoded by 5′ part of exon 3 absent in
DM20 isoform.
Isoelectric point of PLP lies within a strongly basic region, albeit PLP is highly
hydrophobic. Presence of covalently-bound long-chain fatty acids, mostly palmitic
acid, increases the hydrophobicity of PLP. PLP and DM20 isoforms are translated
in the oligodendrocytes by the membrane bound polysomes and are transported
through the Golgi to the plasma membrane. The turn-over of PLP occurs within 90
days (Greer & Lees, 2002).
The oligodendrocytes of PLP-null mice have a condensed intraperiod line and
decreased physical stability that confirms a likely role of PLP in compaction and
stabilisation. Nevertheless, these mice can assemble compacted myelin sheaths. In
addition, during development PLP mutants gain widespread axonal swellings and,
with time, axonal degeneration, hinting on a role of PLP in axonal survival and
maintenance (Klugmann et al., 1997; Jurevics et al., 2003; Rosenbluth et al., 2006).
PLP gene expression is reported to be associated with a general increase of oligo-
dendrocyte number, suggesting a role of PLP in oligodendrocyte development. More-
over, naturally occurring point mutations or duplications in the PLP lead to the
premature apoptosis of oligodendrocytes, and, as a result, reduced amount of white
matter, ultrastructural changes of the myelin and general reduction of the myelin
amount (Yamada et al., 1999). These mutations result in a severe dysmyelinat-
ing disease, for example Pelizaeus-Merzbacher disease (PMD) and spastic paraplegia
type 2 (SPG2).
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1.4.4 Myelin oligodendrocyte glycoprotein, MOG
In contrast to the other protein in the nervous system, MOG is only a CNS
featured protein. It is a quantitively minor component of the myelin sheath, rep-
resenting only a 0.05–0.1% of the total myelin protein amount. It has a molecular
weight of 26/28 kDa (Abo et al., 1993) and is enriched in the outermost compact
regions of the cultured oligodendrocytes and in the periphery of the compact myelin
sheaths in the CNS (Figure 1.4) (Brunner et al., 1989).
MOG X-ray crystal structure elucidation, using a protein from a Norway rat,
revealed it to be a 218 amino acids long transmembrane type I protein from the
immunoglobulins (Ig) superfamily. It possess a single Ig variable domain (Ig-V) on
the N-terminus, exposed to the extracellular space (Berger & Reindl, 2007; Iglesias
et al., 2001). MOG glycoprotein moiety consists of 80% of N-linked oligosaccharides
of the complex type. The C-terminus is pretty short and highly conserved between
species (Iglesias et al., 2001). MOG possess additional hydrophobic stretch that
does not span the membrane. It is either tightly associated with, or integrated into
membrane from the cytoplasmic face (Pham-Dinh et al., 1995).
MOG was identified as a major target for autoantibody-mediated demyelination
in experimental autoimmune encephalomyelitis (EAE) (Pham-Dinh et al., 1995).
Therefore, it was a major suspect in the pathogenesis of multiple sclerosis (MS)
(Iglesias et al., 2001).
The precise function of MOG in the CNS is still unknown, however its Ig-domain
suggests it to be a receptor, or to play a role in the adhesion. Highly conserved
C-terminus on the cytosolic part hints to the interactions of this protein with cy-
toskeleton (Dyer & Matthieu, 1994). Cellular expression of MOG is usually delayed,
comparing to the other myelin components, thus MOG is a perfect marker for the ma-
ture oligodendrocytes (Solly et al., 1996). Moreover, it suggests the role of MOG in
completion, compaction and maintenance of myelin in adolescence (Johns & Bernard,
1999).
1.4.5 Myelin-associated glycoprotein, MAG
MAG is one of the minor myelin compound representatives, contributing only
0.1-1% to the total myelin protein amount. It is restricted to the non-compact
regions of the oligodendrocytes and in vivo is enriched exclusively in the periaxonal
membrane of myelin internodes (Figure 1.4) (Sternberger et al., 1979). Structurally,
MAG is a type I transmembrane protein and consists of 5 N-terminal Ig domains
on the extracellular space and one of two possible alternatively spliced cytoplasmic
domains (Burger et al., 1992). Its overall molecular weight is 100 kDa, with 30%
of it being heterogenous N-linked oligosaccharides (Frail & Braun, 1984). Most of
them are negatively charged due to sialic acid residues or sulphates (Quarles, 2007).
Extracellular domain of MAG comprised 5 glycosylated Ig domains, with N-terminal
being of variable type and 2-5 being of constant type. There are an interdomain
disulphide bridges between domain 1 and 2 (Pedraza et al., 1990).
MAG is a product of an alternative splicing with 2 isoforms, differing only by their
carboxyterminal segments. Expression pattern of these isoforms is strictly regulated
during development, with a short version of MAG (S-MAG) being broadly expressed
in all non-compacted myelin membrane, while L-MAG (long version) is restricted
25
Introduction
only to a periaxonal membrane (Quarles, 2007).
Over past decades, many interaction partners of MAG were reported: tubulin and
protein kinase C for S-MAG; protein kinases C and A, Fyn kinase, phospholipase
Cγ, Src kinase for L-MAG (Kursula et al., 2000; Jaramillo et al., 1994; Afar et al.,
1990; Kursula, 2001; Kursula et al., 1999). Moreover, the presence of Ig domains on
the N-terminus of MAG, enables it to bind to sialic-acid containing oligosacharides
on other glycoproteins and some gangliosides (Varki & Angata, 2006). This feature
of MAG indicates a presence of many possible interaction partners outside the oligo-
dendrocyte, first of all on the axolemma (Quarles, 2007). MAG also is subjected to
the post-translational modifications, phosphorylation of the cytoplasmic domain by
protein kinase C being one of them (Quarles, 2007).
1.5 Lipid behaviour and their dynamical properties
within the membrane
1.5.1 Historical overview of the cell membrane architecture
investigations
The first insights in the field of membrane structure studies arrived from the
physical and chemical studies of the interaction of oil on the surface of water: back
into 1890, lord Raleigh conducted a series of experiments that resulted in calculation
of thickness of the oil film on the water (Tanford, 1989). A year later, the unique
device to study the exact area of an oil film was build in the kitchen of a German
woman – Agnes Pockels. The principle of this machine is still used nowadays, how-
ever, it is now refereed as a Langmuir apparatus, since some improvement was done
by Irving Langmuir (Langmuir, 1917).
About the same time it was discovered by Charles Ernest Overton that nonpolar
substances may pass quickly through the plant membrane into the cell. Based on this
it was proposed for the first time that cell membrane of a plant has some similarities
with oil (olive oil) and that some molecules pass through the membrane by "dis-
solving" the lipid structure (Tanford, 1989). Later, with development of microscopy,
biologists started to pay more precise attention to the cellular membranes.
In 1917 the publication by I. Langmuir arrived where he proposed that fatty acid
molecules form a monolayer on the surface of water by orienting themselves in a
specific way: hydrocarbon chains away from water, and carboxyl groups towards it
(Langmuir, 1917). Only after decades one could realise the key importance of that
publication.
The first classical experiment in the field of animal cell membranology has been
conducted by Gorter and Grendel. Using lipids, extracted from red blood cells they
could show that the lipid molecules could form a bilayer (Gorter & Grendel, 1925).
Even though it was not postulated as a model at that time, it actually may count as
a first description of the animal cell membrane composition, even if several mistakes
during the experimental set-up had occurred (Sadava, 1993).
The first membrane model appeared in 1935, when Danielli and Davidson further
broadened the observation of Gorter and Grendel, postulating that the membrane
is a ’sandwich’ (bilayer) of lipids, covered on both sides with proteins. Later, they
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included protein lipid pores and areas of high protein activity (Danielli & Davson,
1935).
Along the development of electron microscopy technique, the membrane model
encountered some further development. The ’unit membrane’ model was suggested
by Robertson, based on electron microscopy studies. Under magnification of trans-
mission electron microscope, membrane appeared as two outer dark lines (extra-
cellular and intracellular protein layers) with an inner lighter line (lipid bilayer)
(Robertson, 1960).
The fulcrum of the membrane field studies arrived in the early 1970s. The fluid-
mosaic membrane model was developed by Singer and Nicolson (Singer & Nicolson,
1972). This model rendered the previous model inadequate and established a new
paradigm. Proteins were regarded now as globular entities, floating within the lipid
bilayer, rather than forming an outer and inner layers around it. Furthermore, the
complete structure has been viewed as entirely fluid, with all the components under-
going free diffusion. The model also postulated that proteins are present within the
membrane in rather low concentrations (Figure 1.5).
Membrane proteins were further studied by Unwin and Henderson, revealing that
lipid-spanning portion of the proteins has hydrophobic nature and the one out of the
bilayer is hydrophilic (Henderson & Unwin, 1975).
The Singer and Nicolson membrane model became a ’golden standard’ in the
membranology. However, as important as this model is for the field, the rapid de-
veloping and improvement of the light microscopy techniques and, therefore, new
findings over past 40 years had rather weakened its generalised concept. Proteins
are not anymore seen as a scarcely distributed within the membrane, the bilayer
itself is known not to be a smooth sea of homogeneously distributed lipids and the
free diffusion is not considered as the prevalent type of the motion of the membrane
components.
1.5.2 Types of lipid dynamics
Breaking the diffraction limit of light microscopy, STED, PALM/STORM and
single particle tracking (SPT) with quantum dots, greatly advanced the studies of
membrane architecture and organisation. Besides the static disposition of membrane
molecules, also the dynamical perspective of the ensemble could be assessed: trajec-
tories of lipids and proteins throughout the membrane could be visualised. Studies
on molecular dynamics became very important tools in the investigation of how the
plasma membrane is built and how it functions.
Free diffusion
Brownian motion on a macroscopic scales is called free diffusion: due to thermal
agitation processes, molecules are constantly on the move, colliding with each other
and thus bouncing back and forth. General features of free diffusion are:
• the higher the temperature is, the faster diffusion occurs,
• the higher the molecular density is, the higher the possibility of molecular
collision that slows down the diffusion,
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Figure 1.5: Schematic overview of the membrane models. (A) The original Singer-Nicolson
"fluid mosaic model": lipid sea with globular protein islands in it. (B) An updated version, with
proteins being not only globular, but properly transmembrane and integrated through the whole
length of the membrane. From (Engelman, 2005).
• due to the random nature of the forces generated by molecular collisions, there
is no directionality of molecular movements, therefore diffusion creates a ho-
mogenous distribution of molecules.
As mentioned above, the lateral homogeneity of the membrane was an important
hallmark of the fluid-mosaic membrane model of Singer and Nicolson. In this dif-
fusion model, the diffusion coefficient, D, depends only on the hydrodynamic radius
of the protein (was assumed to be cylindrical) and the viscosity of the membrane.
Therefore, distance a molecule diffuses, measured as a mean square displacement in
time t, relates linearly to the diffusion coefficient D:
MSD = 4D tα, α = 1 (Free diffusion)
Free diffusion might become a directional flow, when the transport of the molecule
is assisted by other compounds. Diffusion coefficient of the flow is slower than the
free diffusion, and equation takes into account the flow velocity value squared, v
(Owen et al., 2009).
MSD = 4D t+ v2t2 (Flow directed diffusion)
28
1.5 Lipid behaviour and their dynamical properties within the membrane
Figure 1.6: Schematic overview of the models, characterising the events of dynamics
within the membrane. (A) Brownian motion. (B) Flow directed diffusion. (C) Impermeable
obstacles. (D) Lipid microdomains. (E) Cytoskeleton meshwork, together with proteins that are
aligned along it. See text for explanations. Modified from (Owen et al., 2009).
Anomalous diffusion
Upon development of artificial membrane models (solid supported bilayers, large
and giant unilammelar vesicles, liposomes) it was observed that diffusion in the
plasma membrane for many different lipid probes and proteins (GPI-anchored mostly)
was slower than the one measured in artificial lipid membranes. Various models were
proposed to explain this phenomenon, and the diffusion coefficient retardation was
explained by the following causes (Figure 1.6):
• protein-protein interaction, oligomerisation and large multimeric complexes for-
mation (Douglass & Vale, 2005; Marguet et al., 1999);
• active transport, cytoskeleton interactions with lipids and proteins, confine-
ment of the proteins cytoplasmic tails within actin meshwork (results in direct
and indirect immobilisation) (Kusumi & Suzuki, 2005; Eggeling et al., 2009;
Sahl et al., 2010; Mueller et al., 2011);
• membrane lipid microdomains formation (Simons & Ikonen, 1997; Simons &
Vaz, 2004; van Meer, 2005).
Based on this, the α coefficient in the free diffusion equation deviates from 1, and
diffusion becomes anomalous, loosing its linear relation to time.
MSD = 4D tα, α < 1 (Anomalous diffusion)
Diffusion rates within heterogenous cell membranes depend on a scale. Even
though the global values for diffusion over macroscopic regions of the membrane
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might indicate a free diffusion, on the nanoscale an anomalous diffusion might occur
(Kusumi & Suzuki, 2005). Nanoscopy approaches (single-molecular tracking, STED,
FCS-STED) are of a great importance in the study of this processes (Eggeling et al.,
2009; Sahl et al., 2010; Mueller et al., 2011).
Depending on the nature of the lateral diffusion constraint, several types of
anomalous diffusion are described.
Hop diffusion within cytoskeleton meshwork. In 1980 Sheetz et al. demon-
strated that lateral diffusion was faster in the presence of a disorganised cytoskele-
ton meshwork (Sheetz et al., 1980). Usage of single molecular tracking techniques
by Kusumi and co-workers proposed how this dependence may occur and fence and
pickets model was suggested in 2005. According to it, the cytoskeleton meshwork
forms fences and transmembrane proteins, anchored with their cytoplasmic tails to
this meshwork form pickets (Kusumi & Suzuki, 2005). Comparing to the fences in
the farmers field, the proteins, aligned along the cytoskeleton meshwork form a com-
partment (200 nm scale) and restrict the free passage of the other molecules between
two adjacent compartments (Figure 1.7 A). Molecules, locked within a compartment
between fences undergo fast free diffusion. Upon either thermal fluctuation, or fence
protein oligomerisation, the boundary opens and the molecule slowly diffuses to the
other compartment. Such diffusion mode alteration – fast within a compartment
and slow between adjacent compartments – was termed hop diffusion or hopping
(Kusumi & Suzuki, 2005). Pickets formed by transmembrane proteins trespass the
whole thickness of the membrane and influence molecular diffusion of the lipids and
GPI-anchored proteins in the outer leaflet (Fujiwara et al., 2002).
Trapping within lipid microdomains: membrane partitioning. Microdo-
mains are regions of the membrane with changed characteristics. The most deviat-
ing factors are membrane order, fluidity and protein concentration. The first two
features are highly dependent on cholesterol and sphingolipids levels, since enrich-
ment in these particular lipids increases order and decreases the fluidity. Often such
cholesterol-enriched microdomains contain higher concentration of proteins, build-
ing up functional platforms (Figure 1.7 B) (Brown & London, 2000; Simons & Vaz,
2004). Increasing evidence about microdomains existence crush the initial idea of
the membrane homogeneity, since alteration in the membrane order and fluidity have
a severe impact on the diffusion. It was shown that microdomains resident proteins
exhibit a lower diffusion rate than proteins outside the domains (Shvartsman et al.,
2003).
Lower diffusion rate within these domains is often referred as a trapping: diffusing
molecules reside within the domain for the time t, either due to the direct interac-
tions with one of the domain constituents, or just due to the physical properties
(order/fluidity) that hinder the fast diffusion. The nanoscale size of lipid domains
is a challenge for their excessive study. However methods, such as FCS (fluorescent
correlation microscopy), nowadays often combined with STED facilitate these studies
(Eggeling et al., 2009; Sahl et al., 2010).
An original FCS approach, developed by Wawrieziniec in 2005 – FCS diffusion
law – provides not only an information about diffusion coefficient, but also sheds light
on the type of membrane organisation (Wawrezinieck et al., 2005). This approach
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Figure 1.7: Schematic overview of the cytoskeleton "fence and pickets" trapping mod-
els, and membrane partitioning model. (A) Cytoskeleton meshwork, together with proteins
that are aligned along it, compartmentalise the membrane into nanodomains, perturbing free ran-
dom movements. Molecule within this compartment still undergo fast free diffusion, bouncing from
the "fences" of compartment. Upon thermal fluctuations or some structural changes of the cy-
toskeleton, the hallway opens and molecule can slowly squeeze to another compartment, where it
resembles free diffusion fast mode. This changes of the dynamics from fast to slow and back to
fast movements is named hopping. (B) Lipid microdomains: diffusing molecule is interacting with
the constituents of the microdomains (signalling cascade, receptor binding, fusion, etc), therefore
remains trapped within the domain for some time. Free movement is resolved upon the interaction
abort. Modified from (Owen et al., 2009).
was successfully used to distinguish diffusion mode within lipid microdomains from
one dependent on the actin meshwork (Lenne et al., 2006). Further combination of
FCS setup with STED empowers this method, accessing diffusion behaviour on the
nanoscale levels. For instance, Eggeling and coworkers used the STED-FCS method
to provide a comprehensive study of the anomalous diffusion behaviour of lipids and
impact of the actin meshwork and cholesterol concentration on the lipid diffusion
(Eggeling et al., 2009; Mueller et al., 2011).
Impermeable obstacles: membrane environment and protein complexes
formation. Proteins of the inner cellular membrane (ER, Golgi) were shown to be
more mobile, suggesting that their lateral diffusion in these organelles is less con-
strained (Cole et al., 1996). However, a decrease in the values of diffusion coefficient
was shown for the ER proteins, involved in the functional large complexes formation
(MHC class I and TAP proteins) (Marguet et al., 1999).
It was suggested by Gambin that the diffusion value may be strongly affected
by protein dimensions (Gambin et al., 2006). Therefore, protein and lipid diffusion
might be altered not only by physical barriers within the membrane, but also by
molecular complexes formation and protein oligomerisation. Molecules either slow
down due to direct interactions, or due to indirect bouncing off the obstacle on their
way (Marguet et al., 2006).
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1.5.3 Myelin as a unique membrane in a context of the lipid
diffusion
Dynamical characteristics of the major constituent of the myelin membrane –
lipids – haven’t been studied, due to the structure complexity of the myelin sheath
and absence of a reliable measurement setup. It was shown, however, that myelin is a
very robust system, since radioactively marked lipids remained within myelin within
years (O’Brien, 1965b). It remained unknown, however, whether this robustness is
combined with membrane rigidity, leading to a diffusion blockade and subsequently
low turn-over.
As has been described in previous sections, myelin is enriched in cholesterol,
sphingomyelin. Moreover, myelin lipids often possess high number of long-chain
fatty acids in their structure. These facts might suggest a rather ordered membrane
composition and, therefore, a slow diffusion rate.
However, myelin is scarce in proteins, and due to the MBP properties, cytoplasm
and any cytoplasmic components are squeezed out from the compacted regions. Actin
meshwork also falls under this rule and it has been experimentally proven that com-
pacted myelin lacks filamentous actin (Aggarwal et al., 2011). Low protein crowding
and no actin meshwork turn the scale to favour of unrestricted diffusion within myelin
sheath.
Taking all facts about myelin membrane features into account, what would be
the answer to the question: what is the diffusion behaviour of the lipids in compact





Under the common term cellular polarity one describes the asymmetric organ-
isation of the physical aspects of the cell, including cellular surface components,
intracellular organelles distribution and cytoskeleton rearrangements. Polarity is a
ubiquitous feature among all species in all classes of eucariotes, from the unicellular
yeast, to the multicellular organisms. Cellular polarity of the plasma membrane is
a potent and important regulator involved in all crucial organismal life points, from
the global events of cellular migration, tissue formation and differentiation in the
development, to the more minor, such as epithelium function maintenance, blood
cell migration, cellular division, etc.
Evolutionary, epithelial cells are the most typically polarised cells and approxi-
mately 60% of mammalian organism is of epithelial or epithelia-derived origin. There-
fore, the most studies on the polarity were performed on the simple columnar ep-
ithelium of the mammalian intestine or kidney. Membrane of the epithelial cells is
polarised into two distinct domains: apical and basolateral. Apical surfaces faces in-
ward to the lumen and are specialised mainly for the material exchange. Basolateral
surface, in contrary, promote contacts with the adjacent cells and extracellular ma-
trix (ECM) to provide stability. Therefore, depending on the functional differences,
both cellular parts developed under the polarity control to be strictly organised to
fulfil special needs.
This functional specifications of the cellular membrane, determining cell orienta-
tion, function and fate, occur almost in all cell types. To name a few: neural synapses
are specialised into transmitter release and uptake sites; photoreceptors are divided
into regions of light-sensing activity and connection to the neurons; migrating cells
exhibit asymmetric front-back polarity upon movements towards attractive cues.
One may suggest that to acquire all these different functions a diverse mechanisms
for the polarisation control should be involved. Strikingly, that is not the case. There
are several common mechanistic themes, simple variation of which results in the
perfect orchestration of the polarity events.
Common mechanisms of cellular polarity include:
• Recognition of the intrinsic protein code that determines the part of the cellular
membrane the protein will be delivered to by cytoplasmic adaptor complexes.
• Specific association of the signalling complexes and scaffolding proteins from
the cytosolic side with the appropriate part of the membrane. They define and
stabilise the biochemical features of the building domains.
• Adhesion receptors orientate cells in the three-dimensional space by sensing
the neighbouring cells and extracellular matrix.
The idea of these mechanisms to be conserved among all cells rises mainly from
two considerations: all cell share common cellular machineries for protein traffick-
ing; all cell types are able to lose polarity (cancer circumstances) trough epithelial-
mesenchymal transition, disintegrate from its original tissue, migrate and undergo




1.6.1 Overview of the mechanisms of the cellular polarisation
Sorting, trafficking and retention control
’Boarding pass’ to the right vehicle. Protein sorting and post-translational
modification occurs step-wise within endoplasmatic reticulum (ER) and Golgi sys-
tem. Three classes of proteins were identified so far to be responsible for the cargo
packing into vesicles for the delivery:
• coatomer protein complex-II (COPII) for trafficking from ER to Golgi;
• coatomer protein complex-I (COPI) for delivery from Golgi to ER, and within
Golgi network itself;
• the adaptor protein (AP) clathrin complex is crucial for transport between the
Golgi, the plasma membrane and endosomes.
All these systems use as a ’boarding pass’ the specific sorting signal on their
protein cargo. Regardless the destination, vesicle transport is mediated by a ’rail-
way roads’ of the cells, namely: actin filaments and microtubules. Further fusion
of the delivered vesicles with the point of destination is regulated by organelle-
specific small GTPases (Rabs), vesicle-tethering complexes and SNAREs (Hehnly &
Stamnes, 2007; Grosshans et al., 2006). Upon cellular polarisation these ubiquitous
mechanisms are modified and used to sort proteins into separate plasma membrane
domains.
Cytoskeleton involvement into sorting. To further ensure the precise locali-
sation of the sorted cargo, polarised cells possess a specialised organisations of actin
filaments and microtubules. Actin filament underlie the entire plasma membrane and
interact with membrane proteins via ankyrin-spectrin complexes (Bennett & Healy,
2008). Since actin filaments are closely regulated by small GTPases of the Rho-
family that are involved in several crucial polarisation points, they might indirectly
have an impact on the protein sorting (Rodriguez-Boulan et al., 2005; Schmidt &
Hall, 1998).
Fusion of the sorted proteins with the targeted membrane. Subsequent
fusion of the vesicle with the correct membrane is a next crucial step in the polarity
generation. Special exocyst complex (involves several Rab GTPases) regulates the
docking of a subset of basolateral vesicles, whereas annexin complexes are involved
in the fusion with apical membrane of epithelial cells (Grindstaff et al., 1998; Gerke
et al., 2005; Ang et al., 2004). SNARE complexes (v)-SNAREs (vesicle-associated
membrane protein –VAMP) and target (t)-SNAREs (the syntaxins) regulate the final
step of the vesicle and plasma membrane fusion (Rothman, 1994).
Protein retention within the right domain. The next step after precise re-
cruitment of the membrane proteins into specialised domains is their retention within
these membrane patterns.
Scaffolding proteins complexes, such as ankyrin-spectrin, may interact with the
cytoplasmic domains of the membrane proteins, anchoring them in place. Several
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classes of membrane proteins are sequestered in this way, including ion transporters
and channels (such as the anion exchanger, Na+/K+-ATPase, voltage-gated Na+
channel and Na+/Ca2+-exchanger), receptors (such as Ins(1,4,5)P3 receptor, ryan-
odine receptor and N -methyl-D-aspartate receptor (NMDA-R), and cell-adhesion
proteins (such as E-cadherin, L1 (Ng-CAM) and CD44) (Mellman & Nelson, 2008).
Diffusion barrier is another option to separate membrane domains that are other-
wise part of a continuous lipid bilayer and prevent intermixing of the polarised re-
gions. This barrier in epithelial cells comprises the tight junction and is placed
directly to the boundary between apical and basolateral domains. Tight junctions
create a natural fence within membrane, preventing free diffusion from one domain
to the other (Shin et al., 2006). Only a regulated vesicular transport, such as tran-
scytosis, can overcome this barrier. In the absence of the tight junctions, diffusion
barrier might be created in a different way. Targeted localisation of the scaffolding
proteins and cytoskeleton tend to crowd membrane proteins, increasing their concen-
tration within a particular region of the plasma membrane, therefore impeding the
free diffusion of the molecules. Membrane of the axon initial segment, for example,
has such kind of barrier to restrict axonal membrane proteins to diffuse into soma
(Winckler et al., 1999). Immunological synapse, and budding yeasts are another
examples (Mellman & Nelson, 2008).
Intrinsic cues of the cellular polarity: how does the cell know
where to sort?
The sorting mechanism in the polarised cell is a complicated machinery that
controls where the newly synthesised proteins will be departed. However, what
are the cues for the cell to orientate within a multicellular context and distinguish
between its own ’floor’ and the ’ceiling’?
Protein complexes: PAR, Scribble and Crumbs. PAR (partitioning defec-
tive) complex consists of 6 PAR proteins (PAR-1 to 6) and is required to establish
polarity in early C. elegans development (Kemphues et al., 1988).
It is suggested that Ser/Thr kinases PAR1 and PAR4 are involved in the reg-
ulation of at least two key points of the polarisation event: post-Golgi vesicle de-
livery and their docking and fusion at the plasma membrane (Mellman & Nelson,
2008). Apart from the kinases, PAR complex comprise PAR3 (Bazooka or Baz)
and PAR6 proteins with multiple PDZ domains, 14-3-3 homology protein PAR5 and
RING-finger protein PAR2 that function as a scaffold of the PAR complex (Suzuki &
Ohno, 2006; Goldstein & Macara, 2007). PAR-3 is the first protein of the PAR/aPKC
complex to show strictly apical localisation during epithelial polarity establishment
(Harris & Peifer, 2004). PAR3 and PAR6 actively recruit Cdc42 and atypical protein
kinase C (aPKC). They form a subcomplex that localise to apical junctional complex
in polarised epithelial cells or to the tips of axons in neurons (Mellman & Nelson,
2008). PAR3-PAR6-aPKC subcomplex, positioned at the crucial apical-basolateral
junction, contributes further to the establishment and control of maintenance of
apico-basal polarity in embryonic epithelial cells and to axon formation in neurons
(Mellman & Nelson, 2008).
Basolateral identity is regulated by Crumbs complex that is placed below the
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apical junctional complex and along the membrane at cell-cell contacts. The apical
part of the membrane is under control of Scribble complex, localised to the apical
side of the junctional complex in polarised epithelial cells. Loss of function studies of
either of these complexes revealed drastic defects in the polarity establishment due
to the reduction of the surface area of the apical and basolateral plasma membrane
domains. However, as in case of PAR1 and PAR6, the precise mechanism of the po-
larity regulation by Crumbs and Scribble remains unknown (Figure 1.8) (Tanentzapf
& Tepass, 2003; Bilder et al., 2003).
Role of phospholipids. Apart from the protein polarity complexes, cell use phos-
phoinositols to establish and maintain their polarity. Among plethora of phospho-
inositol species residing in a cell, PIP2 and PIP3 exhibit the key impact during cellular
polarisation events. Local changes in these phosphoinositides moieties within cellular
membrane is acquired via distinct localisation of the two enzymes: phosphoinositide
3-kinase (PI3K) and phosphatase and tensin homologue (PTEN) phosphatase. PI3K
generates phosphatidylinositol-3,4,5-triphosphate (PIP3) and PTEN removes the 3′-
phosphate from PIP3 to yield phosphatidylinositol-4,5-bisphosphate (PIP2) (Figure
1.8) (Sasaki et al., 2009).
Spatial and functional separation of these lipids is very abundant. The tip of
the growing axon is enriched in PIP3 (Shi et al., 2003), as is the leading edge in
migrating cells. In contrary, PIP2 is strictly sequestered to the trailing region of the
migrating cells. In the epithelia, PIP3 is usually restricted to the basolateral part,
while PIP2 is found in the apical part. The enzymes follow the respective pattern:
PI3K is localised to the basolateral domain and the tip of the growing axon and
PTEN resides in the apical part of the epithelial cells and in the trailing region of
the migratory ones (Shewan et al., 2011).
Upon inhibition of PI3K activity, neurons lack axonal differentiation (Shi et al.,
2003) and apico-basal axis in epithelial cells becomes misoriented (Gassama-Diagne
et al., 2006).
Based on the severals studies, PTEN phosphatase was suggested to be a key
regulator of the apical membrane interface establishment. It was shown that PAR3
protein of the PAR3-PAR6-aPKC complex, which has apical asymmetry, binds via
its PDZ domain to the PTEN and this binding is necessary for the epithelial cell po-
larity establishment (von Stein et al., 2005; Feng et al., 2008). Moreover, PAR3 can
also directly bind to PIP3 and PIP2 (Krahn et al., 2010). These findings introduce
a possible coordinatory role of the PAR3 during apical interface specification: on
the one hand PAR3 may recruit PTEN to the apical surface that leads to a subse-
quent removal of PIP3, thus removing the basolateral identification. Simultaneously,
the production of PIP2 occurs, resulting in the establishment of apical membrane
identity.
Of course, several other factors to localise and stabilise PAR3 on the apical sur-
face are needed in this scenario, otherwise PAR3 would randomly bind to PTEN
and PIP3 all over the cell. Moreover, PTEN alone is not sufficient to produce
all PIP2 needed. It is most likely responsible only for the swift elimination of
PIP3. Phosphatidylinositol 5-kinase, (PI(5)-kinase), an enzyme, known to stimu-
late PIP2 production, was found to be localised to the apical surface of MDCK cells,
therefore being a candidate, responsible for the accumulation of PIP2 in this region




There is still lack of understanding how the asymmetry of phosphatidylinosi-
tols occurs at the first place. The general existing model favours the involvement of
signals, generated via interactions with the surrounding extracellular matrix (ECM)
(O’Brien et al., 2002). In the MDCK cells β-integrins are the crucial components in
the cell-ECM interactions and are known to modulate PI3K activity and PIP3 levels
(Parise et al., 2000; Yu et al., 2005). Therefore, one may suggest that specifica-
tion of the basolateral pattern begins with enrichment of the PIP3 and PI3K on
the plasma membrane, upon control of the β-integrins. Cell-cell contacts formation
via E-cadherins and their impact on the PI3K activation might be a next step in
the membrane specification (Kovacs et al., 2002). Elevated PIP3 levels trigger the
avalanche recruitment of the effector proteins to further establish the axis of polarity
and design the proper basolateral interface of the membrane.
As has been mentioned in the previous section, proper cytoskeleton organisation
to provide proper shaping (migratory cells), stability support (epithelia) and vesi-
cle transport of neatly sorted proteins should follow immediately after apical and
basolateral surfaces are determined. Both phosphatidylinositols are known to be
cytoskeleton modulators, however they orchestrate with slightly different outcomes
(see overview in Section 1.3.2).
Extrinsic cues of the cellular polarity
Apart from the intrinsic cues, a cell needs to further sense its positioning towards
other cells and its 3D orientation according to the extracellular matrix (ECM). The
hints for it were acquired upon observing individual epithelial cells grown in suspen-
sion. In the absence of cell-cell and cell-ECM adhesion these cells do not develop
polarity, but instead undergo programmed cell death. In contrary, when grown
on the substrate, individual epithelial cells establish and maintain their apico-basal
axis. Moreover, if this substrate corresponds to one of those that cells encounter in
vivo, cells start to develop the appropriate functionality: neurons specifically form
an axon, while single mammary epithelial cells selectively secrete β-casein from the
apical surface and 3D epithelial cysts polarise correctly (Mellman & Nelson, 2008).
Thus, the presence of the ECM, and cellular adhesion to it, is of a great importance
and provides the final orientation cues for the cellular polarity establishment.
The main polarity regulators are summarised on Figure 1.8.
1.6.2 Polarity within the myelin sheath
Myelin is highly differentiated and specialised structure that is functionally and
structurally polarised into different domains (Figure 1.9).
Along the radial dimension of myelin, there is a division into non-compacted
outer abaxonal and inner adaxonal membrane and compacted multilayered stacks.
Along its longitudinal length myelin is subdivided into internodes, paranodes and
juxtaparanodes (Baumann & Pham-Dinh, 2001). Axonal plasma membrane upon
contact with different areas of myelin also becomes polarised (Özçelik et al., 2010).
Oligodendrocytes in CNS, as well as Schwann cells in PNS are typically polarised
cells. They exhibit segregation between plasma membrane of the cell body and
myelinated region, with further division of the myelin into compact and non-compact
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Figure 1.8: Schematic overview of the major complexes involved in the cell polarity
establishment. Three main protein complexes are shown: Crumbs (red), PAR (dark green) and
Scribble (yellow). Apical membrane is to the top, and basolateral to the bottom and the sides. All
three complexes have an impact on each other localisation. PAR complex reinforces the localisation
and activity (strictly apical) of the Crumbs, as shown with the arrowed black line. PAR and Scribble
mutually antagonise each other (shown with the red lines), therefore controlling the precise location
of each other: Scribble - strictly basolateral, PAR complex - to the apical junctional complex. In
addition to the protein polarity complexes, lipid family of phosphoinositides are directly involved in
the regulation of cell polarity. Two main players are PIP2 and PIP3, localised strictly to the apical
and basolateral membrane, respectively. Together with phosphatidylinositols, enzymes responsible
for their interconvertion are also targeted to different membrane domains: PI3K to the basolateral
part and PTEN to the apical. These components regulate further either via Annexin2 or via Cdc42
cytoskeleton rearrangements that are important for the polar protein and vesicular trafficking.
domains. Compacted areas are enriched in lipids and harbour only few representative
proteins (MBP and PLP in CNS), whereas composition of the non-compact region is
similar to the cell body membrane, with CNP and MAG being predominant markers
(Baumann & Pham-Dinh, 2001).
Oligodendrocytes are remarkably independent from the axonal extrinsic cues in
the establishing of their polarity, since upon cultivation in the absence of axons, oligo-
dendrocytes form flat sheets that recapitulate compact myelin sheath in vivo with
maintenance of all the aforementioned structures and with proper protein/lipid sep-
aration (Kachar et al., 1986). However, for the further completion of the compaction
and wrapping, extrinsic cues from axons are required (Baumann & Pham-Dinh,
2001).
The conserved principles involved in the membrane polarisation has been dis-
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Figure 1.9: Schematic representation of the polarised domains in the myelin sheath
in vivo. Compact and non-compact myelin domains are separated by tight junctions. Septate-like
junctions connect paranodal loops to the axon (adapted from Maier, 2008).
cussed briefly earlier in this section. Along with using the ubiquitous mechanisms,
oligodendrocytes are forced to develop some additional sophisticated ways for protein
sorting and trafficking to overcome their own structural feature: tight packing of the
myelin membrane (Simons et al., 2012).
It was shown that oligodendrocyte sheets lack the trafficking and sorting machin-
ery, i.e., Golgi apparatus, ribosomes and vesicles (Aggarwal et al., 2011). Therefore,
vesicle-mediated transport is confined to the cell body and non-compact processes.
It is suggested that myelin membrane either preassembles within the biosynthetic
pathway into tightly packed complexes, or is accumulated into endosomes that are
subsequently delivered and incorporated to the myelin membrane upon extrinsic sig-
nal for the myelination (Simons et al., 2000). After incorporation into the membrane,
myelin components are then delivered to the sheets region by membrane flow (Simons
et al., 2012).
PLP is a good example of the involvement of the endosomal trafficking: it is
found to be accumulated within the endosomes in the early stages of myelination
and disappear upon myelination termination (Simons et al., 2000). On the other
hand, MBP is translated on the borders of processes/sheets regions. Its mRNA is
transported there via hnRNP granules trafficking (Barbarese et al., 2000). Upon
translation, MBP interacts immediately with negatively charged lipids of the plasma
membrane and is incorporated between the sheets. Its high adhesive properties
might be the case why MBP is translated strictly at the places were two membranes
are ought to be brought together, not to intervene with overall cellular architecture
elsewhere in the cell. The precise mechanisms of the sorting and incorporation of the
membrane components into oligodendrocyte sheets need to be further determined.
The role of the polarity complexes has been shown so far only for the Schwann
cells in PNS. The outer membrane of Schwann cells (abaxonal domain) resembles
39
Introduction
a baso-lateral region of the epithelial cells, and inner membrane (adaxonal part)
the apical region, with PAR and Scribble complexes defining the respective domains
(Cotter et al., 2010; Özçelik et al., 2010). There are no evidence so far, though, that
the same separation occurs in the oligodendrocytes.
Following sorting, membrane components need to be preserved within the des-
tined domains. Diffusion barriers, build either by tight junctions or molecular fences
(Figure 1.7) are usually responsible for this in the polarised cells. Primary oligoden-
drocytes do not form proper tight junctions between cell body and myelin-like sheet.
However, tight junctions are present around the radial component of myelin, as well
as between the internode and the paranodal loops, separating compact region from
non-compact (Pedraza et al., 2001; Salzer & James, 2003). OSP/claudin-11 is so
far the only protein of tight junctions, found in oligodendrocytes (Bronstein, 2000).
OSP/claudin KO mice, lacking tight junctions, result in a slower nerve impulse con-
duction and limb weakness, demonstrating the importance of these structures in the
proper functionality of myelin (Gow et al., 1999).
Moreover, recent studies have shed the light on how MBP is involved into bar-
rier formation between compact and non-compact zones. It was demonstrated that
upon its self-assembly, MBP forms a sieve that prevents proteins with large cytoso-
lic domains from entering the sheets (Aggarwal et al., 2011). The same study also
claims MBP to be an active extruder that actively excludes proteins from the com-
pact regions. Lipid-rich and protein-poor membrane is generated in this elegant way
(Simons et al., 2012).
1.7 Aim of the work
Despite long years of being under investigation, myelin still remains enigmatic.
In my thesis I aimed to investigate lipid dynamics within the oligodendrocyte sheets,
as well as a distribution of PIP2 and PIP3 in there. Due to its special membrane
characteristics, lipid behaviour within myelin sheath might drastically differ from the
one, described so far for other cellular membranes. It would be of a great interest
to investigate this, since lipid diffusion and type of motion would contribute to the
knowledge of myelin membrane architecture and organisation. Continuing with the
question of lipid organisation within the membrane, I investigated a distribution











2.1 Chemicals and Consumables
1. All chemicals, unless stated otherwise, were obtained from:
• Sigma-Aldrich (Sigma-Aldrich Chemie GmbH, Munich, Germany),
• Merck (Merck KGaA, Darmstadt, Germany),
• AppliChem (AppliChem GmbH, Darmstadt, Germany),
• PAA laboratories GmbH, Pasching, Austria.
2. All basal media, supplements, antibiotics and sera for cell culture, unless else
is specified, were purchased from:
• Gibco/Invitrogen (Invitrogen GmbH, Darmstadt, Germany).
3. Consumables were purchased from:
• Falcon (Becton Dickinson Labware Europe, Le Pont De Claix, France),
• Eppendorf (Eppendorf AG, Hamburg, Germany).
4. CELLSTAR culture vessels were obtained from:
• Greiner Bio-One (Greiner Bio-One GmbH, Frickenhausen, Germany).
2.2 Antibodies
Primary antibodies used in this study are listed in Table 2.1. Antibody dilutions
used for immunocytochemistry (IF) and western blot analysis (WB) are given in
brackets. Secondary fluorophore-conjugated antibodies were purchased from Dianova





Target Host species Application Reference
AA3 (PLP) Mouse WB (1:200) home-production
α-actin Mouse WB (1:500) Sigma
phosphoAkt Rabbit IF (1:200) Cell Signalling, Danvers,
MA, USA
CNP Mouse IgG IF (1:200) Sigma-Aldrich
GalC (clone MAB342) Mouse IgG1 IF (1:200) Millipore, Billerica, MA,
USA
MBP Mouse IgG1 IF (1:1000) Sternberger, Lutherville,
MD, USA
MBP Rabbit IF (1:300) DakoCytomat., Carpinte-
ria, CA, USA
O1 Mouse IgM IF (1:50) (Kuhlmann-Krieg, 1988;
Sommer & Schachner,
1981)
PIP2 Mouse IgG2b IF (1:100) Echelon Bioscience
PIP3 Mouse IgM IF (1:100) Echelon Bioscience
Phalloidin-Rhodamine F-actin IF (1:200) Invitrogen (Munich, Ger-
many)
Phalloidin-Fluorescein F-actin IF (1:200) Invitrogen (Munich, Ger-
many)
WGA-488 leptin IF (1:200) Invitrogen (Munich, Ger-
many)
2.3 Specific Software
List of specific software used for data acquisition, processing and analysis can
be found in Table 2.2. The software/applications marked with † are freely available
online.
Table 2.2: List of software
Software Application Source/Manufacturer
ImageJ† image processing and analysis http://rsbweb.nih.gov/ij
Leica Confocal Software, 2.61 acquisition of confocal images Leica Microsystems, Mannheim,
Germany
MBF ImageJ for Microscopy† image processing and analysis http://wwwmacbiophotonics.ca/imagej
Meta Imaging Series 6.1 image processing and analysis Universal Imaging Corp., Down-
ingtown, USA
GraphPad Prism data quantification and statistical analysis www.graphpad.com
LATEX† writing of the manuscript www.latex-project.de




All cell culture incubations were carried out in humidified 37◦C, 7.5% CO2 incu-
bators; further culture conditions are specified below. All solutions and equipment
coming into contact with living cells were sterile, all media were filter-sterilised with
0.22 µm polyethersulfone (PES) filters (Millipore). Cell culture work was carried out
according to security level S1 safety rules.
2.4.1 Primary oligodendrocyte culture
Primary cultures of oligodendrocytes were prepared from postnatal day 1 mouse
brains as described previously (Fitzner et al., 2006; Simons et al., 2000; Trotter
& Schachner, 1989). In brief, cellular mixture from trypsinized mouse brains was
grown in poly-L-lysine (PLL) coated flasks in Basal Medium Eagle (BME) medium
supplemented with 10% horse serum and 100 U/mL each of penicillin and strepto-
mycin. After 7 – 10 days, oligodendroglial progenitors growing on top of a layer of
astrocytes were shaken off and cultured further in SuperSato medium (Table 2.3 on
PLL-coated dishes or round coverslips (d = 18 mm) (R.Langenbrinck, Labor- und
Medizintechnik, Emmendingen, Germany).
Table 2.3: SuperSato composition
B-27 Supplement 50X 2 mL
GlutaMAX-1 supplement 200 mM 1 mL
Penicillin/Streptomycin 5000 U/5000 µg 1 mL
Sodium pyruvate 100 mM 1 mL
Triiodothyronine 5 mM stock in ethanol 10 µl
L-Thyroxine 4 mM stock in 0.26 N NaOH, 25% ethanol 13 µl
Horse serum 100% 1 mL
Prior to cell seeding, coverslips were washed for 1 hour with acid (HCl 37%),
rinsed 3 times thoroughly with ddH2O and sterilised overnight at 260◦C. Cells were
plated at density approximately 3 × 104 cells/cm2 (7 × 104 to 105 cells per well in
a 12-well plate).
Coating for primary cultures was prepared as following: PLL (100 µg/mL) was
applied on the surfaces for 4 – 12 h at 37◦C aspirated and washed with 1X PBS. 10X
PBS was prepared according to (Sambrook & Fritsch, 2001). To obtain 1X PBS,




Table 2.4: Phosphate Buffered Saline (PBS)
NaCl 80.0 g
KCl 2.0 g
Na2HPO4 (or 18.05 g Na2HPO4 × 2H2O) 14.4 g
KH2PO4 2.4 g
2.4.2 PtK2 fibroblast cell line
PtK2 cell line was a courtesy of the NanoBiophotonics Department, Max Planck
Institute for Biophysical Chemistry, Göttingen, Germany. Cells were grown in the
flask with 10 ml of the PtK2-Sato (Table 2.5). To prevent overgrowth, cells were
splited once in 6 – 7 days onto a fresh flask. For the imaging, cells were splited







2.4.3 Nucleic acids delivery into cultured animal cells
Lipofectamin R© 2000 and TransIT R©-based transfection
Introduction of DNA into the cells, using Lipofectamin R© 2000 is based on form-
ing liposomes with encapsulated DNA. Upon interaction with the cell membrane,
liposomes can penetrate it and thus deliver the DNA of interest into the cell (Gre-
goriadis, 1984; Felgner et al., 1987). Exogenous nucleic acids were transiently intro-
duced into primary oligodendrocyte cells by lipofection-based transfection method,
following the manufacturer protocol. Cells were seeded on the 18 mm diameter
coverslips in SuperSato medium and grown for the time needed. For each 18 mm
coverslip the transfection mastermix of the following components were set in two test
tubes: in one, 50 µl of Opti-MEM R©-I (Invitrogen, Carlsbad, CA, USA) were mixed
with 4 µl of Lipofectamin R© 2000 (Invitrogen GmbH, Darmstadt, Germany) and
50 µl Opti-MEM R©-I were mixed with 1.6 µg of purified plasmid DNA in another.
Both mixtures were incubated for 5 min at room temperature. Next, solutions were
combined and incubated further for 20 min at room temperature. Finally, the total
volume of the prepared solution was added drop wise on the coverslip and cells were
returned back to the incubator for 16-20 hrs.
To transfect cultured PtK2 cells, TransIT R© (Mirus Bio LLC, Madison, WI, USA)
was used as transfection reagent. Cells with 75% confluence were preferably taken.
For each coverslip in a 12-well plate, 3 µl of transfection reagent and 1 µg of plasmid
DNA were mixed with 100 µl Opti-MEM R©-I and incubated 30 min at room tem-
perature. The solution was added drop wise; cells were further kept under normal




An assay of the reconstitution of the MBP zipping properties within fibroblast cell
line was established (Aggarwal et al., 2013). In brief, the MBP-GFP-TM chimeric
construct, containing MBP, transmembrane domain, GFP and ER-retention signal,
(Figure 2.1) was designed and cloned. Subsequently, PtK2 cells were transfected with
this construct and subjected to the further analysis after 18 hrs post-transfection.
Cells, positive to the transfection, were recognised due to the GFP-signal.
Figure 2.1: Schematic representation of the MBP-GFP-TM construct, used for the
PtK2 transfection to reproduce MBP membrane zipping in the cell line. (A) Construct
overview: MBP is fused to the transmembrane domain (TM), bearing endoplasmatic reticulum
(ER)-retention signal, and to GFP. (B) Due to its TM domain MBP is anchored in the ER mem-
brane, exposing its positive charge to the plasma membrane and with GFP molecule residing in
the ER-lumen. Since PtK2 cells have flat morphology, ER membrane is in a close proximity to
the cellular membrane. Hence, ER-hooked MBP is exposed to the negatively charged lipids of the
plasmalemma and react with them, bringing two adjacent membranes (ER and cellular) together.
These contacts are visualised due to the GFP signal.
2.5 Inhibitors administration
2.5.1 PTEN inhibition
VO-Ohpic, vanadium trihydrate (Biovision Research Products, Mountain View,
CA, USA), was used as a specific PTEN inhibitor (Rosivatz et al., 2006; Nakai et al.,
2004). It is referred to as VOOH in text and in figures. In general, VOOH was
applied in the desired concentrations (200 pM, 100 nM, 500 µm, 1000 nm) after 24
hrs of shake (day 1) with a repetitive addition of the same concentration on day
2. Cells were either fixed on day 3, or allowed to grow till day 5 without inhibitor
administration between day 3 and day 5.
2.5.2 Ionomycin treatment
Ionomycin was used in stock of 10 mM. Krebs-Ringer solution for the Ionomycin
treatment was prepared as described in Table 2.6. Cells were washed from the
SuperSato 3 times with Krebs-Ringer+Ca2+. 10 µM Ionomycin was applied for
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2 min in Krebs-Ringer+Ca2+ solution. 3 washing steps 1 min each with Krebs-
Ringer+Ca2+ followed. Cells were further incubated for 1 min in saponin (0.005%)
(Sigma, S-7900) in Kebs-Ringer without Ca2+, and subsequently washed 3 times,
again with Ca2+-free Krebs-Ringer. Cells were immediately fixed with 4% PFA,
supplemented with 0.25% GTA and subjected to the immunocytochemistry.
Table 2.6: Krebs-Ringer solution
Substance Working Stock
NaCl 120 mM 1.2 M
KCl 4.7 mM 47 mM
glucose 10 mM 100 mM
HEPES 20 mM 7.4 pH
adjust pH before adding last
two components
CaCl2 1.2 mM 0.5 M
MgSO4 0.7 mM 0.5 M
To prepare Ca2+-free
Krebs-Ringer, substitute CaCl2




To analyse the subcellular localisation of the proteins and lipids of interest in
primary oligodendrocytes and PtK2 cells we performed immunocytochemistry as de-
scribed in (Simons et al., 2002). For common antibody staining, cells on coverslips
were fixed for 10 min at RT with mixture of 4% paraformaldehyde (PFA) and 0.25%
glutaraldehyde in PBS, pH 7.4, followed by three washing steps with 1X PBS. To
access the internal structures, cells were permeabilised with 0.1% Triton X-100 for
1 min at RT and then washed 3 times in 1X PBS. For the surface staining this step
was omitted. To reduce unspecific binding of antibodies, during internal protein
staining, blocking was carried out for 30 min at RT in 2% FCS, 2% BSA and 2% fish
gelatine in 1X PBS (100% blocking solution). Cells were incubated with the primary
antibodies in appropriate dilution in 10% blocking solution for 1 h at room temper-
ature, washed three times with 1X PBS, incubated with the secondary antibodies
in required dilution in 10% blocking solution, washed three times in 1X PBS and
mounted in Mowiol mounting medium. The list of antibodies used can be found in
Table 2.1.
Exception: PIP3 antibodies To analyse the subcellular localisation of PIP3 spe-
cial protocol from manufacturer (Echelon) was applied, since the conventional one
didn’t provide a robust antibody signal. In brief, cells were fixed as mentioned
above, washed 3 times with 1X TBS (Table 2.7) and permeabilise with 0,5% saponin
at room temperature for 15 min, then again washed 3 times with TBS. Blocking
was performed in 10% goat serum in TBS for 30 min at room temperature. Primary
antibodies against PIP3 from Echelon were diluted in 1X TBS and applied for 60 min
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at room temperature. Coverslips were washed with 1% TBS-goat serum with subse-
quent staining with secondary 1X TBS-diluted antibodies. Cells were again washed
3 times in 1X TBS and mounted in Mowiol mounting solution.





2.6.1 Labelling with the small protein probes
Small protein probes, consisting of the specific PH-domain for the PIP2 (from
PLC) and PIP3 (from Grp1) recognition, labelled with either mCitrine or mCherry,
respectively, were courtesy of Geert van den Bogaart, from Neurobiology department,
Max Planck Institute for Biophysical Chemistry, Göttingen, Germany. Probes were
applied onto fixed and permeabilised cells in 1:200 dilution in 1X PBS for 20 min
at RT and afterwards thoroughly rinsed with 1X PBS (up to 10-15 times) (Khuong
et al., 2013; van den Bogaart et al., 2011).
2.6.2 Delivery of PIP3
PIP3 was delivered to the cells via PIP3-shuttle kit from Echelon Bioscience Inc.,
following the manufacturers rules. In brief, PIP3, labeled with BODIPY-FL, was
mixed with Histone H1 carrier (either labeled with TMR or non-labeled) in the 1:1
molar ratios (30 µm working concentration was used in the current experiments) for
15 minutes at RT. Formed complex was diluted to a desired working concentration
with 100 µl of SuperSato medium and applied on cells for 20 min at RT, using the wet
chamber and sterile conditions. After incubation with PIP3, cells were transferred
into fresh SuperSato and returned to the incubator. After 24 hrs cells were fixed
and immunolabelled. The positive delivery was trekked by a positive green signal
from labelled BODIPY-FL-PIP3. Delivery in the control cells was controlled by a
red signal from Histone H1, labelled with TMR-dye.
2.7 Biochemistry
2.7.1 SDS-PAGE – Sodium Dodecyl Sulphate Polyacrylamide
Gel Electrophoresis
Polyacrylamide gels with ionic detergent sodium dodecylsulfate (SDS-PAGE)
were used for the analytical electrophoresis of proteins (Laemli U.K., 1970). Proteins
were separated due to their electrophoretic mobility in vertical electrophoresis sys-
tem Bio-Rad Mini-PROTEAN (Bio-Rad Laboratories GmbH, München, Germany)
in Tris-glycine buffer (25 mM Tris, 192 mM glycine, 0.1% SDS) for 2 – 3 h at 100 V.
Resolving and stacking gels composition are listed below (Table 2.8 and Table 2.9).
In general, prior the loading on the gel, samples were incubated at 60-65◦C for
10 min in sample buffer in non-reducing conditions(Table 2.10).
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Table 2.8: Stacking gel for SDS-PAGE
Acrylamide/bis-acrylamide solution 4%
Tris/HCl, pH 6.8 125 mM
SDS 0,1%
Ammonium persulfate (APS) 0.05%
N’N’N’-tetramethylethylene diamine (TEMED) 0.005%
Table 2.9: Resolving gel for SDS-PAGE
Acrylamide/bis-acrylamide solution 12%
Tris/HCl, pH 8.8 375 mM
SDS 0.1%
Ammonium persulfate (APS) 0.05%
N’N’N’-tetramethylethylene diamine (TEMED) 0.005%
Table 2.10: Non-reducing sample buffer





Molecular weights of the analysed proteins were estimated according to protein
molecular weight, using a marker PageRuler R. Plus Pre-stained Protein Ladder
(Fermentas, St. Leon-Rot, Germany).
2.7.2 Western Blot
Western blot analysis was used for identification and quantification of the proteins
of interest. After SDS-PAGE separation, proteins were transferred onto Whatman
R Protran Nitrocellulose Transfer Membrane (Whatman GmbH, Dassel, Germany).
Transfer was performed for 1 hour, at 100 V in a transfer buffer (Table 2.11), in
Bio-Rad Mini-Protein System (Bio-Rad Laboratories GmbH, München, Germany).
Subsequently, membranes were subjected to immunological detection. To decrease
the nonspecific binding, membranes were first incubated in the 5% non-fat dried milk
(Sigma-Aldrich Chemie GmbH, München, Germany) in PBST (PBS, as described
in Table 2.4, supplemented with 0.1% Tween-20), for 30 min with mild agitation.
Overnight incubation with primary antibodies with appropriate dilution in PBST,
at +4◦C followed. Three washing steps in PBST, for 15 min each, were applied
to remove the unbound antibodies, and secondary anti-mouse or anti-rabbit, HRP-
conjugated (horse reddish peroxidase) antibodies (Dianova, Hamburg, Germany), in
1:2000 dilution in PBST were applied for detection. Following 1 hr at RT incu-
bation, washing steps were repeated. The feature of HRP-enzyme, conjugated to
the secondary antibodies, is the ability to excite luminol substrate by oxidising it;
this results in a light emission. Therefore, labelled proteins on a membrane, were
visualised by this chemiluminescence approach with Pierce ECL Western Blotting
Substrate from Thermo Scientific (Epsom, United Kingdom). Developed X-ray films
(CL-XPosureTM Film, ThermoScientific, Rockford, IL, USA) with detected chemi-
luminescent signals were scanned with a conventional scanner and the signal densities
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were quantified with ImageJ Gel Analysis plugin.





Visualisation of some of the SDS-PAGE was performed by "Quick Coomassie"
protocol (Fairbanks et al., 1971). Solutions for this protocol are listed in Table
2.12. In brief, SDS-gels were boiled in the microwave for 30 sec in each solution
subsequently; each boiling followed by 5 min agitation on a shaker. The last washing
step was done with the ddH2O.
Table 2.12: Solutions for Quick Coomassie
Solution A
Isopropanol 750 ml
Acetic acid 300 ml
Coomassie R-250 1,5 g
Total volume (with dH2O) 3 L
Solution B
Isopropanol 300 ml
Acetic acid 300 ml
Coomassie R-250 150 mg
Total volume (with dH2O) 3 L
Solution C
Acetic acid 300 ml
Coomassie R-250 60 mg
Total volume (with dH2O) 3 L
Solution D
Acetic acid 300 ml
Total volume (with dH2O) 3 L
2.7.4 Preparation of large unilamellar vesicles (LUVs) and
their pull-down with MBP
To investigate binding preferences of MBP to phosphatidylinositols in vitro,
method of liposomal pull-down was used. Liposomes were generated with the fol-
lowing composition: PC:PE, PC:PS, PC:PIP2, PC:PIP3, with the 80 to 20 ratio.
All lipids (except of PIP3) were purchased from Avanti Polar Lipids Inc. PIP3 was
acquired from Echelon Bioscience Inc. Preparation of LUVs was done as described
in (Aggarwal et al., 2011). In brief, lipids were taken in the appropriate molar ratios
and mixed in 500 µl of chloroform. The solvent was then evaporated in a Speed-Vak
centrifuge for 2 hrs, at 30◦C. Dried films were further resuspended in LUVs buffer
(50 mM HEPES, 100 mM NaCl, pH 7.4) to a 1 mg/ml concentration and extensively
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vortexed. Translucent solution was further sonicated on the water bath for 15-20
minutes, at 70◦C, until the solution became transparent. On this step the multi-
lamellar vesicles (MUVs) were generated. To receive the large unilamellar vesicle
from this mixture, the Avanti Polar Lipid Extrusion protocol was applied. MUVs
were subjected to 5 freeze/thaw cycles (liquid nitrogen/60◦C bath, respectively) with
a subsequent 10 extrusion cycles through the extruder (Avanti Polar Lipid manufac-
turer protocol). LUVs with 1000 nm size were generated. The size was controlled
via pore diameter of the filter used in the extrusion procedure. Prepared LUVs were
mixed with 14kDa recombinant MBP (purified by Steffen Frey, Cellular logistics de-
partment, Max Planck Institute for Biophysical Chemistry, Göttingen, Germany)
and incubated for 10 min RT, until a precipitates were visible. Mixture was then
spinned down at the maximum speed for 15 min. Supernatant and pellet were ap-
plied as separate samples on SDS-PAGE gel and visualised after gel run by Quick
Coomassie protocol. Band density quantifications were performed using ImageJ Gel
Analysis plugin.
2.7.5 Soluble/insoluble actin fractionation
To determinate the amount of filamentous (F) and globular (G) actin within cells
the method of soluble/insoluble actin fractionation was used (Papakonstanti, 2007).
In brief, cells, grown on the coverslip for 3 or 5 days, were incubated with 500 µl of
Triton-buffer for 5 min on ice. Supernatant with soluble proteins was collected. Next,
cells were scrapped from the coverslip in 500 µl RIPA-buffer. Any remaining insolu-
ble material was removed by centrifugation (max speed, 10 min). Supernatants were
collected and subsequently processed with SDS-PAGE and Western Blot analysis.
Anti-actin mouse IgG primary antibodies were used for the both fractions recogni-
tions. Quantification of the density bands was performed with ImageJ Gel Analysis
plugin. For the Triton- and RIPA-buffer solutions see Table 2.13 and Table 2.14.
Table 2.13: Triton-extraction buffer
Triton X-100 0,3%








sodium orthovanadate 1 mM
leupeptine 10 µg/ml
aprotinine 20 µg/ml
Adjust the pH to 7.4.
2.7.6 BSA-coupling of artificial lipids
To enable incorporation into cellular membranes, lipids of interest were primarily
coupled to bovine serum albumin (BSA) as described in (Martin & Pagano, 1994)
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Table 2.14: RIPA-extraction buffer
Triton X-100 1%





Adjust the volume with Millipore H2O.
Before use add:
sodium orthovanadate 1 mM
DTT 1 mM
Adjust the pH to 7.4.
with slight modifications. Lipids were first reconstituted in desired concentrations
in the chloroform/methanol solution; liquid was further aspirated to create a lipid
films. 75 nmol lipid films were redissolved in 10 µl of absolute ethanol and vortexed
vigorously. 1 ml of defatted BSA (in Dulbecco’s Modified Eagle Medium DMEM
without phenol-red, buffered with 10 mM HEPES) was added in equimolar concen-
tration to the lipids. Solution was centrifuged at the maximum speed for 3 min to
remove any clumps. Supernatant was stored at -20◦C.
2.7.7 Incorporation of the artificial lipids
To incorporate lipids into cellular membranes, cells were first washed with the
10 mM HEPES-buffered DMEM medium without phenol-red (HDMEM, ice-cold).
Next, BSA-lipid complexes, diluted in HDMEM, were added in the appropriate con-
centrations onto cells in the wet-chamber on ice for 30 min. After incubation, cells
were briefly washed with ice-cold HDMEM and immediately imaged to prevent fur-
ther internalization of lipids. The fluorescent lipophilic organic dye Atto647N (ex-
citation max at 645 nm, emission max at 670 nm; Atto-Tec, Siegen, Germany) was
used as a marker of the incorporated lipids (Eggeling et al., 2009). Cerebroside C23:0
was labelled with KK114 dye.(red emission, Rhodamine family (Wurm et al., 2012).
Lipids, used for the incorporation and diffusion measurements are listed in Table
2.15.
Table 2.15: Artificial lipids for STED-FCS
Label Name Labelling type Reference in text
Atto647N-PE N -(Atto647N)-1,2-dihexadecanoyl-sn-
glycero-3-phosphoethanolamine
head group labelling PE








Thr-Cer-KK114 Cerebroside C23:0 KK114 as 3rd chain labelling 23C-GalC
Lipids were labelled either at the head group (PE), meaning at the water phase
or lipid-water interphase, or via replacement of one the native lipid acyl chains by
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the short acyl chain carrying a dye (acyl-chain replacement – SM, GalC). In case of
23C-GalC, label was introduced as a third chain. Throughout the text these lipids
will be refereed simple as PE, SM, GalC and 23C-GalC. All aforementioned lipids
are the courtesy of the C. Eggeling group from the NanoBiophotonics department,




Fluorescence correlation spectroscopy is a powerful method of time-averaging
fluctuation analysis that is sensitive and statistically robust. Recorded fluctuations
arise due to the behaviour of the trespassing molecules within the illuminated focal
area. These averaged fluctuations δF of the recorded signal F(t) are autocorrelated,
giving the normalised fluctuation autocorrelation function G(τ c) (Magde, 1974).
G(τc) =< δF (t)× δF (t+ τ) > /[F (t)2] (2.1)
Here τ c represents a correlation lag time and triangular brackets indicate averag-
ing over measurements time t.
FCS data recorded for free two-dimensional Brownian lipid diffusion would be
described by following model:





Here, τD is the average transit time of a fluorophore with an apparent diffusion
coefficient D through the observation area of diameter d. The decrease of the di-
ameter of the focal area also contributes to the precise data accumulation with FCS
method: the smaller the observation field, the higher chances to distinguish trap-
ping of the molecule from their slow, but free diffusion. Confocal FCS set-ups are of
course limited in this regard, but this is where a potent STED (stimulated emission
depletion microscopy) technique comes into play.
The main principle of STED nanoscopy lies in th reversible inhibition of the
fluorescence emission of a fluorophore by high power stimulated emission, typically
at the red edge of the spectrum. STED light emission inhibits the fluorescence
everywhere around, except the lone spot within the doughnut-shaped laser beam
(Hell & Wichmann, 1994; Hell, 2009). Changing the STED power, one can modify
the diameter of the doughnut center, therefore changing the size of the effective
fluorescent region.
In our study we investigated the mode of lipid diffusion within the myelin mem-
brane. To elucidate this question, we used a combined STED-FCS technique that
allows to go below conventional diffraction barrier and distinguish diffusion behaviour
on the nanoscale.
In the STED-FCS approach, data of the lipid diffusion are collected for different
STED powers P -STED, meaning for different diameters d (Mueller et al., 2013). To
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deal with the anomalous diffusion in the FCS model an anomalous diffusion exponent
α is introduced into the equation 2.4 (Wachsmuth et al., 2000).





Here, again, τD is the average transit time of a fluorophore with the apparent
diffusion coefficient D through the focal detection area of diameter d. In case of free
Brownian motion, D is constant for different d, therefore τD has a linear dependence
with the focal area d2. However, an event of anomalous diffusion brings a variation
in D with d2. This variation depends on the spatial and temporal characteristics of
the anomalous diffusion trigger (time of the trapping, size of the obstacle, nature
of the interactions, etc). Moreover, one can further extract information and param-
eters to describe anomalous diffusion, in addition to the anomaly parameter 1/α.
Upon calibration of the STED-FCS set-up for the lipid marker Atto647N by SSLBs
measurements, the dependence between the diameter d of the focal area and STED
powers (P)STED is known. Fitting correlation data into equation 2.4, one can obtain
the average transit time τD and plot it against the focal area d2 (Wawrezinieck et al.,
2005). Linear relationship would represent free Brownian diffusion. Any fluctuations
from the linear dependence would indicate an event of trapping, resulting in the
decrease of τD with d2 and a concave function of d2. In contrary, hindered diffusion
within a meshwork or hopping-like diffusion would show an increase in the τD with
d2 and a convex function of d2(Wawrezinieck et al., 2005; Lenne et al., 2006; Mueller
et al., 2013).
STED-FCS experimental setup
The STED nanoscope was based on a home-built confocal microscope setup
equipped with a 640 nm laser (100 ps pulse width, LDH-D-C-640, PicoQuant, Berlin,
Germany) for excitation of the Atto647N dye (ATTO-TEC). The STED beam was
provided by a Titanium:Sapphire laser system (Chameleon, Coherent Inc.) oper-
ating at 780 nm with a repetition rate of 90 MHz. The time interval between the
pulses of both lasers was adjusted using a home-built electronic delay unit, where
the STED pulses served as the trigger master. The STED laser pulses were stretched
from 200 fs to a pulse length of approximately 180 ps using four 30 cm optical SF6
glass rods and a 125 m long polarisation maintaining single-mode fibre (AMS Tech-
nologies). Fluorescence excitation and collection was done using an oil immersion
objective (APON 60x, NA=1.49, Olympus). The laser beams were spatially overlaid
and the fluorescence light filtered by dichroic filters (AHF Analysentechnik). The
doughnut-shaped focal spot of the STED beam featuring a central zero intensity was
produced by introducing a phase-modifying plate (RPC Photonics) into the beam
path, imprinting on the wave front a helical phase ramp exp(iφ) with 0 ≤ φ ≤ 2π.
A λ/4-plate ensured circular polarisation of the STED and excitation beams. The
fluorescence was coupled into a multi-mode fibre splitter (Fibre Optic Network Tech-
nology) with an aperture size corresponding to 1.4x the magnified excitation spot.
The 50:50 split fluorescence signal was then detected by two single-photon counting
modules (avalanche photo diode SPCM-AQR-13-FC, Perkin Elmer Optoelectronics)
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and the recorded fluorescence counts were further processed by a hardware correlator
card (Flex02-01D, Correlator.com). The focal intensity distribution of the excitation
and STED light were measured by scanning a scattering gold bead of 80 nm in diam-
eter (gold colloid, En.GC80, BBinternational) using a non-confocal detector (MP 963
Photon Counting Module, Perkin Elmer). The laser powers P were measured directly
at the sample plane. Together with the full-width-at-half-maximum FWHM (corre-
sponds to effective beam diameter) of the focal laser intensity distribution (≈240 nm
for 640 nm wavelength) they allow for the calculation of the time-averaged intensity,
I (see Eq. 2.6, usually ≈ 22 kW/cm2 stemming from P=10 µW for the excitation
light and ≈ 309 MW/cm2 stemming from P = 140 mW for the highest STED power.
I = P/[π(FWHM/2)2] (2.6)
STED-FCS calibration
Supported lipid bilayers (SLBs) were used to calibrate the STED-FCS setup. The
SLBs were prepared based on a procedure described elsewhere (Mennicke & Salditt,
2002). Briefly, the lipid DOPC (1,2-dioleoyl-sn-glycero-3-phosphocholine, Avanti)
and a fluorescent lipid analogue (DPPE-Atto647N) were mixed in organic solvents
(Chloroform/MeOH 1:1) at a lipid concentration of 1 mg/ml. The ratio of labelled
lipids per non-labelled ones was approximately 1:10000. 50 µl of such solution were
dropped onto a plasma-cleaned (Femto-RF, Diener Electronic) standard microscope
cover glass (diameter 22 mm, no. 1.5 thickness) and spin-coated at 60 Hz for about
one minute. The cover glass was then placed in a microscopy chamber and subse-
quently the dry thin lipid film was rehydrated with 500 µl buffer solution (150 mM
NaCl, 10 mM HEPES). Such bilayers were stable for several hours.
Calibration of the diameter d(PSTED) of the effective focal fluorescence spots
formed by a certain STED power PSTED was performed by STED-FCS measurements
of fluorescent lipid analogues in supported lipid bilayers (SLBs), for that such lipid
bilayers provide a two-dimensional free diffusing system of molecules, labelled with
the same fluorophore used in our cellular experiments. The confocal FWHM being
determined by fluorescent beads (d(PSTED = 0)≈ 240 nm), the other effective dia-
meters d(PSTED 6= 0) can be calculated by performing STED-FCS measurements








In Eq. 2.7, τD stands for the transient times correspondent to each given PSTED.
The relation above stems from the hypothesis that the lipids in SLBs undergo abso-
lute two-dimensional free diffusion, so that the diffusion time scales proportionally
with the diffusion area.
STED-FCS cellular measurements
Day 5 oligodendrocytes and PtK2 cells were grown on standard glass coverslips
(diameter 18 mm, no. 1.5 thickness) to a confluence of about 80% at 37◦C in a
water-saturated atmosphere of 5% CO2 in the air. Incorporation of the fluorescent
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lipid analogues (lipid-Atto647N) by cells was accomplished via BSA coupling. Mea-
surements were performed at 23◦C in HDMEM.
We assessed the dynamics of fluorescent lipid analogues by placing the focused co-
centred excitation and STED beams on random positions at the plasma membrane
and completed all measurements before any significant morphological changes in
the cell could occur. All measurements were carried out during 10 s, providing a
correlation time longer than two orders of magnitude times the typical transient
time of the labelled lipids through the confocal observation area. The calculated
apparent diffusion coefficient for each given effective beam diameter resulted from
the average of measurements performed in different cells. For each cell analysed,
the calculated apparent diffusion coefficient for each given effective beam diameter,
resulted from the average of at least 2 and up to 8 repetitions of the STED-FCS
measurement at the given cell. For each given effective beam diameter, the averaged
values obtained from individual cells were then averaged so that the correspondent
s.e.m. reflects the variance among cells.
STED-FCS analysis
Correlation data were recorded with lipid concentrations resulting in a temporal
average of particle number N ≈ 0.5 – 10 fluorescent particles for the highest STED
depletion and N ≈ 10 – 200 fluorescent particles for confocal recording. We fitted all
correlation data with a model for two-dimensional (possibly anomalous) diffusion, re-
sulting in different values of the average transient time τD and anomaly parameter α.
Free diffusion corresponds to α = 1, while anomalous diffusion displays lower values
of α. Nevertheless, bad fits may also result in low α, reason why we systematically
discarded the infrequent data (<5%) that was fitted with α <0.50 (pre-established
criterion). Each individual measurement resulting in a transient time τD, the corre-
spondent diffusion coefficient D was calculated based on the knowledge of the effective
beam diameter, provided by the calibration of the system:
D = d2/(8τDln(2)) (2.8)
2.8.2 Confocal Microscopy
For morphological examination of myelin membrane sheets produced by primary
oligodendrocytes we chose laser scanning confocal microscopy. This technique gives
an advantage of high resolution in combination with control over depth of field, which
is invaluable for the analysis of organisation of thin membrane sheets.
Confocal microscopic images were acquired with Leica DMIRE2 microscope and a
Leica TCS SP2 AOBS confocal laser scanning setup (Leica Microsystems, Mannheim,
Germany). 40X NA 1.25 or 63X NA 1.4 oil plan-apochromat objectives (Leica Mi-
crosystems, Mannheim, Germany) were used for image acquisition.
2.9 Image Processing and Statistical Analysis
Images were processed and analysed with the public domain Java-based image
processing software ImageJ (created by Rasband, W.S., National Institutes of Health,
57
Materials & Methods
Bethesda, Maryland, USA), or with an MBF collection of plugins for ImageJ ("MBF
ImageJ for Microscopy”).
Quantification of relative cell surface area occupied by the myelin proteins oligo-
dendrocytes was performed using the following options in ImageJ: application of
threshold from background (with the Segmentation Plugin to avoid user-bias from
manual setting of the threshold (Chen & Leung, 2004)), defining cell area (Freehand
selection tool), followed by measurement of the area fraction, occupied by the signal
(Set measurements – Area fraction – Measure).
SDS-PAGE gels, stained with Coomassie and Western blot membranes densit-
ometric analysis was carried out on the blot and gel scans with the ImageJ Gel
Analyser plugin: Analyse – Gels – Select lanes – Plot lanes – Measure peak areas.
Statistical analysis was performed using GraphPad Prism software (Table 2.2):
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can ever prove me right; a single




Part I: Lipid dynamics and
organisation in the myelin membrane
sheets
This part of my thesis presents results from investigation of lipid behaviour within
oligodendrocyte sheets. Since myelin in vivo is a system of the wrapped membrane
layers around the axon, assessment of a single-layered membrane becomes challeng-
ing. In our studies we used a well-established 2D model of the myelin sheath – cul-
tured oligodendrocytes (Aggarwal et al., 2011). Mouse oligodendrocytes are grown
on coverslips and expand their sheath-like structures (sheets) that are easy to study
with microscopy methods.
3.1 Cultured oligodendrocytes as a model system
Primary cell culture was extensively used in this work. With respect to the mature
oligodendrocyte morphology, two major subcellular domains were distinguished: cell
body together with the processes and most outer part of the cell (referred to as rim)
and thin flat membrane expansions in between the processes, referred to as sheets.
2′,3′,-cyclic-nucleotide-phosphodiesterase (CNP) was used as a marker for the former
domain, and myelin basic protein (MBP) for the latter one (Figure 3.1). The day
of the seeding (shake) is referred to as day 0. We further classify cells, based on
their morphological appearances. On day 1 after shake the majority of cells on the
coverslip are represented by oligodendrocyte precursor cells (OPC) with only several
brunched processes and no sheets (Figure 3.1, A1-A3). After three days in culture
(day 3), majority of the cells on the coverslip have CNP-positive sheets in between
the brunched processes. MBP-positive regions start to appear at this stage. Cells
at this stage are referred to as immature and they are characterised morphologically
by a large rim. This is a stage of the active growth of the oligodendrocytes (Figure
3.1, B1-B3). After five days in culture (day 5), majority of the cells have MBP-
positive compacted sheets, with CNP being present only in processes and outer rim.
Processes become less brunched. Cells on this stage are referred to as the mature.
They are characterised morphologically by a small rim and decrease in the number
of processes(Figure 3.1, C1-C3).
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Figure 3.1: Domains of oligodendrocytes, cultivated in vivo. Cultured oligodendro-
cytes were fixed with 4% paraformaldehyde and 0.25 % glutaraldehyde (PFA 4% + GTA 0.25
%) on day 1 (A1-A3), day 3 (B1-B3) and day 5 (C1-C3). After fixation cells were incubated with
anti-MBP antibodies (in green – A1, B1 and C1) to visualise a start of the MBP expression (B1,
white arrowhead) and compact membrane sheets (C1, white arrowhead). Anti-CNP antibodies
were used to visualise non-compact sheets on day 1 (red, A2), non-compact regions on day 3 (red,
B2, green arrowhead) and non-compact processes (C2, blue arrowhead) and outer rim (C2, yellow
arrowhead) on day 5. Scale bar = 10 µm.
3.2 Unique features of myelin membrane sheath that
influence lipid behaviour
In contrast to artificial membranes (SSLBs, liposomes, black membranes) where
lipid diffusion is free, in the plasma membrane lipid diffusion might exhibit anomalous
behaviour. Anomalous diffusion in the cellular membrane occurs due to the protein-
protein interactions, confinements of the protein cytoplasmic tails by cytoskeleton
and self-organisation of the lipids into the microdomains with changed membrane
order and viscosity (Owen et al., 2009). Membrane lipids show different behaviour
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throughout a cellular membrane. This behaviour is classified into free diffusion, tran-
sient trapping and hopping. It was shown that cortical actin has a large influence
on lipid dynamics in the membrane, however this impact is mostly indirect. Actin
anchors various transmembrane proteins by their cytoplasmic tails and aligns them
along the actin cytoskeleton, thus creating rows of pickets against the free diffusion
of lipids. Moreover, when transmembrane proteins get immobilised, the viscosity of
the membrane around it becomes higher, due to hydrodynamic friction effects at the
surface of the immobilised protein. Therefore, when there is a high number of an-
chored transmembrane proteins aligned along the actin cytoskeleton, this contributes
to the changes in the lipid behaviour (Kusumi & Suzuki, 2005).
Additionally, lipid diffusion was shown to depend on cholesterol level in the mem-
brane (Eggeling et al., 2009; Mueller et al., 2011). The lipid-ordered phase, created
by cholesterol-rich domains, dramatically decreases free diffusion of lipids, enhancing
lipid trapping, in comparison to the disordered phase, albeit for short distances (<20
nm) and for short periods of time (10-20 ms) (Eggeling et al., 2009).
Studies of lipid diffusion were performed on different cell types, all of them,
however, sharing a very common membrane composition. Myelin lipid composition is
very distinct from the usual cellular membrane. Myelin membrane has an increased
number of highly saturated long-chain fatty acids together with high cholesterol
amount. In addition, protein number in myelin is very scarce with the ratio of 80%
of lipids and only 20% of proteins with myelin basic protein (MBP) and proteolipid
protein (PLP) being the most prominent ones. Additional feature comes from myelin
development: upon maturation the amount of the filamentous actin dramatically
drops, leaving an adult myelin membrane without any cortical actin cytoskeleton
underneath. Role of MBP as an extruder that creates this specific protein-poor
and lipid-enriched membrane where cytoskeleton meshwork is absent was extensively
discussed (Aggarwal et al., 2013; Aggarwal et al., 2011; Yurlova et al., 2011).
Dynamical aspects of the lipids within myelin sheath haven’t been addressed
before. Therefore, the aim of this part of my PhD project was to shed some light on
the lipid behaviour in this specific environment.
The most powerful method to resolve modes of diffusion and diffusion coefficients
with high precisions is fluorescence correlation spectroscopy (FCS), combined with
stimulated emission depletion microscopy (STED) (see Section 2.8.1 in Methods)
(Eggeling et al., 2009; Sahl et al., 2010). The limitation of resolution to 250 nm due
to the diffraction limit restricts confocal microscopy from the differentiation between
free and hindered diffusion of molecules on small scales. However, the subdiffraction
spot, created by STED beam on top of the confocal focal spot makes it possible
to study lipid diffusion within a subdifraction spot. Assuming that freely mov-
ing molecule dwells only shortly within the STED detection area, whereas trapped
molecules stay longer, it is possible to precisely distinguish restricted movements
from free diffusion.
PtK2 fibroblast cell line was taken as a control cellular system for our studies.
Lipid dynamics and behaviour were thoroughly characterised in these cells elsewhere
(Eggeling et al., 2009; Mueller et al., 2011). It was shown, for instance, that actin
and cholesterol amount have a major influence on the lipid diffusion in these cells.
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Figure 3.2: Diffusion coefficient of the PE, SM and GalC in oligodendrocytes is higher
than in PtK2 cells. Cultured oligodendrocytes on day 5 were incubated with a mixture of BSA-
coupled artificial lipids labelled with Atto647N. After 30 minutes incubation with BSA-coupled
lipids, oligodendrocytes were subjected to a STED-FCS. PtK2 control cells were subjected to the
same procedure. Diffusion coefficients were measured at the smallest effective STED beam diameter
(d = 40 nm, highest STED power) for the PE, SM and GalC for PtK2 (green) cells and oligoden-
drocytes (blue). Diffusion coefficient for PE is very similar in both cellular systems, although it is
slightly higher in oligodendrocytes . GalC and SM diffusion is faster in oligodendrocytes, than in
PtK2 cells. N = 20 cells, error bars represent s.e.m.; * – p < 0.05, *** – p < 0.0001, t-test.
3.3 Lipid diffusion in oligodendrocyte sheets versus
PtK2 cell membrane
To determine the dynamical properties of the lipids (diffusion coefficient and
mode of diffusion) within the oligodendrocyte sheet we used the following Atto647N-
labelled artificial lipids, as analogs of the endogenous membrane lipids:
• N -(Atto647N)-1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine as an ana-
log of phosphatidylethanolamine (referred to as PE);
• N -(Atto647N)-sphingomyelin as an analog of sphingomyelin (referred to as
SM);
• N -(Atto647N)-galactosylsphingosine as an analog of galactosylcerebroside (re-
ferred to as GalC).
These lipids were introduced into the membrane via BSA-coupled method, see
Section 2.7.6 inMethods. Measurements of the dynamical characteristics where taken
on the STED-FCS setup and analysed in collaboration with D. M. Andrade (depart-
ment of NanoBiophotonics, C. Eggeling group, Max Planck Institute for Biophysical
Chemistry, Göttingen, Germany).
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To assess the mode of lipid diffusion, we measured the diffusion coefficient for the
highest STED power (DSTED) at effective beam diameter (d) of the observation area
of 40 nm. As it is illustrated in the Figure 3.2, values for the diffusion coefficient
of PE in PtK2 cells and oligodendrocytes, measured at the highest STED power
(that is with the smallest observation area for the molecule to cross), are similar:
0.48 µm2/s ± 0.05 s.e.m. for the PtK2 cells and 0.51 µm2/s ± 0.05 s.e.m. for the
oligodendrocytes. However, values for the diffusion coefficient for SM and GalC
are strikingly different between the two cell types: slow diffusion for the SM (0.19
µm2/s ± 0.016 s.e.m.) and GalC (0.32 µm2/s ± 0.026 s.e.m.) in the PtK2 and
fast in oligodendrocytes: 0.45 µm2/s ± 0.06 s.e.m. for SM and 0.42 µm2/s ± 0.044
s.e.m. for GalC.
Next, we divided values of diffusion coefficient, acquired at the highest STED
power, by values of diffusion coefficient measured at confocal effective beam diameter
(Dconf ) (d = 250 nm). DSTED/ Dconf provide us with a value of D-ratio: represen-
tation of the level of anomality of the diffusion. The closer D-ratio is to 1, the lower
is anomality of the diffusing molecule and vice versa. Based on the experimental
data (Mueller et al., 2011), we chose D-ratios below 0.5 to describe an anomalous
diffusion.
As it is shown in Figure 3.3, PE and SM in oligodendrocytes have a tendency
to the free diffusion mode, since their D-ratio approaches 1. GalC in oligodendro-
cytes shows a tendency to an anomalous diffusion, however not as prominent as in
PtK2 cells. D-ratio in oligodendrocytes for GalC – 0.62 µm2/s ± 0.07 s.e.m., for
SM – 0.86 ± 0.13 s.e.m., and for PE – 0.73 ± 0.09 s.e.m. In the case of PtK2
cells, only D-ratio for the PE indicates free diffusion (D-ratio = 1.16 ± 0.13 s.e.m.),
whereas D-ratios for SM and GalC are low (0.44 ± 0.06 s.e.m. and 0.42 ± 0.06
s.e.m. , respectively) and show an anomalous diffusion. Since D-ratio for GalC in
oligodendrocytes is very close to an anomalous diffusion threshold, we decided to
further analyse the diffusion behaviour of tested lipids.
To further distinguish an anomalous diffusion from a free behaviour we used a
method, proposed by Lenne and co-workers (Lenne et al., 2006). In this method,
one measures diffusion coefficient at different STED powers, starting from 250 nm of
the confocal effective beam diameter and down to the lowest STED effective beam
diameter possible (usually the lowest effective beam diameter is setup-dependent).
The values of the diffusion coefficient are then plotted as a function of the corre-
sponding STED effective beam diameter [τD(d2)]. The acquired plot was named
FCS diffusion law or FCS diffusion plot (Wawrezinieck et al., 2005). For each type
of the anomalous diffusion the simulated slope fits are calculated. This simulations
are used to fit experimental data. In brief, the expected τD(d2) dependencies from
the theoretical fit are as follows: τD is expected to vary linearly with d2 for free
diffusion; τD is a concave function of d2 for transient trapping into nanodomains.
To build our experimental FCS diffusion plots, we measured diffusion coefficients
at different STED powers, from 250 nm of confocal effective beam diameter to 40 nm
of the last effective STED beam diameter, with several steps in between. Acquired
FCS diffusion laws for the oligodendrocytes and PtK2 cells are shown in the Figure
3.4. Based on the proposed theoretical fits, PE, and SM in oligodendrocytes exhibit
free diffusion without trapping, whereas only PE in PtK2 cells undergoes a free
diffusion, with SM and GalC being strongly trapped (Mueller et al., 2011). GalC in
oligodendrocytes has a slight trapping, however, not as strong as in PtK2 cells.
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Figure 3.3: Diffusion ratio of PE, SM and GalC in oligos is higher than in PtK2
cells. Cultured oligodendrocytes on day 5 were incubated with a mixture of BSA-coupled artificial
lipids labelled with Atto647N. After 30 minutes incubation with BSA-coupled lipids, oligodendro-
cytes were subjected to a STED-FCS. PtK2 control cells were subjected to the same procedure.
Diffusion ratio, as a measure of the anomalous diffusion, is shown for PE, SM and GalC. D-ratio
is acquired by dividing diffusion coefficient measured at the STED lowest effective beam diame-
ter (40 nm) by diffusion coefficient measured at the confocal effective beam diameter (250 nm):
DSTED/Dconf . This value represents the anomality of the diffusion: the more D-ratio deviates
from 1, the more anomalous is the diffusion. D-ratio lower than 0.5 was considered to indicate
trapping. N = 20 cells, error bars represent s.e.m.
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Figure 3.4: FCS diffusion plots for SM and PE in oligodendrocytes demonstrate free
diffusion mode, and decrease of trapping for GalC. Cultured oligodendrocytes on day 5
were incubated with a mixture of BSA-coupled artificial lipids labelled with Atto647N. After 30
minutes incubation with BSA-coupled lipids, oligodendrocytes were subjected to a STED-FCS.
PtK2 control cells were subjected to the same procedure. (A) Representative shapes of the curves
for free diffusion and trapping are depicted. FCS diffusion plots for GalC (B), PE (C) and SM (D)
in oligodendrocytes (green) and PtK2 (red) cells. N = 20 cells, error bars represent s.e.m.
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3.4 Mimicking the oligodendrocyte sheets in PtK2
cells
A cellular system to reconstitute myelin sheets in fibroblasts was recently de-
veloped (Aggarwal et al., 2013). In brief, a chimeric construct that contains MBP,
transmembrane domain, GFP, and endoplasmatic reticulum (ER)-retention signal
(MBP-GFP-TM) was designed (Figure 2.1 in Methods Section 2.4.4). PtK2 cells,
transfected with this chimeric construct hereafter are referred to as PtK2-MBP+.
Upon transfection of PtK2 fibroblast cell line, this construct gets anchored within the
ER membrane, with GFP inside the ER lumen and MBP facing the plasmalemma.
Here MBP interacts with the negatively charged lipids and brings two adjacent mem-
branes (ER and cellular) together. The areas where MBP brings in contact two mem-
branes are GFP-positive (Figure 3.5). In a number of experiments it was shown that
these MBP+ GFP-positive regions closely resemble oligodendrocyte sheets: filamen-
tous actin is depleted in these regions, cytoplasm is squeezed out and cytoplasmic
and transmembrane proteins are extruded (Aggarwal et al., 2013). Representative
images of the transfected PtK2-MBP+ cells are shown in Figure 3.5: middle panel
(Figure 3.5 B1-B3) shows absence of actin in the MBP+ GFP-positive regions and
lower panel (Figure 3.5 C1-C3) depicts extrusion of glycoproteins.
We used this sheet-mimicking system as a convenient tool to answer the question
whether MBP might influence lipid behaviour. We performed measurements of the
lipid diffusion in the GFP-positive MBP+ regions of PtK2 cells transfected with
MBP-GFP-TM. Values of diffusion coefficient and D-ratios, acquired for PE, SM and
GalC in PtK2-MBP+ cells, compared to previous data from control (non-transfected)
PtK2 cells and oligodendrocytes, are shown on Figure 3.6 and Figure 3.8.
Interestingly, diffusion coefficient at 40 nm effective STED beam diameter in the
PtK2-MBP+ for all three lipids was very high: 0.73 µm2/s ± 0.07 s.e.m. for GalC,
0.73µm2/s ± 0.08 s.e.m. for PE and 0.75 µm2/s ± 0.0 s.e.m. for SM, in comparison
to PtK2 control cell and oligodendrocytes (Figure 3.6).
Figures 3.7 and 3.8 show D-ratio and FCS diffusion laws for the lipids of interest
in three cellular systems. As we can see from these data, mode of diffusion for PE
remains the same. However its speed changes: within the PtK2-MBP+ regions PE
becomes faster than in oligodendrocyte sheets. Diffusion mode of the SM and GalC
changes drastically: trapping disappears. Thus, in the regions where MBP brings two
adjacent membranes together creating sheets-like structures, mode of lipid diffusion
changes from trapping to free diffusion, together with an overall increase of the
diffusion velocity.
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Figure 3.5: Oligodendrocyte sheets and sheets-like regions within PtK2-MBP+ cells
are free of actin and glycoproteins. Cultured oligodendrocytes were fixed with PFA 4% + GTA
0.25 % on day 5 and incubated with WGA-488 leptin (A1, cyan in A4), Rhodamine-phalloidin (A2,
red in A4) and anti-MBP antibodies (A3, green in A4) to visualise glycoproteins, actin and compact
membrane sheets, respectively. Cultured PtK2 cells were transfected with MBP-encoding construct
(PtK2-MBP+) (B-C) and fixed with PFA 4% + GTA 0.25% 16 hours after transfection. MBP+
regions were highlighted due to GFP expression (B1, C1, green in B3 and C3). After fixation
cells were incubated with Rhodamine-phalloidin (B2, red in B3) and WGA-488 leptin (C2, red in
C3), to visualise actin and glycoproteins, respectively. Glycoproteins and actin are absent in both,




Figure 3.6: Diffusion coefficient of the SM and GalC in PtK2-MBP+ regions is higher
than in oligodendrocyte sheets and control PtK2 cells. Cultured oligodendrocytes on day
5 were incubated with a mixture of BSA-coupled artificial lipids labelled with Atto647N. After
30 minutes incubation with BSA-coupled lipids, oligodendrocytes were subjected to a STED-FCS.
PtK2 control cells were subjected to the same procedure. Cultured PtK2 cells were transfected
with MBP-encoding construct (PtK2-MBP+) and lipid diffusion within MBP-positive regions was
measured 18 – 20 hours post transfection. MBP+ regions within transfected cell were visualised
due to GFP-expression. Artificial lipids were introduced into the membrane of transfected cells via
BSA-coupled method, see Section 2.7.6 in Methods. PE, SM and GalC diffusion coefficients were
acquired at the highest STED power (d = 40 nm) for PtK2 (green), oligodendrocytes (blue), and
PtK2-MBP+ (red) cells. Diffusion coefficient for PE is very similar in all cellular systems. GalC
and SM diffusion is faster in oligodendrocytes, than in PtK2 cells and even faster in PtK2-MBP+
regions, compared to the oligodendrocyte sheets. N = 20 cells, error bars represent s.e.m.; * – p <
0.05, *** – p < 0.0001, t-test.
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Figure 3.7: Diffusion ratio of the PE, SM and GalC in PtK2-MBP+ regions is higher
than in oligodendrocyte sheets and control PtK2 cells. Cultured oligodendrocytes on day
5 were incubated with a mixture of BSA-coupled artificial lipids labelled with Atto647N. After
30 minutes incubation with BSA-coupled lipids, oligodendrocytes were subjected to a STED-FCS.
PtK2 control cells were subjected to the same procedure. Cultured PtK2 cells were transfected with
MBP-encoding construct (PtK2-MBP+) and lipid diffusion within MBP+ GFP-positive regions was
measured 18 – 20 hours post transfection. MBP+ regions within transfected cell were visualised
due to GFP-expression. Artificial lipids were introduced into the membrane of transfected cells via
BSA-coupled method, see Section 2.7.6 in Methods. Diffusion ratio, as a measure of the anomalous
diffusion, is shown for PE, SM and GalC. D-ratio is acquired by dividing diffusion coefficient at the
STED lowest effective beam diameter (40 nm) by diffusion coefficient at the confocal effective beam
diameter (250 nm): DSTED/Dconf . This value represents the anomality of the diffusion: the more
D-ratio deviates from 1, the more anomalous is the diffusion. D-ratio lower than 0.5 was considered
to indicate trapping. N = 20 cells, error bars represent s.e.m.
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Figure 3.8: FCS diffusion plots for SM, PE and GalC in PtK2-MBP+ regions demon-
strate absence of the anomalous diffusion. Cultured oligodendrocytes on day 5 were incubated
with a mixture of BSA-coupled artificial lipids labelled with Atto647N. After 30 minutes incuba-
tion with BSA-coupled lipids, oligodendrocytes were subjected to a STED-FCS. PtK2 control cells
were subjected to the same procedure. Cultured PtK2 cells were transfected with MBP-encoding
construct (PtK2-MBP+) and lipid diffusion within MBP+ GFP-positive regions was measured 18
– 20 hours post transfection. MBP+ regions within transfected cell were visualised due to GFP-
expression. Artificial lipids were introduced into the membrane of transfected cells via BSA-coupled
method, see Section 2.7.6 in Methods. FCS diffusion plots for GalC (A), PE (B) and SM (C) in
oligodendrocytes (green), PtK2 (red) and PtK2-MBP+ (blue) cells are shown. According to the
plots, all three lipids tested exhibit a free diffusion within MBP+ GFP-positive regions of trans-
fected PtK2, when compared to control PtK2. Moreover, lipids within MBP+ domains have a
faster diffusion, when compared to oligodendrocytes and control PtK2 cells. N = 20 cells, error
bars represent s.e.m.
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3.5 Effects of fatty acid chain length
All lipids that are described in this study contain short-chain (C16) fatty acids.
As was mentioned before, myelin sheaths are enriched in long-chain fatty acids lipids
(C20, C23, C24) that influence the thickness of the myelin membrane. Length of
the fatty acid chain might have an impact on diffusion properties. Therefore, we
used an additional artificial lipid – Thr-Cerebroside-KK114 – as a long-chain analog
of the endogenous galactosylcerebroside (GalC), further referred to as 23C-GalC.
This lipid was labelled with KK114 dye and not with Atto647N. Data was collected
only for the control PtK2 cells and transfected PtK2-MBP+ (Figure 3.9). We did
not observe any difference between both cell systems. In both systems 23C-GalC
was extremely slow: in control cells the diffusion coefficient was 0.29 µm2/s ± 0.03
s.e.m. and in MBP-PtK2+ – 0.25 µm2/s ± 0.025 s.e.m. Intriguingly, in both systems,
23C-GalC had a free mode of diffusion (Figure 3.9 B and C). Since the 23C-GalC
lipid is labelled with another dye, a possible impact of the labelling should be taken
into account when comparing the data to the short-chain GalC. So far, we base our
conclusions only on the measurements acquired from the short-chain lipids.
Based on the data obtained so far, we suggest an absence of constrained diffu-
sion in oligodendrocyte sheets for the short-chain lipids. MBP might contribute to
the membrane lipid rearrangements to facilitate this uniform lipid distribution, via
extruding proteins and, most importantly actin, from underneath the membrane.
This results in the release of membrane lipids from the constrains for free diffu-
sion the proteins usually create. Thus, short-chain lipids, regardless of their nature




Figure 3.9: Diffusion characteristics for 23C-GalC in PtK2 control and PtK2-MBP+
cells. Cultured control PtK2 cells were incubated with a mixture of BSA-coupled 23C-GalC. After
30 minutes incubation PtK2 cells were subjected to a STED-FCS. Cultured control PtK2 cells were
transfected with MBP-encoding construct (PtK2-MBP+) and lipid diffusion within MBP+ GFP-
positive regions was measured 18 – 20 hours post transfection. MBP+ regions within transfected cell
were visualised due to GFP-expression. 23C-GalC was introduced into the membrane of transfected
cells via BSA-coupled method, see Section 2.7.6 in Methods. Diffusion characteristics for 23C-GalC
in PtK2 control and PtK2-MBP+ cells are shown in the graphs. (A) Diffusion coefficient acquired
at the highest STED power for PtK2 control (black) and PtK2-MBP+ (grey). N = 5 cells. (B)
Diffusion ratio, as a measure of the anomalous diffusion, is shown for 23C-GalC. D-ratio is acquired
by dividing diffusion coefficient measured at the STED lowest effective beam diameter (40 nm) by
diffusion coefficient measured at the confocal effective beam diameter (250 nm): DSTED/Dconf .
This value represents the anomality of the diffusion: the more D-ratio deviates from 1, the more
anomalous is the diffusion. D-ratio lower than 0.5 was considered to indicate trapping. D-ratio
for 23C-GalC suggests a free diffusion in both cellular systems for this lipid. (C) FCS diffusion
law of 23C-GalC for PtK2 control (light blue) and PtK2-MBP+ (green). According to the plots,
23C-GalC exhibits a free diffusion in the both cellular systems. N = 3 cells.
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Part II: Polarity of the
phosphatidylinositols in the
oligodendrocytes
3.6 Distribution of phosphatidylinositols in oligoden-
drocytes
Under the common term cellular polarity one describes the asymmetric organi-
sation of the cell, including cellular surface components, intracellular organelles dis-
tribution and cytoskeleton rearrangements. Polarity is a ubiquitous feature among
all species in all classes of eucariotes, from the unicellular yeast, to the multicellu-
lar organisms. Cellular polarity of the plasma membrane is an important regulator,
involved in all crucial organismal life points, from the global events of cellular mi-
gration, tissue formation and differentiation during the development, to the more
minor, such as epithelium function maintenance, blood cell migration and cellular
division (Mellman & Nelson, 2008).
There are several common mechanistic themes, simple variation of which results
in the perfect orchestration of the polarity events (for more information, see Section
1.6).
Polarity plays an important role in the development of CNS and PNS. Polari-
sation of axons occurs very early in the development, when the growth cone of a
neuron starts to extend towards the gradient, established by growth factors. This
extension is characterised by accumulation of PIP3 in the growing tip, followed by
axon polarisation and further outgrowth. Oligodendrocytes, the myelin producing
cell in the CNS, are also polarised and form specific domains, both in vivo and in
vitro (Figure 1.9 and Figure 3.1).
This part of my PhD thesis was aimed to explore the polarised distribution of
phosphatidylinositols in the oligodendrocytes, using 2D cultures of the mouse oligo-
dendrocytes, as a model system.
3.6.1 Defining the differential localisation of PIP2 and PIP3 in
the mature oligodendrocytes
In this Section, the morphological characterisation of the phosphatidylinositols lo-
calisation within the membrane of cultured oligodendrocytes is described. Analysis
was performed using immunocytochemistry, associated with laser scanning confocal
microscopy.
First, immunocytochemical analysis with anti-PIP2 and anti-PIP3 antibodies re-
vealed very poor detection of these phosphatidylinositols within all parts of oligoden-
drocytes (Figure 3.10 A-B). It was reported that phosphatidylinositols are extremely
sensitive to the fixative agents due to their easy extractability form the membrane
75
Results
during fixation. In our case, usage of only 4% PFA led to washing out most of the
phosphatidylinositols, leading to dramatic signal decrease. However, mixing 4% PFA
with 0.25% GTA (Sharma et al., 2008) resulted in a significant increase of the signal
quality and overall signal-to-noise ratio (Figure 3.10 C-D). All further immunolabel-
ing protocols were done, using 4% PFA with 0.25% GTA as a fixatives.
Immunocytochemical analysis, with a proper fixating conditions revealed simi-
lar localisation of phosphatidylinositols in the mature oligodendrocytes: both were
mostly enriched in the non-compact domains (Figure 3.11).
Due to its highly positive charge, MBP interacts directly with negatively charged
phospholipids of the inner leaflet (Musse et al., 2008; Harauz et al., 2009; Nawaz
et al., 2009). We suggested that such interaction might occur as well between MBP
and phosphatidylinositols in the inner leaflet of the myelin membrane in the compact
region. This interaction might have influenced the immunolabelling, by masking the
phosphatidylinositol epitopes from the antibodies. To elucidate this we detached
MBP from the membrane with subsequent labelling of PIP2. MBP detachment upon
Ionomycin treatment of the cells is an established method by Nawaz (2009). Indeed,
after 2 min of Ionomycin treatment, we could detect an increase of the PIP2 signal
within the sheets (Figure 3.12 A-B). Intriguingly, we haven’t observed any changes
within PIP3 localisation upon Ionomycin treatment (Figure 3.12 C-D).
To support our findings, we used an alternative to conventional antibodies la-
belling: small molecular probes, possessing PH-domains that specifically recognise
either PIP2 (mCitrine-PLCγ) or PIP3 (mCherry-Grp1), (Figure 3.13) (van den Bo-
gaart et al., 2011). Cells were treated with Ionomycin, as described previously.
Again, consistent with the antibody labelling, upon detachment of MBP from the
membrane we could identify PIP2 (Figure 3.13 A-B), but not PIP3 (Figure 3.13 C-D)
in the sheet region. Quantifications of the signal intensity distribution from processes
to sheets upon Ionomycin treatment shows that the PIP2 signal in sheets remains on
the same level, as in processes, whereas PIP3 signal drops (Figure 3.13 E and F).
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Figure 3.10: Fixative agents extract PIP2 and PIP3, decreasing efficiency of antibody
labelling. Cultured oligodendrocytes were fixed with 4% paraformaldehyde (PFA 4%) (A-B) or
with 4% paraformaldehyde, combined with 0.25 % glutaraldehyde (PFA 4% + GTA 0.25%) (C-D)
on day 5. After fixation cells were treated with anti-MBP antibodies (in green – A1, B1, C1,
D1) to visualise membrane sheets, and either with anti-PIP2 (red – A2, C2) or anti-PIP3 (cyan
– B2, red – D2) antibodies to visualise localisation of phosphatidylinositols. Phospholipids are
easy to extract from the cellular membrane, hence the appropriate fixative agent is of a great
importance. Enrichment of 4% paraformaldehyde fixative with 0.25% of glutaraldehyde increased
fixation reaction speed and thus both PIP2 and PIP3 are better preserved within the membrane
(C-D), in comparison to 4% paraformaldehyde alone (A-B). Scale bar = 10 µm.
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Figure 3.11: PIP2 and PIP3 are found in the processed and in the rim of mature
oligodendrocytes. Cultured oligodendrocytes were fixed with PFA 4% + GTA 0.25% on day 5.
After fixation, cells were treated with anti-MBP antibodies (green – A1 and B1) to visualise sheets
and either with anti-PIP2 (red – A2) or anti-PIP3 (red – B2) antibodies to visualise localisation of
phosphatidylinositols. Distribution of the signal intensity (intensity density) for PIP2 and PIP3 is
shown as a line profile plot (C). Antibody signal for PIP2 and PIP3 was measured from a middle
of process as a starting point and towards the sheet as an end point (40 µm of the total length
measured). Signal distribution between PIP2 (grey) and PIP3 (black) varies only slightly. Scale
bar = 10 µm. Error bars represent s.e.m. N = 3, with at least 20 cells per experiment.
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Figure 3.12: PIP2, but not PIP3 is masked by MBP in the sheets of oligodendro-
cytes. Cultured oligodendrocytes on day 5 were treated with 10 µM Ionomycin to detach MBP
from the membrane (Nawaz et al., 2009) and subsequently fixed with PFA 4% + GTA 0.25%. Af-
ter fixation, cells were treated with anti-MBP antibodies (green – A1-D1) to visualise sheets and
either with anti-PIP2 (red – A2, B2) or anti-PIP3 (red – C2, D2) antibodies to visualise locali-
sation of phosphatidylinositols. Upon the shift of intracellular membrane charge, MBP detached
from the membrane with subsequent PIP2 exposure (unmasking). This resulted in the increase of
anti-PIP2 antibody signal in the sheet region (B2). Interestingly, Ionomycin treatment of oligo-
dendrocytes did not lead to an increase of PIP3 signal in the sheets and PIP3 remained enriched
strictly at the margins and processes zones (D2). Line profile plot of the signal intensity densities
of PIP2 (E, black squares – control, grey squares – after treatment) and PIP3 (F, black squares
– control, grey squares – after treatment) demonstrates the effect of Ionomycin treatment on the
PIP3 distribution. Antibody signal for PIP2 and PIP3 was measured from a middle of a process
as a starting point and towards the sheet as an end point (40 µm of the total length measured).
PIP2 signal increases drastically, upon its unmasking from MBP, with PIP3 showing the same ten-
dency as in the non-treated condition. Scale bar = 10 µm. Error bars represent s.e.m. N = 3, with
at least 20 cells per experiment.
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Figure 3.13: PIP3 localises strictly to the processes and the rim in oligodendrocytes.
Cultured oligodendrocytes on day 5 were treated with 10 µM Ionomycin to detach MBP from
the membrane (Nawaz et al., 2009) and subsequently fixed with PFA 4% + GTA 0.25%. After
fixation, cells were treated with small fluorescent probes to visualise PIP2 (mCitrine-PLC, yellow
– A1, B1) or PIP3 (mCherry-Grp1, red – C2, D2) and with anti-MBP antibody (cyan – A2,
B2 and green – C1, D1) to visualise sheets. Upon the shift of intracellular membrane charge,
MBP detached from the membrane with subsequent PIP2 exposure (unmasking). This resulted
in the increase of anti-PIP2 antibody signal in the sheet region (B1). Ionomycin treatment of
oligodendrocytes did not lead to an increase of PIP3 signal in the sheets and PIP3 remained enriched
strictly at the margins and processes zones (D2). (E) Line profile plot of the signal intensity densities
of PIP2 (grey squares) and PIP3 (black squares) demonstrates the effect of Ionomycin treatment
on the phosphatidylinositols distribution. Antibody signal for PIP2 and PIP3 was measured from
a middle of a process as a starting point and towards the sheet as an end point (25 µm of the total
length measured). As in the case of immunocytochemistry, upon Ionomycin treatment, PIP2 gets
visible in sheets whereas enrichment of PIP3 remains strictly at the cell margins and processes
zones. Scale bar = 10 µm. Error bars represent s.e.m. N = 3, with at least 20 cells per experiment.
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3.6.2 Defining the onset of the separate localisation of phosphati-
dylinositols
Next, we addressed the question at what point of the oligodendrocytes devel-
opment this segregation of phosphatidylinositols occurs. Thus, we labelled phos-
phatidylinositols in the OPC (day 1 cells in culture) to visualised their localisation
on the early developmental stage. Intriguingly, both phospholipids showed rather uni-
form distribution over the sheet region (Figure 3.14), with PIP3 levels being slightly
higher at the rim and in the processes (Figure 3.14 B2). We could conclude, thus,
that PIP2 and PIP3 are first uniformly distributed and their segregation occurs only
upon cell maturation.
To further support our findings, we decided to transfect oligodendrocytes with
plasmids including specific PH-domains, fused to GFP: PLC-GFP for PIP2 recogni-
tion and Akt-GFP for PIP3 recognition. Transfection of oligodendrocytes was done
at two different developmental stages: matured cells – day 4 and immature cells –
day 1, with subsequent staining either at day 5 (Figure 3.15 C-D) or at day 2 (Figure
3.15 A-B), after 16-18 hours post-transfection.
At the early stage, PIP2 and PIP3 were uniformly distributed over the sheet
region. Upon cell maturation, signal from both phosphatidylinositols became visible
only in the rim and processes. This cellular localisation of PIP3 is in line with the
observation from the antibody labelling. Residing of PIP2 in the non-compact rim
and processes at the mature stage was expected, due to the fact that MBP does
not permit bulky proteins (as PLC-GFP is) to enter the sheet region at this stage
(Aggarwal et al., 2011).
3.6.3 Role of MBP in the localisation of phosphatidylinositols
The major change that distinguish between immature oligodendrocytes from ma-
ture ones is a presence of MBP-zipped sheets. Hence, based on the knowledge that
MBP was reported to interact with negatively charged lipids, we though that this
protein might be involved in the active segregation of two different phosphatidyl-
inositols’ species into separate domains.
To test this assumption, we used an MBP-free model system: oligodendrocytes de-
rived from the shiverer mutant mice. These cells still are able to develop sheets,
however these structures remain unzipped, due to the lack of MBP expression. We
again performed antibody staining (Figure 3.16) to address the question, whether
the presence of MBP is crucial for the phosphatidylinositols differential location.
Intriguingly, shiverer oligodendrocytes did not exhibit phosphatidylinositols sep-
aration on the mature stage: both, PIP2 and PIP3 are distributed throughout sheets
and processes (Figure 3.16). Therefore, these experiments supported our idea that
for phosphatidylinositols to be separated into different domains MBP presence is
crucial.
3.6.4 MBP interactions with differently charged phosphati-
dylinositols
It was shown previously that MBP interaction with phosphatidylinositols is of
an electrostatic nature (Musse et al., 2008; Harauz et al., 2009; Nawaz et al., 2009).
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Figure 3.14: PIP2 and PIP3 localise to the sheets at the early stages of oligodendro-
cytes. Cultured oligodendrocytes on day 1 were fixed with PFA 4% + GTA 0.25%. After fixation,
cells were treated with anti-CNP (red – B1) and anti-O1 (cyan – A2) to visualise yet non-compact
sheet regions of the immature cell, with anti-MBP antibody (grey – A4, B4) to ensure that cells
reside in the immature stage and with anti-PIP2 (red – A1) and anti-PIP3 (cyan – B2) to visu-
alise phosphatidylinositols localisation at the early stage. Antibody labelling at this stage revealed
that PIP2 starts to fill up the sheet before MBP translation takes place. PIP2 is more uniformly
distributed throughout the sheet (A1), than PIP3, with latter one being more pronounce in the
process region and on the rim (B2). Scale bar = 10 µm.
Albeit, from results acquired so far, we observed that MBP masked only PIP2, but
not PIP3. Therefore, we asked the question, whether MBP interacts with PIP3.
To answer this question, we performed a liposomal pull-down of MBP. In this assay,
phosphatidylcholine was chosen to be a liposome "body". PIP2 was used as a positive
control; phosphatidylserine and PIP3 – as examples of lipids with one and three
negative charges, respectively. Non-charged phosphatidylethanolamine was used as a
control. MBP was added to the each fraction of the liposomes in the non-saturating
conditions. After incubation time, samples were centrifuged (see Methods Section
2.7.4 for details). Acquired pellet and supernatant were separately applied onto SDS-
PAGE gel and stained with Coomassie after gel run to determine in what fraction
MBP amount was higher (Figure 3.17 A). We expected MBP to precipitate upon
binding with negatively charged liposomes and therefore to be enriched in the pellet
fractions (Figure 3.17 B). According to the liposomal pull-down, MBP indeed did
not exhibit a preferential binding to any of the negatively-charged lipids tested.
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Figure 3.15: PIP3 localisation changes from uniformly distributed to processes and rim-
enriched upon oligodendrocytes maturation. Cultured oligodendrocytes were transfected
either on day 1 (A1-B4) or on day 4 (C1-D3) with either PIP2-specific plasmid (PLC-GFP, green
– A1, C1), or PIP3-specific plasmid (Akt-GFP, green – B1, D1). Cells, transfected on day 1 were
fixed with PFA 4% + GTA 0.25% after 18 – 20 hours post-transfection (on day 2) and treated with
anti-O1 antibody to visualise non-compacted sheets on day 2 (red – A2, B2) and with anti-MBP
antibody (grey – A4, B4) to ensure absence of MBP expression. Cells, transfected on day 4 were
fixed with PFA 4% + GTA 0.25% after 18 – 20 hours post-transfection (on day 5) and treated
with anti-MBP antibody (red – C2, D2) to visualise compact sheets. When cells were transfected
on day 1, PIP2- and PIP3-specific constructs were uniformly spread over whole cellular membrane
after 18 hours post-transfection (A1 and B1). When cells were transfected on day 4, PIP2- and
PIP3-specific constructs were both residing in the processes and cellular margins after 18 hours
post-transfection (C1 and D1). This cellular localisation of PIP3 on day 5 is in line with the
observation from the antibody labelling. Residing of PIP2-specific construct in the non-compact
rim and processes at the mature stage was expected, due to the fact that MBP does not permit
bulky proteins (as PLC-GFP is) to enter the sheet region at this stage (Aggarwal et al., 2011).
Scale bar = 10 µm.
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Figure 3.16: PIP2 and PIP3 are uniformly distributed in the membrane of oligoden-
drocytes from shiverer mice. Cultured oligodendrocytes from shiverer mice were fixed with PFA
4% + GTA 0.25% on day 5 and treated with anti-O1 (cyan – B1) and anti-CNP (cyan – B2) to
visualise non-compact sheets of the mutant cell and with anti-MBP antibody (grey – A4, B4) to
ensure that cells was shiverer and did not express MBP. Anti-PIP2 (red – A1) and anti-PIP3 (red
– B1) antibodies were used to visualise localisation of phosphatidylinositols. Line profile plot of the
signal intensity densities of PIP2 (C, grey squares) and PIP3 (C, black squares) demonstrated equal
distribution of PIP2 and PIP3, disregarding membrane region (compare to Figure 3.11). Antibody
signal for PIP2 and PIP3 was measured from a middle of a process as a starting point and towards
the sheet as an end point (40 µm of the total length measured). Scale bar = 10 µm. Error bars
represent s.e.m. N = 3, with at least 10 cells per experiment.
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Figure 3.17: Pull-down of MBP by liposomes with different negatively charged lipids
composition did not reveal preference of MBP binding to any of the phosphatidylinos-
itols. Liposomes, composed of phosphatidylcholine as a liposomal ’body’ and different negatively
charged lipids (PIP2 as a positive control; PIP3 and phosphatidylserine (PS) as triple- an single-
charged carriers) were prepared in a 80:20 ratio. Non-charged phosphatidylethanolamine (PE) was
used as a control. After incubation time, samples were centrifuged (see Methods Section 2.7.4 for
details). Acquired pellet and supernatant were separately applied onto SDS-PAGE gel and stained
with Coomassie after gel run to determine in what fraction MBP amount was higher (A, sup –
supernatant, pel – pellet). Relative amount of MBP in each fraction was calculated, based on the
relative densities of the Coomassie-stained bands (B). Liposomes with non-charged PE (control) did
not pull-down MBP efficiently. MBP from the pellet in this case might come from its spontaneous
oligomerisation and aggregation. Liposomes with phosphatidylserine (PS), PIP2 and PIP3 could
precipitate MBP into the pellet, completely removing it from the supernatant. This data revealed
no preferences of MBP binding to a particular kind of negatively-charged phospholipids tested. N
= 3, error bars represent SD.
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3.7 PIP3 influences non-compact region of the oligo-
dendrocytes
Establishment of polarity plays an immense role in many processes in our organ-
ism, both in development and in adolescence. Brief overview of the factors, involved
in the cellular polarity regulation, including phosphatidylinositols, is provided in
Section 1.6 of Introduction. As it has been already mentioned, oligodendrocytes are
morphologically polarised. This work has also demonstrated the existence of the
phosphatidylinositol ’ polarity in cultured oligodendrocytes. Our next question was:
what role does polarity of phosphatidylinositols play in oligodendrocyte development.
3.7.1 Interference with the endogenous PIP3 levels in the oligo-
dendrocytes
Approach 1: increase of the PIP3 amount via inhibition of PTEN
One of the major pathways that regulates levels of PIP3 and PIP2 in the distinct
compartments of the cell is the mutual interconversion of these lipids by two enzymes:
PI3K and PTEN. Phosphorylation by kinases (PI3K) produces PIP3 out of PIP2, and
dephosphorylation of PIP3 by PTEN leads to generation of PIP2. Despite the fact
that PTEN dephosphorylation of PIP3 is not the only pathway of the PIP3 turnover
executed within the cells, it is considered to be a the major one (Sasaki et al., 2009).
To interfere with endogenous PIP3 and PIP2 levels, we chose to use VO-Ohpic
inhibitor (further referred to as VOOH) due to its high specificity and low toxicity
at a low dosage (Tanaka et al., 2010; Katso et al., 2001).
Due to the former observation that separation of phosphatidylinositols occurs
after the MBP translation (between day 2 and day 3 in culture), we applied PTEN
inhibitor at the early developmental stage, namely on day 1 (24 hrs after shake), with
subsequent additional application on day 2 (48 hrs after shake). Cells were grown
till day 3 in culture, fixed and immunolabelled for compact and non-compact regions
(MBP and CNP respectively). Additionally, cells were cultivated till mature stage –
day 5 – and fixed at this time point.
As a control for the successful PTEN inhibition we checked for the differences in
the PIP3 amounts (Figure 3.18). As it was expected, PTEN inhibition with VOOH
resulted in increased levels of endogenous PIP3.
Since PTEN is a known inhibitor for the cellular growth and proliferation, next
question we would like to address was whether oligodendrocytes would have a faster
rate of the sheet development upon PTEN inhibition. Hence, we subjected oligoden-
drocytes to the PTEN inhibitor treatment 16 hrs after shake, left cells to grow for
another 12 hrs and then fixed and stained them for membrane sheet marker, CNP.
The read out of this experiment was the amount of the oligodendrocytes that already
on day 2 have developed CNP-positive and yet MBP-negative sheets. Figure 3.19
demonstrates that upon PTEN inhibition, oligodendrocytes tend to develop their
sheets more rapidly than under normal circumstances.
To further describe morphological changes, size of the growth zone (outer rim
region) and non-compact regions were quantified (Figure 3.20). In this experiment,
cells were harvested either on their immature stage (day 3), or were allowed to reach
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Figure 3.18: Treatment with 200 pM PTEN inhibitor leads to the increased amount
of endogenous PIP3 in oligodendrocytes on day 3. Cultured oligodendrocytes were fixed
with PFA 4% + GTA 0.25% on day 3. After fixation cells were treated with anti-MBP antibodies
(green – A1, B1) to visualise membrane sheets, and with anti-PIP3 (red – A2, B2). White dashed
lines in A2 and B2 highlight the edges of the cells. Scale bar = 10 µm. (C) Quantification of the
cell area, occupied by PIP3 in % of the total cell area, with (VOOH) and without (cntrl) PTEN
inhibition. Mean ± s.e.m. , N= 2, at least 15 cells per experiment, * = p < 0.05, t-test.
maturation (day 5). VOOH was not applied to the cells between day 3 and day 5. To
check whether normal cell morphology could be restored in the post-mature phases of
the development, a population of cells was placed in the fresh medium without VOOH
after maturation and they were kept in culture for the additional two days (till day
7) (Figure 3.20 B). The growth zone size showed a significant increase only on day
5. Size of the growth zone was again restored after inhibition removal (Figure 3.20
B). When VOOH was not removed on day 5, cellular morphology was not restored
(data not shown). Increase of the non-compact area after VOOH treatment was
observed at immature and mature stages. Moreover, even at the very late stage of
development (day 7 and 10), oligodendrocytes after VOOH treatment had increased
size of the non-compact regions (Figure 3.20 C).
Since the growth zone was increased upon treatment of cells with VOOH, we also
quantified amount of phosphoAkt. Phosphorylated Akt is an active form of Akt, one
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Figure 3.19: Treatment with 200 pM PTEN inhibitor leads to the increased amount of
oligodendrocytes with CNP-positive, but yet MBP-negative sheets on day 2. Cells were
treated with the PTEN inhibitor after 16 hours after the plating on the coverslips and fixed after
24 hours with PFA 4% + GTA 0.25%. After fixation cells were treated with anti-MBP (green – A1)
and anti-CNP (red – A2) antibodies to determine oligodendrocytes CNP-positive and MBP-negative
sheets. The percentage of cells with CNP-positive/MBP-negative sheets were calculated from the
total amount of cells per coverslip (B). Upon PTEN inhibition (VOOH), there were more cells with
CNP-positive and yet MBP-negative sheets at the early stage of the development, compared to the
non-treated (cntrl). Data shown in the % of the total cells. N > 700 cells per condition.
of the downstream effectors of the activated mTOR pathway and therefore might be
used as an indicator of the growth pathway enhancing. Akt becomes phosphorylated
upon its binding to the membrane via PH-domain that recognises PIP3 (Wood et al.,
2013). As it was expected, PTEN inhibition with VOOH resulted in increased levels
of activated phosphoAkt (Figure 3.21).
Furthermore, different concentrations of the VOOH were tested to see the concen-
tration-dependent impact on the non-compact area. As Figure 3.22 demonstrates,
the difference in the area between compact and non-compact regions was detectable
already upon administration of 100 nM VOOH during first 48 hrs after shake. MBP-
positive areas decrease drastically, whereas CNP-positive area of the processes in-
creases together with the growth zone (the rim). This coincides with the increase of
the phosphorylated Akt, and therefore hinted to an overall activation of the growth
regulating mTOR pathway. Together with a prolonged (48 hours) treatment, a short
4 hours (acute) exposure to the high dosage of 1µM of VOOH on day 3 only was
done. This acute treatment also resulted in the increase of the non-compact region
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Figure 3.20: Treatment with 100 nM PTEN inhibitor leads to an increase of rim size,
as well as an increase of the non-compact regions. (A) Overview of the experiment: cells
were treated repeatedly with 100 nM VOOH (blue drop – A) on day 1 and day 2 after seeding and
fixed either on day 3 (immature), or on day 5 (mature). Fresh medium (yellow drop – A) was applied
to the part of the cells after day 5 and they were allowed to grow in the fresh medium till day 7. In
this case we tried to assess the reversibility of the PTEN inhibition effects. Batches of cells from day
3, day 5, day 7 and day 10 were fixed with PFA 4% + GTA 0.25% and analysed for morphological
changes. Letters above the arrows indicate which graph corresponds to the experimental setup.
After fixation cells were treated with anti-MBP and anti-CNP antibodies to determine compact
and non-compact regions, respectively. (B) Rim size (growth zone) increases on day 3 and day
5 upon treatment with 100 nM VOOH, in comparison to the non-treated (cntrl) cells. Mean ±
s.e.m. of the rim size (µm). (C) Non-compact myelin area is increased in the late developmental
stages of oligodendrocytes (day 7 and day 10) upon treatment with 100 nM of VOOH, in comparison
to the non-treated (cntrl) cells. Mean ± s.e.m. of % of the area, occupied by the non-compact region
(CNP as a marker). For all graphs: N=3, minimum of 30 cells per experiment, *** = p < 0,001,
one-way ANOVA with Tukey post-test.
(Figure 3.22,F1-F3).
Summarising the data acquired after PTEN inhibition in the oligodendrocytes at
the early stages of development, one can conclude that these observations illustrate
an importance of the phosphatidylinositol homeostasis for the establishment of the
proper ratio of the compact/non-compact regions.
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Figure 3.21: Treatment with 200 pM PTEN inhibitor leads to the increased amount
of phosphoAkt in oligodendrocytes on day 3. Cells were treated on day 1 and day 2 after
plating with 100 nM VOOH and fixed on day 3 with PFA 4% + GTA 0.25%. After fixation cells
were treated with anti-MBP antibodies (red – A2, B2) to visualise membrane sheets, and with anti-
phosphoAkt (green – A1, B1). Scale bar = 10 µm. (C) Quantification of the cell area, occupied by
phosphoAkt in % of the total cell area, with (VOOH) and without (cntrl) PTEN inhibition. Mean
± s.e.m. , N= 2, at least 15 cells per experiment, ** = p < 0.01, t-test.
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Figure 3.22: Treatment with 100 nM PTEN inhibitor leads to the increase of non-
compact region and decrease of the compact domain in oligodendrocytes on day 3.
Cells were treated on day 1 and day 2 after plating with the given concentration of the inhibitor
and fixed on day 3 with PFA 4% + GTA 0.25% (A-E). Short treatment for 4 hours with high
concentration (1 µM) of VOOH was done on day 3 only and cell were fixed on day 3 with PFA 4%
+ GTA 0.25% (F1-F3). After fixation cells were treated with anti-MBP antibodies (green – A1–
F1) to visualise membrane sheets, and with anti-CNP (red – A2–C2 and cyan D2–F2) to visualise
non-compact regions. Scale bar = 10 µm. (C) Quantification of the fold change in the MBP to
CNP ratio upon different concentrations of VOOH and without (cntrl). Mean ± s.e.m. , N= 5, at
least 15 cells per experiment, *** = p < 0.001, one-way ANOVA with Tukey post-test.
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Approach 2: increase of the PIP3 amount via delivery of exogenous PIP3
Delivery of the phosphatidylinositols with a shuttle system is an established
method to study their cellular role (Tian et al., 2003). Therefore, we decided to
use this approach as an alternative to the PTEN inhibition to avoid some bias from
the inhibitor treatment.
Cells were subjected to the BODIPY-FL-labelled PIP3 delivery during their im-
mature stage (day 3) and allowed to grow for two days (48 hours). MBP and CNP
were used to visualise compact and non-compact cellular domains. Control cells were
treated only with an empty cargo carrier (Figure 3.23). We didn’t observe changes
in the compact/non-compact ratio upon exogenous PIP3 delivery. Rim size also
remained unaffected upon these conditions.
3.7.2 Actin as a downstream effector of the PIP3 signalling
Molecular relations between actin and PIP3 are briefly summarised in the Section
1.3.2 of the Introduction. We decided to investigate, whether increase of PIP3 in the
oligodendrocytes due to the PTEN inhibition would lead to the subsequent rise in
the filamentous actin levels.
First, cells were treated with different concentrations of VOOH during first 48
hours after shake (Figure 3.24 A2-A4). Additionally, a separate batch of cells was
treated only for 4 hours on day 3 with high concentration (1 µM) of VOOH (acute
treatment) (Figure 3.24 A5). Filamentous actin was visualised with Rhodamine-
labeled phalloidin. Both treatments did not result in any particular changes in the
filamentous actin amount during the growth phase on day 3 (Figure 3.24 B).
Next, cells were again treated with with different concentrations of VOOH during
first 48 hours after shake and filamentous actin was visualised with Rhodamine-
labeled phalloidin on day 5 (Figure 3.25 A-B). As a result, we could identify a
small increase of the filamentous actin within the mature oligodendrocytes (Figure
3.25 C). Since filamentous actin (F-actin) usually resides within the processes and
the growth zone of the cell, this finding coincides with the previous observation
of the increased outer rim and processes upon PTEN inhibitor administration at
the mature stage of the oligodendrocytes. To further support this observation, we
performed a biochemical extraction of the two distinct fractions of the actin (globular
and filamentous) at the stages of the active growth and complete maturation (Figure
3.25 D). Similar to the immunocytochemistry data, Western blot analysis showed
increased amount of F-actin in VOOH-treated mature (day 5) oligodendrocytes.
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Figure 3.23: Delivery of the exogenous PIP3 did not influence neither morphology, nor
actin amount in the oligodendrocytes on day 3. BODIPY-FL-PIP3 (green – B4, D4) was
delivered into cells, using Histone H1 as cargo-carrier (C2-carrier, non-labelled – A4,C4). Delivery
was held during the active phase of the oligodendrocyte growth (day 3). Cells were allowed to
reach maturation and samples were fixed on day 5 with PFA 4% + GTA 0.25%. After fixation
cells were treated with anti-MBP antibodies (cyan – A2–D2) to visualise membrane sheets, with
anti-CNP (red – A1–B1) to visualise non-compact regions and with Rhodamine-phalloidin (red –
C1-D1) to visualise filamentous actin. Scale bar = 10 µm. (E) MBP to CNP ratio did not change
upon PIP3 delivery, comparing to control (cntrl). The size of the rim was also unaffected (F), as is
the area occupied by actin (G). N = 2, minimum 10 cells per experiment. Mean ± s.e.m.
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Figure 3.24: Treatment with different concentrations of PTEN inhibitor did not affect
filamentous actin amount in oligodendrocytes on day 3. Cells were treated on day 1 and
day 2 after plating with the given concentration of the inhibitor and fixed on day 3 with PFA 4%
+ GTA 0.25% (A2-A4). Acute treatment with 1 µM VOOH (A5) was done only on day 3 for 4
hours, followed by immediate fixation and labelling procedure. After fixation cells were treated
with Rhodamine-phalloidin to visualise filamentous actin. Scale bar = 10 µm. (B) Relative area,
occupied by actin in % of a total cell area upon treatment with different concentrations of VOOH
(A2–A5) and without (control – A1). N = 3, minimum 20 cells per experiment. Mean ± s.e.m.
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Figure 3.25: Treatment with 100 nM PTEN inhibitor resulted in increase of filamen-
tous actin amount in oligodendrocytes on day 5. Cells were treated consequently on day 1
and day 2 after plating with the given concentration of the inhibitor and fixed either on day 3, or
on day 5 with PFA 4% + GTA 0.25%. After fixation cells were treated with anti-CNP antibody
(red – A1, B1) to visualise non-compact domains, Fluorescein-phalloidin to visualise filamentous
actin (green – A2, B2) and anti-MBP antibody (cyan – A4, B4) to visualise sheets. Scale bar = 10
µm. (C) Relative area, occupied by actin in % of a total cell area upon treatment with 100 nM of
VOOH (A2–A5) and without (cntrl). N = 3, minimum 20 cells per experiment. Mean ± s.e.m. ,
* = p < 0,05. (D) Western blot of filamentous (F) and globular (G) actin fractions in the cells at
the stage of the active growth (day 3 cells) and at mature stage (day 5 cells), with (VOOH 100
nM) and without (control) PTEN inhibition. Amount of the filamentous actin is increased in the
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4.1 FCS-STED to study lipid behaviour
Stimulated emission depletion (STED) microscopy is a process that provides su-
per resolution by selectively deactivating fluorophores to enhance the imaging in that
area. It was developed by Stefan W. Hell in 1994 (Hell & Wichmann, 1994). In com-
bination with fluorescence correlation spectroscopy (FCS) it is a powerful method to
study dynamical behaviour of the membrane components, both lipids and proteins.
As has been mentioned before, myelin possess several unique features that dis-
tinguish it from all other membrane types. Briefly, those features are:
• high lipid-to-protein ratio with 80% of the dry weight being lipids;
• prevalence of the long-chain fatty acids within the lipid: more than 20 carbons
in the chain, against 12C-16C;
• high amount of cholesterol;
• enrichment in specific lipid species, such as plasmalogens;
• extrusion of the cytoplasm and almost all cytoplasmic proteins upon matura-
tion by MBP compaction;
• as an important follow-up of the previous feature is an absence of actin cy-
toskeleton within the compact area of myelin;
• large areas of the negatively-charged lipids, sequestered by MBP.
These features of myelin make it hard to apply any of the existent models that
were proposed so far to characterise membrane organisation. For example, "fence
and pickets" models can not be accurate, when applied to myelin membrane, due to
the absence of actin. Therefore there is a need for a new model, especially designed
for myelin, taking into account all the main features known for it. To propose such
a model, one first should investigate how the lipids of the myelin behave within its
specific environment.
Therefore, the goal of this part of my PhD project was to collect data to make
it possible to describe and to understand what are the dynamic characteristics of
lipids, the major components of the myelin membrane and to suggest a model that
would embrace within itself all the main myelin features.
This work was accomplished in collaboration with C. Eggeling group (department
of NanoBiophotonics, Max Planck Institute for Biophysical Chemistry, Göttingen,
Germany). STED-FCS setup and artificially labelled lipids used in these studies
were previously described in Mueller et al. (2011) and Sahl et al. (2010).
To determine the dynamical properties of the lipids (diffusion coefficient and
mode of diffusion) within the oligodendrocyte sheet we used the following Atto647N-
labelled artificial lipids, as analogs of the of the endogenous membrane lipids:
• N -(Atto647N)-1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine as an ana-
log of phosphatidylethanolamine (referred to as PE);




• N -(Atto647N)-galactosylsphingosine as an analog of galactosylcerebroside (re-
ferred to as GalC).
These lipids were introduced into the membrane via BSA-coupled method, see
Section 2.7.6 in Methods
It was previously shown that PE diffuses freely within the plasma membrane, in
contrast to SM which diffusion behaviour was characterised by a strong trapping.
Moreover, when other lipids with ceramide (or sphingosine) backbone were tested,
their behaviour was similar to SM. Therefore, the authors suggested that ceramide
(or sphingosine) backbone might be a reason, why this class of lipids encountered
trapping (Mueller et al., 2011). Hydroxyl and amino groups of the ceramide func-
tion as hydrogen-bond donors close to the water-lipid interface, and might facilitate
hydrogen bonds to (endogenous) membrane components, such as proteins (Pascher,
1976). Moreover, sphingomyelin diffusion and trapping was shown to be dependent
on cholesterol (Mueller et al., 2011; Eggeling et al., 2009). Upon treatment with
cholesterol-depleting agent, a release of SM trapping could be achieved. This was
explained by the authors by the presence of cholesterol-assisted molecular complexes,
that slowed down SM diffusion.
Our experiments suggest that SM in oligodendrocytes was moving faster than in
PtK2 cells (Figure 3.2). This might be explained by an absence of such complexes
in the oligodendrocyte sheets and more uniform distribution of cholesterol in the
membrane. Furthermore, SM diffusion was reported to be dependent on underlying
actin cytoskeleton: upon treatment with actin depolymerising agent (Latrunculin
B), SM diffusion increased (Mueller et al., 2011; Eggeling et al., 2009).
We observed a faster diffusion for PE, SM and GalC in oligodendrocytes, when
compared to PtK2 cells. Moreover, we discovered a complete absence of SM trapping
in the oligodendrocyte sheets and a decreased trapping for GalC. PE showed free dif-
fusion in oligodendrocytes, as well as in control PtK2 cells. Our findings support
the suggested model of Mueller and Eggeling that endogenous SM diffusion depends
strongly on actin (Mueller et al., 2011; Eggeling et al., 2009). Since oligodendro-
cyte sheets are deprived of actin and poor in proteins, no hindrance of the diffusion
speed occurs. GalC might still show some trapping in oligodendrocytes due to the
specific and so far unknown interactions in the myelin sheath.
4.1.1 Impact of MBP on lipid diffusion
A well-characterised system to mimic oligodendrocyte sheets in fibroblast cells
was developed and reported recently (Aggarwal et al., 2013). It is based on the
expression of myelin basic protein (MBP) in the PtK2 cell line that leads to the
formation of the sheet-like structures. We used this PtK2-MBP+ model to address
the question of how MBP-membrane interactions might affect the behaviour of the
lipids in the sheets. Diffusion of SM, PE and GalC in these sheet-like structures of
PtK2-MBP+ cells was calculated using FCS diffusion law approach(Figure 3.8) and
the values were found complementing the ones derived from the oligodendrocytes.
Data from PtK2-MBP+ model suggest that presence of MBP is sufficient to
influence the behaviour of the lipids within the cellular membrane. Upon introducing
MBP in the system, lipid behaviour changed drastically: complete disappearance of
trapping for GalC and SM, together with increased diffusion coefficient for all three
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lipid species measured. It is known that MBP works as an extruder, creating a
protein-poor environment in the myelin sheath (Aggarwal et al., 2013), probably
leading to a decrease of obstacles for the lipid diffusion. Moreover, lack of actin leads
to the absence of membrane compartmentalisation into domains that also contributes
to the free diffusion mode of lipids. Therefore, presence of MBP is sufficient to
promote homogenous organisation of lipids within the oligodendrocyte membrane.
These data can be further extrapolated to the myelin sheath, since our cellular model
was proven to bear enough similarities with its in vivo counterpart (Fitzner et al.,
2006; Yurlova et al., 2011; Aggarwal et al., 2011; Aggarwal et al., 2013; Bakhti et al.,
2011; Bakhti et al., 2013).
One of the myelin membrane characteristics is a high amount of cholesterol in the
membrane. Diffusion speed values suggest a rather mild effect of cholesterol: all lipids
tested in oligodendrocyte membrane diffused slower, in comparison to their diffusion
in PtK2-MBP+ cells. We hypothesise that cholesterol becomes also homogeneously
distributed within the oligodendrocyte sheet membrane, rather than accumulate in
specific cholesterol-rich domains, as it is the case within plasma membrane of control
fibroblasts.
4.1.2 Length of the fatty-acid chain in myelin
One of the common features of lipids within myelin sheath is a presence of the
long fatty acids in their composition, that are often over 20 carbon atoms in their
length, whereas usually the plasma membrane of fibroblasts consists of mostly 16C
– 18C long fatty acids. The artificial lipids, used in this study contained also 16C-
long fatty acids. Therefore we measured diffusion coefficient together with mode of
diffusion for an analog of the endogenous galactosylcerebroside (GalC) that contains
long-chain fatty acids in its structure. We referred to this artificial lipid as 23C-GalC.
Measurement of the long-chain 23C-GalC diffusion coefficient, showed slower dif-
fusion, in contrast to a short-chain GalC. Interesting, in contrast to short-chain GalC,
23C-GalC showed a free diffusion behaviour in PtK2 control cells. This behaviour
was unexpected, since long-chain fatty acids were supposed to increase trapping of
the lipid within the membrane. However, this observation might be biased due to
the poor incorporation rate of the long-chain lipids into the cellular membrane. Ad-
ditionally, 23C-GalC was labelled with another dye (KK114 and not Atto647N) that
might also influence the results. Further experiments are needed to understand the
observed free diffusion of the 23C-GalC lipid.
Therefore, we make a conclusive statement only on basis of data from short-chain
lipids. We suggest an absence of constrained diffusion in oligodendrocyte sheets
for the short-chain lipids. We hypothesise that studied lipids, regardless of their
nature, get homogeneously distributed within oligodendrocyte sheet. Together with
protein extrusion by MBP during development (Aggarwal et al., 2011; Aggarwal
et al., 2013), this kind of lipid distribution creates a unique membrane structure.
Such a uniform membrane organisation is favourable indeed for the processes of
myelin wrapping around axons and fast delivery and spread of the newly synthesised
components during the growth phase. Figure 4.1 summarise main differences between
oligodendrocyte membrane and a control fibroblast plasma membrane.
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Figure 4.1: Differences between oligodendrocytes and PtK2 cell membrane. This picture
summarises and compares the established differences in the lipid organisation between oligodendro-
cytes and plasma membrane of fibroblast cell line used in this study. (A) The common view of the
normal fibroblast plasma membrane organisation is depicted: actin in red, membrane microdomains
in dark blue, different proteins in the various colours and shapes. As one can see, the membrane
is crowded with tremendous amounts of interaction taking place at a given time point, all influ-
encing in a different way the diffusion of the lipids. (B) To compare: the schematic view of the
myelin membrane organisation: MBP (green) zips the two adjacent membrane sheets, extruding
cytoplasm and proteins with long cytoplasmic domains, creating a unique membrane plateau with
a scarce impregnation of the transmembrane proteins (PLP – brown, or MOG – magenta). Such
homogeneous membrane array does not oppose free membrane diffusion of the constituent lipids.
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4.2 Role of phosphatidylinositols in the cellular po-
larity
Cellular polarity of the plasma membrane is a potent and important regulatory
mechanism, involved in many crucial events, from the cellular migration, tissue for-
mation and differentiation during development, to the more minor cases, such as
epithelium function maintenance, blood cell migration, cellular division, etc. The
brief overview of the polarity establishment prerequisites is given in the Section 1.6
of the Introduction. Phosphatidylinositols play an important role during cellular
polarisation. Spatial and functional separation of these lipids is very broad. The
tip of the growing axon is enriched with PIP3 (Shi et al., 2003), as does leading
edge in neurons and migrating cells. In contrary, PIP2 is strictly sequestered to the
trailing region of the migrating cells. In the epithelia, PIP3 is usually restricted to
the basolateral part, while PIP2 is found in the apical part. Local changes in these
phosphoinositides moieties within cellular membrane is acquired via distinct locali-
sation of the two enzymes: phosphoinositide 3-kinase (PI3K) and phosphatase and
tensin homolog (PTEN) phosphatase. PI3K generates phosphatidylinositol-3,4,5-
triphosphate (PIP3) and PTEN removes the 3′-phosphate from PIP3 to generate
phosphatidylinositol-4,5-bisphosphate (PIP2). These two enzymes are mutual antag-
onists (Sasaki et al., 2009) and they follow the respective pattern of the separation
of phosphatidylinositols: PI3K is localised to the basolateral domain and the tip of
the growing axon and PTEN resides in the apical part of the epithelial cells and in
the trailing region of the migratory cells (Shewan et al., 2011).
The most direct study to illustrate the importance of the PIP3 and PIP2 segrega-
tion to a respective polar domain of the cell was performed by Gassama-Diagne and
co-workers (Gassama-Diagne et al., 2006). In this study, they applied an exogenous
PIP3 to the apical surface of the epithelial cells. Strikingly, this alone was able to
force the cell to change the identity of the apical part to the basolateral. This change
was characterised by recruitment of PI3K and other basolateral protein to a former
apical region, concomitant with the exclusion of apical proteins. When cells were
treated with PI3K inhibitors (causing decreased PIP3 levels), they were forced to
diminish in height, due to the shrinkage of the lateral sides.
Interesting studies of the role of distribution of phosphatidylinositols during cel-
lular polarisation were done using MDCK cells. These cells, when grown in three-
dimensional culture, form polarised cysts with a centrally located apical surface and
fluid filled lumen (O’Brien et al., 2002). The work of Martin-Belmonte and co-workers
provided interesting results on how the ability of these cells to form apical domains
might be affected (Martin-Belmonte & Mostov, 2007). PTEN and PIP2 both become
specifically localised to the apical surface of the MDCK cells during early events of
the cyst formation. Upon inhibition of PTEN activity, segregation of phosphatidyl-
inositols becomes awry, leading to the disruption of lumen formation. The further
delivery of the exogenous PIP2 to the basolateral surface of the cysts resulted in the
lumen shrinkage and recruitment of apical membrane proteins, following the change
of the membrane identity from basolateral to apical. Despite the striking findings
from the mentioned studies, it is important to note that PIP3, being a common
second messenger, may reside in a small portion throughout the plasma membrane.
However its function there is distinct from the polarity regulation (Shewan et al.,
103
Discussion
2011; Czech, 2000; Prehoda et al., 2000; Rohatgi et al., 2000).
Oligodendrocytes in the CNS are morphologically polarised into two functional
domains: compact regions that enwrap axons and produce myelin sheath and non-
compact parts that enable connectivity of myelin membrane to the cell body and
are responsible for trafficking of the membrane components and molecular nutrients
delivery to the compact areas parts. Taking into account a role of PIP2 and PIP3 in
majority of the cells, we questioned whether these lipid species are also differentially
localised within oligodendrocytes.
4.2.1 Mature oligodendrocytes show distinct localisation of
the phosphatidylinositols
Mouse oligodendrocytes grown on glass coverslips develop flat membrane exten-
sions that mimic the biochemical and morphological composition of myelin sheath
in vivo (Aggarwal et al., 2011; Aggarwal et al., 2013; Bakhti et al., 2011; Fitzner
et al., 2006). Moreover, it was described that these plasma membrane extensions are
polarised into distinct membrane domains, resembling compact and non-compact
myelin. These domains develop without a need to wrap around the axon, illustrat-
ing sufficient intrinsic cellular mechanisms within the oligodendrocytes. Possibility
to cultivate primary oligodendrocytes in the absence of axon enables the localisation
of molecules with the light microscopy.
First, we determined localisation of PIP2 and PIP3 within the membrane of the
oligodendrocytes. Using several immunolabelling-based approaches, we managed to
demonstrate the following: PIP2 is enriched in the oligodendrocyte sheet (compact
region) and PIP3 is restricted in the processes and outer rim (non-compact region)
(Figure 3.11).
It was previously demonstrated by independent studies that MBP has an ability
to sequester PIP2 (Musse et al., 2008; Harauz et al., 2000). Furthermore, it was
suggested that PIP2 and MBP interaction are important to stabilise MBP association
with the membrane (Nawaz et al., 2009). In our study we demonstrated that MBP
interacts with PIP2 in the oligodendrocyte sheets, masking it from the antibody
recognition: PIP2 presence in the sheets could be visualised only upon detaching of
MBP from the cytosolic part of the plasmalemma. However, MBP detachment from
the membrane has no influence on the PIP3 detection. Based on these observations,
we concluded that MBP sequesters PIP2, but not PIP3 in the oligodendrocyte sheets.
4.2.2 Early-stage oligodendrocytes, and those from shiverer
mice, lack differential localisation of the phosphatidyl-
inositols
Next, we addressed the question when does the differential localisation of phos-
phatidylinositols take place. Immunolabelling analysis of the early-stage oligoden-
drocytes showed an absence of the strict separation of phosphatidylinositols when
MBP was yet absent and sheets were non-compacted. Nevertheless, PIP3, but not
PIP2, showed a slight enrichment towards the outer parts of the cell, already on the
early stage.
As was concluded in the Part I of this work, lipids diffuse free within the oligo-
dendrocyte sheet. Therefore, if PIP3 diffusion becomes restricted, there should be
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a mechanism to exhibit this confinement. Since PIP3 interacts with a broad range
of the PH-containing proteins, these interactions might restrict the free diffusion of
PIP3 from the outer rim.
One also might suggest that MBP is a force that separates PIP2 and PIP3 into
distinct pools within the membrane on the later stages. We studied the localisation
of phosphatidylinositols in the shiverer mice, where no MBP is present even at
the mature stages. We found that in shiverer mouse oligodendrocytes, PIP2 and
PIP3 have the same localisation, as in the early stage oligodendrocytes: absence of
the strict phosphatidylinositols separation with slight enrichment of PIP3 towards
the outer parts of the cell (Figure 3.16). Therefore, MBP is necessary to separate
phosphatidylinositols.
4.2.3 MBP as a phosphatidylinositols’-separating protein
From the data of the liposomal pull-down, there are no preferences in binding of
MBP towards any of phosphatidylinositols tested. It might suggest, therefore, that
binding and masking of PIP2 by MBP takes place primarily due to the initial spatial
separation of phosphatidylinositols: PIP3 enrichment in the growth zone region, and
PIP2 residing in the sheets. This spatial separation occurs on the early stage of the
cellular development, before MBP appears in the sheets. Subsequently, when MBP
starts to zip the sheets, it interacts with PIP2 that leads to PIP2 sequestration in
the sheet region.
PIP2 is one of the most abundant phosphatidylinositol species present in the
inner leaflet (up to 2%) where it is involved into ample amount of cellular processes
(Czech, 2000; McLaughlin et al., 2002). In contrary, amount of PIP3 in the resting
cell is scarce, and even upon activating signals it does not rise more than 1% of the
total lipid amounts (Stephens et al., 1993). Despite its little amount, PIP3 is one of
the major signalling molecules within a plasmalemma, a potent growth and survival
signal (Bohdanowicz & Grinstein, 2013).
One of the pathways under PIP3 tight regulation is the PI3K/Akt/mTOR path-
way, involved in cell growth, proliferation and survival. PH-domain of the Akt binds
the membrane PIP3 and enables the proper positioning of Akt on the membrane
for its further phosphorylation and cascade onset. In contrary, dephosphorylation
of PIP3 by PTEN has an inhibitory effect on this pathway (Wood et al., 2013).
PI3K/Akt/mTOR pathway involvement in the differentiation of oligodendrocytes
and myelination onset has been already described in several studies (Narayanan
et al., 2009; Tyler et al., 2011; Guardiola-Diaz et al., 2012).
The most outer rim of the oligodendrocytes, where the PIP3 enrichment was
shown, was suggested to play a role of a growth zone, where all the necessary growth
pathway constituents are gathered. We suggest that early in the development accu-
mulation of PIP3 occurs in this outer most rim, followed by its recognition by Akt.
After binding to a specific region of the plasma membrane, Akt gets phosphorylated
and its activated form triggers the growth pathway (Wood et al., 2013).
In contrary, PIP2 is spread over the whole plasmalemma (McLaughlin et al.,
2002). However, due to the natural diffusion, both phosphatidylinositols species
intermix, even though the enrichment of PIP3 in the rim and elimination of PIP3 in
the sheets might be under surveillance of PI3 kinase and PTEN, respectively.
Differentiation and growth of the oligodendrocytes in culture starts immediately
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after their attachment to the poly-L-Lysine (PLL)-coated coverslips (several hours
after shake of the cells from the tissue flasks). MBP translation and compaction of
the sheet follows with a 2 – 3 days delay and is mostly completed on the day 5.
Growth on the rim side and compaction, thus, both occur at a certain time window
simultaneously. Feature of the MBP translation is the transport of its mRNA via
hnRNP granules to the sites of its expression. Upon release from the ribosomes
in the processes, MBP gets attracted to the negatively charged membrane where
it recognises PIP2 (and most likely phosphatidylserine). Upon reaching the crucial
concentration and due to its intrinsic properties, MBP molecules undergo a phase
transition into a tight network (Aggarwal et al., 2013). Proceeding in this step-wise
way (interaction with PIP2, followed by a phase transition into a sieve-like struc-
ture), MBP zips two adjacent membranes together, extruding most of the proteins
and rearranging lipids and forming a unique compact sheet (Aggarwal et al., 2011;
Aggarwal et al., 2013; Yurlova et al., 2011).
The suggested cascade of the events occurring from the early phase of the non-
compact oligodendrocytes to a full sheet closure in a mature state is summarised in
the Figure 4.2.
Data acquired from the shiverer oligodendrocytes, where phosphatidylinositols
separation does not occur due to the lack of the MBP and, subsequently, absence of
the compact zone formation, support this model. Therefore, shiverer oligodendro-
cytes reside in the state, shown on the Figure 4.2 A.
The growing part of the cell is in a constant need of the molecular transport
and protein synthetic machinery. Membrane sheets are, however, deprived of it
(Aggarwal et al., 2011; Aggarwal et al., 2013). Therefore, there should be a signalling
pathway involved to keep the growth zone of the cell non-compact. We suspect
PIP3 enrichment within the growth zone might play a role in this. To test this
assumption, we decided to intervene with phosphatidylinositols levels by increasing
amounts of one of the phosphatidylinositol species, namely PIP3.
4.2.4 Compact/non-compact domain ratio can be altered upon
augmentation of PIP3 in the oligodendrocytes
Proper functioning of the cell highly depends on the phosphatidylinositols home-
ostasis: PTEN inhibition leads to the increased PIP3 accumulation, hyperactivation
of Akt-pathway. As a result, such a malfunction of the growth regulation leads to
cancer (Sasaki et al., 2009; Chalhoub & Baker, 2009). We decided to shift phos-
phatidylinositols’ equilibrium to follow possible changes in the cellular morphology
and MBP compaction behaviour. To achieve the shift, we used two independent
approaches.
Approach 1: PIP3 increase due to PTEN inhibition. Vanadium tryhidarte
compound (VO-Ohpic, further referred to as VOOH) was reported to be potent
and highly selective inhibitor of PTEN (Rosivatz et al., 2006; Nakai et al., 2004).
Therefore, we used it to increase PIP3 amount in the oligodendrocytes. We confirmed
a success of the PTEN inhibition by an increase in the PIP3 and phosphorylated Akt
(activated form of the Akt) signals via immunostaining (Figure 3.18 and Figure 3.21).
Normally, during maturation, non-compact domain zone decreases proportionally
106
4.2 Role of phosphatidylinositols in the cellular polarity
Figure 4.2: Model of phosphatidylinositols unmixing by MBP. (A) PIP3 (magenta) is
more enriched within so called growth zone at the rim, where it most likely takes part in the
mTOR signalling pathway, enabling sheet to grow further. Due to the unrestricted lipid diffusion
in the sheets with no MBP at the early stages of development, PIP3 diffusion occurs and PIP3 could
be identified within the sheet regions as well. PIP2 (lime), as a general component of the cellular
membrane, is more uniformly distributed over the cell. Sheets are filled with CNP (dark blue) and
other proteins (not shown on a sketch) at this stage. (B) MBP translation begins, followed by MBP
interaction with the negatively-charged lipids of the inner membrane leaflet; next, two inner leaflets
are brought together and zipped. (C) An extrusion of CNP and other lipids from the sheets follows.
Upon binding of MBP to the PIP2 in the sheet region, the masking of the latter from antibody
recognition occurs. The PIP3 residues might also take part in the MBP-membrane binding, even
though they are scarce in these regions. Newly generated PIP3 molecules are now restricted to the
place of their synthesis (rim and process).
to the increase of the MBP-positive zone. Mature cells on the day 5 have a small
portion of the processes and a thin outer rim with small growth zone. On even later
stages, non-compact zone resides only within the tiny processes that close completely
when cells are cultivated longer than 7 – 8 days in culture (Aggarwal et al., 2011).
Upon PTEN inhibition with VOOH we observed enlarged rim and non-compact
areas in the mature cells (Figure 3.22). Moreover, inhibition of PTEN at the early
stages of development led to a decrease of the compact zone. This effect was
concentration-dependent (Figure 3.22). Albeit, after removal of the PTEN inhi-
bition (via washing and adding a fresh medium) cells could restore a normal profile
of the compact/non-compact domain (Figure 3.20 C).
Furthermore, application of the PTEN inhibitor immediately after cell seeding
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on the coverslips could force the cells to expand non-compact sheets faster, in com-
parison to the untreated cells (Figure 3.19).
Approach 2: PIP3 increase due to the exogenous PIP3 delivery. Any appli-
cation of the inhibitor is a stress for the cell, since it could affect some of the survival
pathways. In addition, every cell type reacts slightly differently to the treatment.
Therefore, we decided to deliver exogenous PIP3 via a shuttle system as another
method to increase PIP3 levels. Cells were subjected to the BODIPY-FL-labelled
PIP3 delivery at their active growth stage (day 3) and fixed at the mature stage
(day 5). In this particular experimental setup delivery was carried out for 48 hours,
to reproduce time window for the PTEN-inhibition (also 48 hrs). We did not ob-
serve any cellular phenotype using this method. One reason for this might be a low
concentration used to achieve a response from the oligodendrocytes. Another rea-
son could be a fast dephosphorylation of the exogenous BODIPY-FL-PIP3, as was
previously observed by Tian and co-workers (Tian et al., 2003). Hence, one might
consider repetition of the delivery and establishing a precise window for the oligoden-
drocyte cellular response, as well as a proper concentration of the BODIPY-FL-PIP3.
4.2.5 Increased levels of PIP3 and actin might regulate the
size of the non-compact domains
A link between increased PIP3 level and enlarged non-compact domains was dis-
cussed in the previous sections. We suggest that PIP3 might have a signalling role
for the MBP to prevent the compaction. Since electrostatic interactions between
PIP3 and MBP occur in vitro (as shown by the liposomal pull-down experiment
(Figure 3.23), there might be a physical obstacle that prevents interaction between
MBP and PIP3 in the plasma membrane in vivo, resulting in the termination of
compaction at the rim. One of the suggested candidate to serve as such an obstacle
is a filamentous actin.
Increase in the actin amount in the regions, enriched with PIP3 might be expected,
due to the tight regulation between PIP3 amount and cytoskeleton rearrangements
discussed in the Introduction Section 1.3.2 of this work. We also could detect an
increase of the filamentous actin amounts at the mature stage of oligodendrocytes ’
development upon VOOH treatment (Figure 3.24 and 3.25). This is an interesting
finding, since filamentous actin depolymerisation was described to be a prerequisite
for the MBP compaction to take place.
Therefore, we suggest a filamentous actin to be candidate to regulate the ratio
between compact and non-compact zones. At physiological conditions, actin might
perturb the interactions of MBP with membrane and thus leave the growth zone
non-compact. When actin levels expand, as when triggered by high levels of PIP3,
MBP molecules encounter a physical obstacle and, failing to compact the sheet, most
likely undergo premature degradation. This leads to the increase of the non-compact
domain. For the summary of the cascade of suggested events after PIP3 levels increase
in the oligodendrocytes see Figure 4.3.
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Figure 4.3: Model of the PTEN inhibition effect on the compact/non-compact domain
development. (A) Representative sketch of the non-compact myelin domain. CNP (blue barrels)
is filling the space. Actin cytoskeleton (red lines) is enriched under the membrane. PIP2 (lime)
and PIP3 (magenta) are mixed within the inner leaflet. (B) Following the MBP translation, com-
paction takes place. This results in extrusion of all the non-compact domain proteins (Aggarwal
et al., 2011) and, as has been demonstrated in this work, segregates phosphatidylinositols. (C)
PTEN inhibition leads to an increased cytoplasmic volume, due to the growth cascade activation;
furthermore, augmented amounts of filamentous actin accumulated beneath the plasma membrane.
These facts create sufficient obstacle for the MBP to establish an electrostatic interaction with the
phosphatidylinositols of the inner leaflet. As a follow up, MBP gets degraded and decrease in the
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The work presented in this thesis characterised lipid dynamics and distribution
of the PIP2 and PIP3 within myelin membrane sheet. To overcome the extreme
compaction and thickness of the myelin layers in vivo, we addressed our questions
using primary cultures of myelin-producing cells in CNS – oligodendrocytes (Aggar-
wal et al., 2011; Aggarwal et al., 2013; Yurlova et al., 2011; Bakhti et al., 2011;
Fitzner et al., 2006). Since this system has been proven to successfully recapitulate
myelin-sheath in vivo, we suggest that acquired data could be mirrored to the in vivo
situation.
To determine the dynamical properties of the lipids (diffusion coefficient and mode
of diffusion) within the oligodendrocyte sheet we used STED-FCS. The fibroblast cell
line, PtK2 cells, was used as a control. Following artificial lipids were used in this
work, as analogs of the endogenous membrane lipids:
• N -(Atto647N)-1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine as an ana-
log of phosphatidylethanolamine (referred to as PE);
• N -(Atto647N)-sphingomyelin as an analog of sphingomyelin (referred to as
SM);
• N -(Atto647N)-galactosylsphingosine as an analog of galactosylcerebroside (re-
ferred to as GalC).
These lipids were introduced into the membrane via BSA-coupled method. We
found that the values for PE diffusion are similar between oligodendrocytes and PtK2
cells; however, SM and GalC diffusion coefficients were strikingly different: slow in
PtK2 and fast in oligodendrocyte sheets. Furthermore we demonstrated an absence
of anomalous diffusion in the plasma membrane of primary oligodendrocytes for PE
and SM. In the control PtK2 cells, only PE was undergoing free diffusion, whereas
SM and GalC showed strong trapping. Trapping of GalC was reduced in oligoden-
drocyte sheets, comparing to PtK2 control cells.
To further investigate an involvement of MBP in the lipid behaviour, we mimicked
oligodendrocyte sheets in the PtK2 cells. In brief, PtK2 cells were transfected with
a chimeric construct, consisting of MBP, GFP, transmembrane domain and an en-
doplasmatic reticulum (ER)-retention signal. Cells, transfected with this construct,
were referred to as PtK2-MBP+ cells. Upon introducing the sheets-like structures
in the fibroblasts, diffusion of SM and GalC changed dramatically: these lipids lost
their trapping, and their diffusion coefficient strongly increased. Diffusion coefficient
for PE also increased in the PtK2-MBP+ cells.
We concluded, hence, that MBP, due to its intrinsic characteristics, via extrusion
of the cytoplasmic proteins during compaction might create a plausible homogenous
environment that favours free lipid diffusion within the oligodendrocyte sheet. Such
flexible constitution of this membrane might be indeed beneficial for the wrapping
of myelin around the axon and for the delivery of the newly synthesised components
to the fast growing membrane.
To investigate a distribution of the PIP2 and PIP3 within myelin membrane sheet,
we again used primary oligodendrocyte cell culture. We determined a distinct local-
isation of the two phosphatidylinositols species: PIP2 enrichment in the sheet region
and PIP3 localisation within the outer rim and processes. We demonstrated that dif-
ferent localisation of phosphatidylinositols starts at the early developmental stage,
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with PIP3 being slightly enriched in the outer cellular regions, and PIP2 broadly
distributed over the cellular membrane. Upon MBP expression, PIP2, but not PIP3,
got sequestered and masked by MBP within sheets regions, whereas PIP3 remained
strongly enriched in non-compact region. Furthermore, when the level of PIP3 was
increased due to the inhibition of PTEN, a dramatic morphological change was ob-
served: an increase in the non-compact region of the oligodendrocytes. Amount of
the filamentous actin was also increased in these cells at the mature stage.
We speculate, therefore, that spatial segregation of phosphatidylinositols at the
early developmental stages, might have a signalling purpose: PIP2 within the sheets
serves as a membrane docking point for the MBP upon its translation; whereas
PIP3 enriched zones highlight the regions where MBP should not zip. We suspect
filamentous actin to be a downstream-effector molecule of the PIP3 signalling, that
would hinder the MBP-membrane interaction and in this way prevent compaction.
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